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ABSTRACT OF THE DISSERTATION 
The Natural Variants of the Streptococcus NAD+-glycohydrolase SPN Modulate Divergent Host 
Cell Signaling Pathways and Death 
by 
Sukantha Chandrasekaran 
Doctor of Philosophy in Molecular Microbiology and Microbial Pathogenesis 
Washington University in St. Louis, 2013 
Professor Michael G. Caparon, Chairperson 
 
Streptococcus pyogenes has an arsenal of virulence factors that promote its ability to 
cause a broad range of diseases and fight host defenses. One of these factors is the S. pyogenes 
NAD+-glycohydrolase (SPN), which is secreted from the bacterial cell and translocated into the 
host cell cytosol where it contributes to cell death. Every strain examined to date has SPN and 
recent studies suggest that SPN is continuing to evolve diverging into two variants that correlate 
with tissue tropism, one of which lacks the signature NADase activity.  SPN’s roles in both 
cytotoxicity and niche selection are unknown. To gain insight into the forces driving the 
adaptation of SPN, a detailed comparison of representative glycohydrolase activity-proficient 
and -deficient variants was conducted.  
Out of a total 454 amino acids, the glycohydrolase activity-deficient variants differed at 
only 9 highly conserved positions. A mutational approach to exchange these residues between 
variants revealed that reciprocal changes at 3 specific residues were required to both abolish 
activity of the proficient version and restore full activity to the deficient variant. Remarkably, all 
versions of SPN were equally cytotoxic to cultured epithelial cells. However, differences in 
 ix 
glycohydrolase activity had a significant influence in cell signaling resulting in cellular necrosis 
and the subsequent inflammatory response. 
Necrosis requires SLO, which activates JNK and PARP. However, in combination with 
the NADase active SPN cells underwent a glycolytic cell death through the depletion of NAD+ 
and ATP. As a consequence of active SPN, these cells were unable to accumulate PAR despite 
PARP activation. These effects were associated with the release of HMGB-1 from the nucleus 
and low levels of Il-8 and TNF alpha production. In contrast, the NADase inactive SPN 
accumulated PAR and underwent a JNK mediated cell death. These events likely contribute to 
the increased Il-8 and TNF alpha production seen in these infections however HMGB-1 is not 
released as in the NADase inactive infections.  
Taken together, these data indicate that the glycohydrolase activity of SPN is not the only 
contribution the toxin has to the pathogenesis of S. pyogenes and that both versions of SPN play 
an important role during infection. 
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Classification 	  
The Streptococcus genus is a gram-positive lactic acid group of bacteria classified in the phylum 
Firmicutes. The genus has been divided into Lancefield groups which are based on the their 
serologic typing of the cell wall group A carbohydrate (41). Streptococci are non-motile, chain 
forming, spherical shaped facultative anaerobes. They are further categorized by their ability to 
lyse red blood cells and fall into one of three classes - alpha, beta or gamma. Alpha hemolytic 
Streptococcus species appear greenish on blood agar plates. Beta-hemolytic species show 
complete clearance due to the presence of Streptolysin S and O, while gamma hemolytic species 
lack the ability to lyse red blood cells. Streptococcus pyogenes, a Lancefield Group A species, is 
categorized as beta-hemolytic (13).  
Group A Streptococcus or S. pyogenes is also differentiated within its species into classes 
based on the major virulence factor M protein adhesion, which is found on the surface of the 
bacterium. The N-terminus of this protein is hyper variable and over 200 emm gene types have 
been found (6) (78).  Since the advent of serological typing of M protein, another method has 
been employed, termed emm pattern.  This pattern is based on a highly correlated nucleotide 
sequence that involves the 5’ end region of the emm gene that encodes the M protein as well as 
up three other genes which are encoded in the cell wall spanning domain (33, 34). Upon analysis 
of S. pyogenes strains, three main emm pattern groups have emerged and these are known as A-
C, D, and E (8). It is also important to note the emm types are restricted to a single pattern 
meaning that no strain can fall into two different pattern groups. These groups have a strong 
correlation for tissue tropism. The emm patterns A-C have a strong propensity to cause throat 
infections while emm pattern D strains tend to cause impetigo (9). These strains are considered 
to be specialists due to their propensity to cause infections at a single site, the pharynx or the 
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skin, while emm pattern E strains are considered to be generalists since they cause infections at 
both the pharynx and the skin.  A recent study of over a 1000 isolates found emm patterns D and 
E to be the most prevalent with only 20% of the strains emm pattern A-C.  (50). Figure 1 depicts 
the difference between these emm patterns on the genotypic level. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Map of the emm patterns found in S. pyogenes strains. Represented are the most 
common gene combinations that consist of the emm and FCT region within different emm pattern 
grouping. Genes shown in blue are found in emm patterns A-C, D (84) and E (purple). Adapted 
from Ref (9). 
 
Diseases and Prevalence and Burden 
Streptococcus pyogenes is a significant human pathogen due to its versatility. It can cause 
more types of disease than any other bacterium and infects many different sites within the human 
host (Figure 2). This large spectrum of infections ranges from superficial infections, like 
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impetigo and pharyngitis, to systemic infections like toxic-shock-like syndrome, as well as the 
severe and invasive necrotizing fasciitis. Suppurative infections of the soft tissue including skin, 
tonsils and soft membranes can lead to more invasive infections, though these are less common. 
The most common infections are pharyngitis and pyoderma and occur most often in children (77) 
(25). Other infections include streptococcal toxic shock syndrome (STSS), cellulitis, bacteremia, 
pneumonia, and puerperal sepsis. Typically, these infections are treated with β-lactam antibiotics 
such as penicillin and cephalosporins 
 
 
 
 
 
 
  
Figure 2: Pathogenesis of Streptococcus pyogenes infections. S. pyogenes can infect      
numerous sites within the host as depicted in the diagram. Adapted from (61) 
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In addition to these infections, post-infection sequelae can manifest and are due to 
autoimmune reactions by cross-reactive antibodies. These sequelae include rheumatic fever and 
post-streptococcal glomerulonephritis (23). Rheumatic fever can manifest 1 to 5 weeks after the 
initial pharyngeal infection and occurs due to an autoimmune reaction by T cells to streptococcal 
components and host tissue. This can lead to endocarditis, arthritis, subcutaneous nodules and 
erythema marginatum (79). Post-streptococcal glomerulonephritis occurs 1 to 4 weeks after the 
initial streptococcal infection and is characterized by edema, hypertension, and hematuria. It is 
also based on cross-reactive antibodies to both streptococcal and host antigens.  S. pyogenes is 
capable of both stimulating a strong immune response and in converse causing non-inflammatory 
infections. In many cases, these bacteria can be carried asymptomatically. These features make 
S. pyogenes an intriguing and formidable human pathogen.  
The global burden of S. pyogenes is significant and has a major role in mortality and 
morbidity.  It is thought to cause over 700 million cases of superficial infections and over 18 
million cases of severe infections each year ultimately causing over 500,000 deaths (15). Within 
the U.S., approximately 10,000 invasive cases of S. pyogenes are reported with a 10% mortality 
rate (18). Necrotizing fasciitis accounts for 6-7% of these cases. Although invasive cases are 
relatively rare, once the infection has progressed mortality rates can reach up to 25%. In recent 
years there has been a dramatic increase in the number of severe invasive S. pyogenes infections 
(57). There is also a significant economic burden in the U.S. costing between 224 million and 
539 million US dollars for pharyngitis in children alone (63).  
 Though post-infection sequelae are not as common in developed countries, these are 
prevalent in developing countries.  It is estimated that over 2 million children are affected with 
rheumatic heart disease with a total of 15 to 19 million people alive with rheumatic heart disease 
 6 
(15).  Around 80% of all rheumatic heart disease cases come from less developed countries. The 
same is true for glomerulonephritis. Around 400,000 cases occur per year with around 95% of 
these cases occurring in less developed countries (15). A more recently discovered sequela of S. 
pyogenes is the Pediatric Autoimmune Neuropsychiatric Disorders associated with streptococci 
or PANDAS. Although controversial, a link has been discovered between the streptococcal 
infection and obsessive-compulsive behavior that can be resolved with treatment with penicillin 
(45, 88). 
In addition to causing active infections S. pyogenes can also be carried asymptomatically 
and has been reported to be found in the throats of 15% of school-aged children. Other studies 
have shown that S. pyogenes can be found in the tonsils of asympotomatic carriers (60) (81).  In 
addition to the nasopharynx, the vagina has been a site for asymptomatic carriage and the source 
of S. pyogenes outbreaks (7).  Though vaginal carriage is typically low at 0.03%, the presence of 
Streptococcus in the vagina is increased after or during an episode of pharyngitis (4, 51).  
Occasionally, these carriers can give rise to outbreaks (76). Recently, the global transcriptional 
factor catabolite control protein A, CcpA was found to play an important role in asymptomatic 
murine vaginal colonization. CcpA has a major role in the regulation of virulence factor 
expression in response to the environment, thus implicating a function for virulence factors in 
carriage (87). Asymptomatic carriage allows for easier dissemination of the pathogen and can 
contribute to an eventual infection (49).  It is thought that the failure to eradicate S. pyogenes 
after antibiotic treatment occurs in 5-30% of pharyngitis and this failure may contribute to 
asympotomatic carriage or recurrent infections (48, 64, 73).  S. pyogenes is strictly a human 
pathogen, thus carriage becomes an important means for dissemination.  
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Thus far, S. pyogenes has not developed resistance to the β-lactam class of antibiotics 
although there are cases of macrolide resistance (26).	  	  Some models suggest S. pyogenes ability 
to maintain reservoirs despite antibiotic treatment is based on their ability to invade host 
epithelial cells.  Electron microscopy and immunohistochemistry of pharyngeal epithelial cells 
from patients with tonsillitis demonstrated the presence of intracellular S. pyogenes (60).  Other 
studies indicate that a specific transcriptional profile is necessary for survival within 
macrophages (31). While there are several studies suggesting S. pyogenes can be found 
intracellularly, it does not seem to be its primary or preferred environment since the majority of 
the bacteria are found extracellularly. 
 
Adhesion 
One of the most important interactions between S. pyogenes and the human cell is 
adherence. This initial interaction is the determining factor for successful colonization as the 
bacteria has to overcome several barriers such as the mucosal layer. For S. pyogenes, there are 
several factors that contribute to adhesion including M protein, F protein, lipoteichoic acid 
(LTA), hyaluronic acid and several others (10, 14, 59) .  Attachment to different cells is likely 
dependent on different sets of adhesions.  Of these is M protein and can be grouped into different 
emm patterns (Figure 3).  Specifically, M protein has been found to be important in keratinocyte 
adherence and binds to CD46 on the host cell membrane (58). This protein has a conserved 
carboxyl terminus consisting of C repeats and an amino terminus that is highly variable (Figure 
3).  Deleting C1 and C2 repeats of the M protein reduces adherence to keratinocytes (62). 
Additionally, the heterologous expression of M protein in Lactococcus lactis conferred 
adherence on A549 cells expressing CD46 (68). M protein has a multifactorial role due to its 
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ability to interact with multiple proteins on the host cell for adherence as well as to confer 
phagocytic resistance.   
 
Figure 3. The structure of various M proteins grouped by emm pattern.  The proline-glycine 
rich C terminus is covalently linked to the peptidoglycan. A, B, C, D represents blocks of amino 
acid repeats found in each M type. The C block is generally conserved while A and B blocks are 
variable between serotypes and linked to the N-terminal hypervariable region. Above are 
representative M proteins from each emm pattern group. Adapted from (74). 
 
 Another group of proteins made by S. pyogenes termed fibronectin binding proteins 
FnBPs bind to fibronectin, a large glycoprotein found in the extracellular matrix of human cells, 
to adhere to cells. Fibronectin interacts with membrane receptor proteins called integrins, which 
are important in cell-to-cell adhesion, growth and migration. S. pyogenes makes a diverse 
number of FnBPs and although not all isolates make this protein, it may contribute to tissue 
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tropism (19). Currently, 11 FnBPs have been discovered, most of which are bound to the 
bacterial wall via an LPXTG motif (90). Protein F, the first FnBP identified, has been shown to 
bind free fibronectin which subsequently inhibits the protein’s ability to bind to cellular 
fibronectin (1). Deletion of this Protein F also completely abrogates the ability of S. pyogenes to 
bind to epithelial cells even in the presence of M protein (30). This protein may act like a 
receptor for S. pyogenes in a two-step mechanism that depends on LTA as the initiating 
molecule. After this initial interaction between LTA and fibronectin, a second adhesin like 
protein F or M strengthens the bond to the host (19) (72) . In addition to adherence, the 
interaction between FnBPs and fibronectin can stimulate signal transduction pathways in the host 
cell as well as help S. pyogenes evade the innate immune system (90). 
  Without adherence, S. pyogenes would not be able to cause an infection as it would 
likely slough off with the epithelium or mucosa. Adherence of the bacterium also allows for the 
onslaught of virulence factors S. pyogenes produces that affect so many processes within the host 
cell. 
 
Virulence Factors  	  
 S. pyogenes is a versatile pathogen due to the impressive number of virulence factors it 
produces during the course of an infection (Figure 4) (22). These factors are often dependent on 
environment and the growth phase of the bacteria.  One of these is the hyaluronic acid capsule, 
which adheres to cells expressing CD44 (5). In addition to contributing to adherence along with 
M protein, it is also required for resisting phagocytosis (89).   The capsule consists of a high 
molecular mass polymer that is nearly identical to polysaccharides in the human host, thus 
facilitating host evasion (21) (22) . Isolates of S. pyogenes can differ in the amount of capsule 
 10 
made and knockout of the has operon responsible for the production of the capsules can reduce 
virulence the strain in certain types of infections (3).   
 Another mechanism for S. pyogenes to subvert the immune system is the production of 
several superantigens known as streptococcal pyrogenic exotoxin. These proteins enhance toxic 
shock by targeting T-cell receptors and MHC II molecules to cause these cells to proliferate and 
mount an excessive inflammatory response. The resulting cytokines can lead to multi-organ 
failure. Some evidence suggests these superantigens also play a role in contributing to 
autoimmune responses resulting in post-infection sequelae (86). Conversely, S. pyogenes also 
produces several proteins to subvert the immune system, such as C5a peptidase. This serine 
protease is anchored to the bacterial cell wall and can cleave the human complement protein C5a 
to prevent recruitment of immune cells. This is another barrier to the complement system and 
phagocytosis in conjunction with M protein (37).  
 One of the most abundantly made virulence factors is a broad-spectrum cysteine protease 
called streptococcal pyrogenic exotoxin or SpeB. During stationary phase, this protein is secreted 
through the sec machinery as a 40 kDa zymogen that is proteolytically cleaved to its active form 
at 28 kDa. Nutrient availability and environmental cues also contribute to activating the 
expression of SpeB (44). Although the speB gene is highly conserved and found in the majority 
of strains (91), it is not always expressed from these strains due to various factors.  SpeB has 
multiple roles including cleaving both host and bacterial proteins. In terms of the host, SpeB 
cleaves or degrades several host immune factors including immunoglobulins, complement 
protein C3b, chemokines, fibrinogen, and integrins (56) (39). SpeB not only helps evade the host 
immune system by degrading these proteins but it also contributes to inflammation by cleaving 
pro-interleukin Il-β into its active form (38). On the bacterial side, SpeB hydrolyzes adhesins 
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including M protein and protein F contributing to the release of the bacteria from the host cell 
membrane. In addition, SpeB cleaves other proteins secreted by the bacteria including virulence 
factors streptokinase, DNase SdaI, and Streptolysin O. This may contribute to both immune 
evasion as well as altering the function of these proteins during an infection (56).  SpeB is a 
model for transcriptional regulation of a virulence factor as it is controlled by several different 
mechanisms that factor into how the protein contributes to virulence.  
 Streptolysin O and Streptolysin S (SLS) are two hemolysins that are capable of lysing 
cells, however they play distinct roles in pathogenesis. SLS is a small peptide typically bound to 
the bacterial cell presumably through an interaction with LTA (83). This non-immunogenic 
peptide is modified extensively post-translation before secretion (55). The toxicity of this oxygen 
stable protein is based on contact between the bacterial cell and host. SLS also affects the host’s 
ability to recruit neutrophils, possibly by affecting chemoattractants. In the zebrafish model, an 
SLS mutant was less virulent than the wild-type strain and exhibited an increase in neutrophil 
recruitment (43). Although capable of hemolysis, SLO is considerably different. This oxygen 
labile protein is a large cholesterol dependent cytolysin that is secreted from the sec machinery 
and required for the delivery of another virulence factor, SPN. 
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Figure 4.  Virulence Factors produced Streptococcus pyogenes.  Over 40 proteins are 
produced by the bacterium and contribute to the versatility of this pathogen.  Several proteins are 
necessary for adhesion and colonization while others are necessary for host damage and immune 
evasion.  Adapted from (54). 
 
Cholesterol-Dependent Cytolysins 
 
This large family of proteins is produced by many Gram-positive species including Listeria, 
Arcanobacterium, Gardnerella, and Bacillus. Since the discovery of pneumolysin, the CDC 
belonging to Streptococcus pneumoniae, over 25 more CDCs have been reported. These secreted 
proteins have 40-70% amino acid sequence similarity (35). These CDCs form large beta-barrel 
pore complexes that consist of 35-50 soluble monomers assembled on the host cell membrane to 
form pores between 25 to 30 nm in diameter. Cholesterol functions as a receptor for many of 
these proteins however other cellular structures function as the primary receptor as in the case of 
Intermedilysin, lectinolysin, and vaginolysin which bind CD59. Though in these cases, binding 
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may still require the presence of cholesterol.  Structurally, CDCs can be divided into four 
discontinuous domains based on the solved structure of Clostridium perfringens perfringolysin O 
(Figure 5) (63)(70).  The mechanism of CDC pore formation is based on the extensive studies 
performed on this structure.  Secreted monomers bind the host cell membrane and form 
oligomers before inserting into the membrane.  The initial interaction is between the CDC and 
cholesterol is based on a conserved amino acid motif called the undecapeptide 
(ECTGLAWEWWR) found in domain 4 as well as the loops that anchor the monomer to the 
membrane (67). Monomers interact through this tip perpendicular to the membrane. The 
interaction with the membrane then leads to several conformational changes with several 
monomers to form the pre-pore complex that forms a ring without the insertion of the beta-barrel 
pore. Domain 3, positioned above the bilayer, unravels two alpha helices creating two 
transmembrane beta- hairpins (β1- β4). Specifically, the β1 strand of one monomer interacts with 
the β4 of the adjacent monomer. The prepore complex then inserts the amphipathic beta-hairpins 
into the membrane to finally form the pore (Figure 5).    
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Figure 5. Structure of PFO and CDC pore formation. The structure of PFO is divided into 4 
domains (35).   Once Domain 4 has anchored into the membrane domain 3 then undergoes a 
conformational change to insert beta-hairpins into the membrane. Domains 1 and 2 collapse to 
allow domain 3 to insert β-hairpins into the membrane to form the pore   Adapted from (32). 
 
  Although these CDCs share a large degree of similarity, their differences contribute 
variable interactions with the membrane and ultimately function. For example, ILY, a CDC that 
binds to CD59 only lyses human cells due to its unique domain 4 sequence (66).  SLO is a 
unique CDC as it also possesses an 66 residue N-terminal extension (40)(52). This unique 
extension also contains a cleavage site for SpeB which leads liberates 47 amino acids from SLO 
(65).  Each form of SLO is made abundantly and retains hemolytic activity. Although SLO binds 
cholesterol, its receptor is still unknown. SLO forms pores large enough to allow for passive 
diffusion of foreign proteins (85). Interestingly at sub-lethal concentrations of SLO, pores can be 
healed by the cell through the release of the damaged membranes in a calcium dependent manner 
(36, 85). Although this group of proteins is well characterized for their ability to form pores, 
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recent studies show there are alternative functions independent of pore formation. In the case of 
SLO, it also functions to translocate the NAD+- glycohydrolase SPN into the host cell cytosol. 
This process has been shown to be pore independent indicating a multifunctional role for SLO 
(47).  
 
Cytolysin Mediated Translocation 	  
 This injection-like mechanism is the first of its kind to be described in a Gram-positive 
bacterium. This process is much like the Type III secretion system (T3SS) found in many Gram-
negative bacteria. The T3SS Gram-negative species largely contributes to virulence and effectors 
from this pathway often modify different processes within the host (29, 50, 78). This system is 
specialized in that it forms a needle-like complex that functions to secrete proteins through two 
bacterial membranes as well as the host cytoplasmic membrane  (Figure 6)(18).  Gram-positive 
bacteria lack this outer membrane and typically secrete proteins into the extracellular milieu. S. 
pyogenes specifically only possesses the Sec system of secretion thus all secreted proteins utilize 
this machinery.  In S. pyogenes, once released from the secretion machinery, SLO interacts with 
SPN at the host cell membrane to translocate SPN into the host cell.  
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Figure 6. Type III secretion found in some pathogenic Gram-negative bacteria. Several 
proteins form this needle-like complex that traverses two bacterial membranes and the host 
membrane to allow for the translocation of effector proteins. Adapted from (20).  
 
In the S. pyogenes genome, spn and slo genes are encoded in the same operon along with 
a third gene, ifs, which is the endogenous inhibitor of SPN (Figure 7). All strains examined to 
date possess the gene for spn (2, 69). Little is known about the regulation of this operon. 
Presently, it is thought a promoter is present upstream of spn which is expected to control all 
three genes. However, other studies have suggested slo has an automonous promoter found 
within ifs sequence (71). The same study reported a negative regulator of SLO, sloR, found 19kb 
upstream of the slo gene. This regulator is thought to act solely on SLO and has no effect on the 
transcription of spn. Findings within our lab suggest all three are co-transcribed under the same 
promoter as a polar insertional activation of SPN abolished the expression of SLO (46).  
The recent emergence of a highly virulent strain of S. pyogenes has given some insight 
into the regulation of the operon encoding SPN and SLO. This M1T1 strain is most often 
associated with invasive infections and carries a mutation in the two component regulatory 
 17 
system CovRS. This mutation in the regulatory covR gene leads to increased production of 
several virulence factors including capsule, DNase Sda1, Il-8 protease SpyCEP, SLO and SPN 
(16, 80). Also associated with this is the loss of SpeB production, which can cleave SPN and 
SLO (17). S. pyogenes has numerous methods for transcriptional regulation and this is just one 
mechanism employed during the course of an infection. 
 
  
  
 
 
 
Figure 7. SPN, IFS and SLO operon.  The three genes involved in CMT are encoded in the 
same operon occupying approximately 3.7 Kb of the chromosome. Only SPN and SLO are 
secreted through the Sec machinery. Upstream of spn is nusG, a transcription termination factor 
not involved in CMT.  
 
 SPN and SLO possess a secretion signal at the N-terminus allowing for the secretion of 
these two proteins from the bacterial cytosol through the sec machinery and into the extracellular 
space. If a host cell is present, the interaction between these two proteins allows for the 
translocation of SPN through the cell membrane and into the cytosol (Figure 8). In the absence 
of SLO, translocation cannot occur. The deletion of SPN reduces cytotoxicity despite the 
presence of SLO pore formation (46). Together, SPN and SLO contribute to cytotoxicity in a 
synergistic manner. 
  In addition, CMT is dependent upon adherence of the bacteria to the host cell membrane 
as a deletion of M protein abolishes translocation in epithelial cells (46). It is well known SLO 
spn nusG ifs slo 
5’ 3’ 
0 1Kb 2Kb 3Kb 
 18 
can form pores large enough (30nm) for passive diffusion of proteins (85), however infection 
with isogenic slo and spn deletion mutants does not restore CMT indicating that this is an active 
process. Once secreted, approximately 80% of the total amount of SPN is translocated into the 
cytosol. This process is also dependent specifically on SLO, substituting with PFO, a highly 
similar CDC, does not confer CMT despite pore formation (52).  The N-terminal of SLO is 
unique and removal of this sequence abolishes CMT. However, attaching this sequence to PFO 
also does not reconstitute CMT.   Recently, our lab has shown that this complicated mechanism 
is not pore dependent. Mutating SLO to the monomer locked form (G398V/G399V) or the 
prepore locked form (Y255A) abolished the ability of SLO to form pores however despite this 
loss, SPN was still translocated into the cytosol (47). This prepore oligomer sits on the surface of 
the membrane and is based on the formation of hydrogen bonds between monomers (24). In the 
case of the prepore locked form, the amount of SPN found in the cell is near wild-type levels and 
approximately 50% of wild-type in the monomer locked SLO infection. Thus pore formation and 
translocation of SPN can be uncoupled. Taken together, CMT requires a specific interaction 
between SLO and SPN that occurs in close proximity at the host cell membrane. It is likely SPN 
also interacts with a different receptor on the host cell. This process is coordinated through the 
interactions between SPN and SLO as well as SLO and the host membrane.  
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Figure 8.  Cytolysin Mediated Translocation. SPN, SLO and IFS are made within the bacteria 
during exponential growth. Within the bacterial cytosol, IFS can bind to SPN to prevent NAD+ 
cleavage within the host cell. SPN and SLO are translocated from the bacterium through the sec 
machinery into the extracellular milieu. The bacteria can adhere to the host cell M protein and 
CD46. Secreted SLO monomers then oligomerize on the host membrane and form pores. The 
interaction between SLO and SPN on the host cell membrane allows for the translocation of SPN 
into the host cell cytosol and is not pore dependent.  
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SPN 	  
SPN is the only known effector of CMT. SPN was first discovered for its NAD+- 
glycohydrolase activity, able to cleave β-NAD+ at the nicotinamide-ribosyl bond into two 
products: nicotinamide and ADP-ribose (Figure 9). This robust enzymatic activity is thought to 
contribute to virulence of S. pyogenes (2, 17, 36, 82). Prior to extensive studies done in the 
Caparon lab, it was previously reported that SPN also contained cyclase and ADP-ribosyl 
transferase abilities (2). However, since developing the capacity to purify SPN in an E. coli 
expression system, we have found that SPN ultimately lacks both of those activities as well as 
the inability to catalyze methanolysis or transglycosidation (27). SPN is a strict β-NAD+-
glycohydrolase and is unlike other classes of NAD+ cleaving enzymes that are multi-functional 
and capable of further catalyzing products from the initial reaction.  SPN is capable of cleaving 
NAD+ at incredibly fast rates, greater than 8000 molecules per second, which is uncharacteristic 
of these multi-functional NAD+ cleaving enzymes that typically cleave approximately 10 
molecules of NAD+ per second (27).  SPN also has low product inhibition while nicotinamide 
can compete for the active site in these other classes.  
 
 
 
 
 
Figure 9. NAD+ cleavage. β-NAD+ is cleaved at the nicotinamide-ribosyl bond to form 
nicotinamide and ADP- ribose. Adapted from (27).  
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Though we know SPN is translocated through its interaction with SLO during CMT, it is 
still unknown if CMT requires a signal sequence. It is also unknown if other effectors are 
injected in the host cytosol along with SPN. Thus far, studies within the Caparon lab have shown 
that the process of CMT is specific and discriminates between substrates. A study involving a 
different secreted toxin called mitogenic factor (MF) showed that MF is not translocated into the 
host cytosol unless it is fused with SPN in its entirety (28).  Furthermore, any deletions within 
SPN also abolish CMT though deletions of up to 190 amino acids in the N-terminal portion of 
SPN do not abolish the NADase activity, thus uncoupling translocation from the NADase 
domain. Deletions in the C-terminus of SPN abolished NADase activity as well as CMT. To 
further elucidate SPN’s specificity for CMT, chimeras of MF and increasing amounts of N-
terminus of SPN were constructed and it was found that none of these proteins could be 
translocated. Placing MF in the middle of SPN also abolished CMT, although it had no effect on 
the NADase activity. The only case in which mitogenic factor can enter the host cell is when it is 
positioned at the end of the entire SPN sequence. In this case, the chimera was both CMT 
competent and as well as NADase active (28). The fact that any deletion in SPN has a deleterious 
effect on CMT indicates that it is specific effector for this discriminating process. It also 
indicates an intact SPN is likely necessary to successfully interact with both the secretion system 
within the bacteria in addition to SLO on the eukaryotic membrane that ultimately leads to the 
translocation of SPN into the cytosol. 
Based on the above data, SPN has two domains. The first 190 amino acids of SPN 
resemble a “jelly roll” domain, which likely binds to a target other than SLO on the host 
membrane that allows for translocation. The data mentioned above show that this N-terminus is 
necessary but not sufficient for CMT and that NADase domain can properly fold into an active 
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enzyme in the absence of the N-terminus.  Analysis of the primary sequence of SPN shows that 
these 190 amino acids do not share any homology to other eukaryotic NAD+- glycohydrolases.  
Taken together, SPN is a multi-domain toxin that interacts with the host cell in stages via SLO. 
As robust NAD+- glycohydrolase, SPN is also toxic to the bacteria. β−ΝΑD+ is a co-
factor for many metabolic factors in both the eukaryotic and prokaryotic systems. This made 
SPN impossible to clone in E. coli until the discovery of the immunity factor of SPN termed IFS 
(53). This gene is located in between spn and slo in the same operon and is essential for the 
maintenance of NADase active SPN. IFS resides in the cytoplasm and acts on SPN in a one to 
one ratio by competitively blocking the active pocket from NAD+ thus neutralizing the toxic 
effects of SPN within the bacteria (Figure 10).  It is also important to note there are two subtypes 
of both SPN and IFS (69). One subtype is the well-known NADase active enzyme that is 
dependent on the presence of IFS however another subtype exists that completely lacks this 
NADase activity and is associated with a truncated form of IFS. In this case, IFS is no longer 
necessary for the bacteria to maintain this NADase inactive form. 
 
 
 
 
 
 
 
Figure 10.  The crystal structure of SPN and IFS.  SPN residues 191 to 451 were crystalized 
with IFS showing IFS binds to SPN blocking the active site for NAD+. SPN is presented in 
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yellow and IFS in blue. The first 38 amino acids are the signal sequence. Residues 39 to 190 
could not be crystallized (green). Adapted from (75). 
 
The NADase domain from residues 191 to 491 was crystallized along with IFS to 
determine how IFS binds to SPN and prevents NAD+ cleavage (Figure 10). IFS undergoes major 
conformational change upon binding to SPN. Unbound IFS has a free C-terminal tail that when 
bound to SPN becomes a compact structure located on stop of the active site of SPN. Deleting 
various portions of the tail has been shown to cause toxicity to E. coli during the induction of 
SPN in an expression system (Chandrasekaran, unpublished).  Structural analysis of SPN and its 
interaction with IFS has given us insight into how these two proteins interact as well as structural 
similarities of SPN with other NAD cleaving enzymes. Despite lacking the ability to transfer 
ADP-ribose to an acceptor molecule, SPN does share some major similarities. The overall 
structure of SPN overlays with two other bacterial ADP-ribosyl transferase families:  the cholera 
toxin and diphtheria toxin.   There are 3 motifs characteristic of this superfamily: the Arg/His, 
STS, and ADP-ribosyl turn turn motif (ARTT) that consists of two glutamic acids essential for 
the cleavage of NAD+ in this family.  An alignment of SPN with others in the ADP-RT family 
shows that it has a His of the A/H motif (His273) and the bi-glutamic acid motif (E389 and 
E391) (Figure 11). However, the STS motif is lacking in SPN though it does have amino acids 
similar in structure in place of these specific residues. Interestingly, mutation of the bi-glutamic 
acid motif in SPN does reduce the enzyme’s ability to cleave NAD at fast rates. Though it does 
completely abolish the NADase activity, an E391Q mutation reduces the rate of cleavage from 
approximately 8400 molecules per second down to 2 molecules per second. Another major 
difference between SPN and the ADP-RT family is the “scorpion” motif (42). This motif 
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consists of X-Y10-X that contributes to substrate interaction and cleavage in ADP-RTs. In the 
cholera toxin family, the STS motif is found at one of this scorpion and acts as the attacker in the 
process of NAD+ cleavage. Though SPN does not have a typical scorpion motif, it does have an 
elongated sequence similar to a scorpion that is flanked by the FVT sequence that replaces this 
STS motif.  This structural analysis has given us insight into two families of NAD+ cleaving 
enzymes and reasons as to why SPN is not able to transfer ADP-ribose groups to acceptor 
molecules.  
 
 
 
    
 
 
 
Figure 11.  The ARTT-like motif of SPN overlayed with ADP-ribosylating toxins in the  
dipherthia toxin family (DTx) and the cholera toxin family (CTx/C3).  SPN residues 
corresponding to each motif is colored accordingly. The R/H motif is shown in orange, ARTT 
motif shown in green and the STS motif shown in purple.  Adapted from (75).  
 
Every strain of S. pyogenes examined to date maintains the full-length gene for SPN. A 
recent genotypic study on various S. pyogenes strains conducted in the Caparon lab has shown 
that both the NADase active and inactive versions of SPN are equally prevalent (69) (2). This 
collection consisted of 113 strains from various types of infections, locations and spanning over 
67 years.  SPN was also found to be evolving under positive selection at several residues thought 
The deleted N-terminal CMT domain (residues 1–190) is pre-
dicted to have a b strand structure (Rost et al., 2004), and the
ProDom database (Servant et al., 2002) predicts a ‘‘jelly-roll’’
fold for this region. Although the N-terminal CMT domain is
required for translocation of SPN into host cells and biological
activity (Ghosh and Caparon, 2006), it has no significant effect
on enzymatic activity in vitro (Ghosh and Caparon, 2006). The
SPNct-IFS complex produced w ll-diffra ti g crystals (Figure 1A
and Table 1; see Figure S2 available online), and the structure
was determined at 2.8 A˚ resolution using phasing information
from a selenomethionyl-labeled derivative by a multiple wave-
length anomalous diffraction X-ray experiment (Table 1).
The SPNct domain has a mixed a/b fold (Figure 1B), with
a shape reminiscent of an open bowl. IFS serves as a lid covering
the active site pocket of SPN (Figure 1A). The active site motifs
and core b sheet structure of the RTase family are conserved
in the SPNct protein (Figure 3), as described inmore detail below.
The core structure of IFS comprises a single domain of eight
helices that are connected by several extended loops (Fig-
ure 1C). Two of these loops make intimate contacts with SPNct,
and we have named them the SPN Interaction Loops, SIL1 (resi-
dues 29–50) and SIL2 (residues 137–150; Figures 1C and 5). SIL1
is preserved as a loop in the bound and free conformations of
IFS, whereas SIL2 rearranges in the unbound form of IFS and
is incorporated into a continuous helix projecting from the
protein core (Figure 5A). This extended helix is incompatible
with the binding interactions seen in the SPNct-IFS complex.
SPNct Is Structurally Homologous
to Ribosyltransferases
We compared the structure of SPNct with those of related
b-NAD+-dependent enzymes. There are no structures of strict
GHases in the Protein Data Bank, and the amino acid sequence
of SPN has limited homology with other proteins, except for SPN
orthologs from other Streptococcus spp. (e.g., Kimoto et al.,
2005). The SPN sequence and structure are unrelated to those
of multifunctional GHase/ACases, including human CD38 and
a GHase/ACase from Aplysia californica (Love et al., 2004),
which contain multiple disulfide bonds that stabilize the protein
fold. Furthermore, the eukaryotic GHase/ACases are homo-
dimers, wherea SPNct is a monomer (Meehl et al., 2005). Based
on these criteria, we determined that SPNct is not structurally
homologous to these enzymes.
However, the SPNct structure superimposes well onto several
different RTases, including two universally conserved motifs in
the active site (Figure 3). Although the sequences of bacterial
RTases are divergent, these proteins share a conserved core
structure consisting of seven b strands arranged in two perpen-
dicular b sheets that bracket the b-NAD+ binding pocket (Han
and Tainer, 2002). This core b sheet sandwich is decorated
with different configurations of helices, forming a variety of mixed
a/b structures in various RTase family members. A helix or a vari-
able-sized loop lies on one side of the b-NAD+ binding pocket in
various RTase family members and is hypothesized to be impor-
tant for substrate recognition (Han et al., 2001). A structure-
based alignment of the SPN amino acid sequence with several
structurally homologous RTases did not reveal this element, or
any significant sequence homology outside of a few active site
motifs described below.
All RTases harbor an ADP-ribosyl-turn-turn (ARTT) motif in
their active site, which includes a catalytically essential glutamic
acid (Holbourn et al., 2006). SPN’s ARTT motif features Glu391,
which is required for enzymatic activity in vitro (Ghosh et al.,
2010). A second highly conserved residue of the ARTT motif is
a glutamic acid or glutamine (SPN Glu389) located two residues
N terminal to the essential catalytic glutamic acid. The
Figure 2. SPNct Has a RTase-like Fold
(A) Structural alignment of SPNct with ribosyltransferases: diphtheria toxin (1 dtp), cholera toxin (2a5f), C3bot (1gzf), C3tau (1ojz), and Vip2 (1qs2). In the left panel,
SPNct is shown in blue (RTase domain) and red (helical linker), with the other RTases shown in gray. The helical linker of SPNct is not present in other RTase super-
family enzymes. Conserved active residues of the DTx (center) and CTx/C3 (right) families of RTases are present in SPNct. SPNct residues corresponding to the
ARTT motif (green), the Arg/His motif (orange), and STS motif (purple) are shown as sticks (cf. Figure 1C).
(B) Aligned sequences of RTase motifs colored according to the scheme in (A).
Structure
Structure of S. pyogenes IFS and SPN
194 Structure 19, 192–202, February 9, 2011 ª2011 Elsevier Ltd All rights reserved
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to be involved in the NADase activity. Four Bayesian clusters were identified based on 10 of the 
23 polymorphic amino acid residues, two active and two inactive (Table 1).  
 
Table 1. Polymorphic residues span the length of SPN. Four Bayesian clusters of SPN were 
discovered upon analysis of S. pyogenes strains.  NADase activity was based on the presence of 
an aspartic acid at residue 330 rather than a glycine. These isolates were also associated with a 
truncated IFS indicating the loss of NADase activity. Adapted from (69).  
 
This finding correlates with the hypothesis that SPN is multifunctional and is preserved 
for reasons beyond the NADase activity. Despite the presence of full length SPN, IFS was found 
to be degrading as it is truncated when associated with SPN containing the G330D 
polymorphism that reduces NADase activity.  The NADase activity of SPN could not be 
associated with severity of disease however one major finding did conclude that SPN could be 
correlated to tissue tropism.  This study showed that the majority of NADase active strains were 
generalists (emm pattern E) able to cause infections at both the pharynx and the skin while the 
NADase inactive were associated with specialists (emm pattern A-C and D).  Taken together, 
these data suggest a NADase independent role for SPN that has yet to be studied.  IFS is under 
purifying selection while SPN is maintained it its entirety and is found equally among clinical 
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isolates.   A NADase independent role of SPN must be contributing to the pathogenesis of SPN. 
This role is unknown and is the focus of the studies undertaken for this thesis. Prior to this work, 
few studies have been focused on how the NADase activity of SPN may contribute to virulence 
(11, 12) but none have examined the possibility of a NADase independent function to SPN.  
 
AIM and SCOPE of THESIS 
The goal of this thesis was to gain a greater understanding of SPN and how the toxin 
contributes to the pathogenesis of S. pyogenes. The work described here focuses on two aspects 
of the natural variants of SPN: the enzymatic activity and the effects of SPN on the host cell.   
Thus far, extensive studies on the residues important for the NADase activity and the differences 
between the two variants have not been conducted. Despite the presence of the NADase inactive 
SPN, research has not been conducted concerning possible roles for this version during an 
infection. The lack of NADase activity was also thought to be a lack of toxicity however 
research described in this thesis shows that is not the case and in fact, the NADase inactive SPN 
has a role in the pathogenesis of S. pyogenes. Both the active and inactive form of SPN generates 
different signaling events within the cell that eventually leads to two different types of necrosis. 
Thus, SPN is a multifunctional toxin and the work presented in this thesis highlights the 
versatility of S. pyogenes pathogenic abilities. 
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SUMMARY 
 
 The Streptococcus pyogenes NAD+ glycohydrolase (SPN) is secreted from the bacterial 
cell and translocated into the host cell cytosol where it contributes to cell death.  Recent studies 
suggest that SPN is evolving and has diverged into NAD+ glycohydrolase inactive variants that 
correlate with tissue tropism.  However, the role of SPN in both cytotoxicity and niche selection 
are unknown. To gain insight into the forces driving the adaptation of SPN, a detailed 
comparison of representative glycohydrolase activity-proficient and -deficient variants was 
conducted.  Out of a total 454 amino acids the activity-deficient variants differed at only 9 highly 
conserved positions.  Exchanging residues between variants revealed that no one single residue 
could account for the inability of the deficient variants to cleave the glycosidic bond of β-NAD+ 
into nicotinamide and ADP-ribose.  Rather, reciprocal changes at 3 specific residues were 
required to both abolish activity of the proficient version and restore full activity to the deficient 
variant.  Changing any combination of one or two residues resulted in intermediate activity. 
However, a change to any one residue resulted in a significant decrease in enzyme efficiency. A 
similar pattern involving multiple residues was observed for comparison to a second highly 
conserved activity-deficient variant class.  Remarkably, despite differences in glycohydrolase 
activity, all versions of SPN were equally cytotoxic to cultured epithelial cells. These data 
indicate that the glycohydrolase activity of SPN may not be the only contribution the toxin has to 
the pathogenesis of S. pyogenes and both versions of SPN play an important role during 
infection. 
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INTRODUCTION 	  
Within a single bacterial species, allelic variation of a specific gene can arise through the 
process of niche specialization. For bacterial pathogens, this can occur when a generalist 
population diverges into distinct subpopulations with strong tropism for different hosts or for 
different tissues within the same host. Diversity emerges as continued selection pressure results 
in variants of virulence genes that function to increase fitness for infection of a particular niche. 
Understanding the functional consequences of these changes can provide important insights into 
how a specific virulence factor contributes to exploitation of a niche and its role in pathogenesis.   
Variation in the Streptococcus pyogenes (group A streptococcus) NAD+ glycohydrolase 
toxin (SPN, also known as NGA) has been associated with niche specialization. This Gram-
positive pathogen is one of the most versatile pathogens of humans capable of causing both 
superficial and invasive diseases including pharyngitis, impetigo, and necrotizing fasciitis, as 
well as post-infection sequelae such as rheumatic fever and acute glomerulonephritis. Part of this 
versatility can be attributed to its ability to secrete a multitude of proteins that affect host cell 
function in numerous ways (8). One of these is SPN, which was originally identified by its 
ability to cleave the nicotinamide-ribosyl bond of β-NAD+ to produce nicotinamide and 
adenosine diphosphoribose (ADPr). All S. pyogenes strains examined to date possess the gene 
encoding SPN (26). However, more recent studies have shown that these spn alleles exhibit 
diversity. Furthermore, SPN is evolving under positive selection and is diverging into multiple 
subtypes, including subtypes that lack its signature NAD+ glycohydrolase (NADase) activity. 
Neither the function of the NADase-inactive subtypes nor the molecular basis of their loss of 
activity are well-understood. 
 42 
However, it is understood that while there is not a clear consensus as to whether SPN subtypes 
have any association with isolates that can cause invasive disease, there is a strong association 
between SPN subtype and tissue tropism. Most cases of S. pyogenes infection are superficial and 
occur at one of two tissue sites: the throat (pharyngitis) or the skin (impetigo). Substantial 
epidemiological evidence indicates that there are distinct subpopulations of strains that are 
specialized for infection of just one of these two tissues (specialists). There is also a distinct 
subpopulation (generalists) that readily infects either tissue. Analysis of a collection of 113 
strains that was assembled to maximize diversity revealed that intact alleles of spn were found in 
all strains and that NADase-active and –inactive haplotypes were equally prevalent (26). Of 
interest, tissue and throat specialist strains correlated with NADase-inactive SPN, while 
generalist strains correlated with NADase-active SPN. The reason underlying these associations 
is unknown. Furthermore, since there is evidence that SPN’s NADase activity can contribute to 
pathogenesis, the prevalence of NADase-inactive SPN is unclear. 
The observation that NADase-inactive SPN remains under positive selection suggests 
that it does contribute to pathogenesis. Support for this idea comes through analysis of an 
endogenous competitive inhibitor of SPN’s NADase activity known as Immunity Factor for SPN 
(IFS). The gene encoding IFS is located immediately adjacent to spn and the ability of S. 
pyogenes to produce NADase-active SPN is absolutely dependent on IFS, which acts to inhibit 
self-toxicity that may arise from any SPN molecules that inadvertently fold prior to their export 
from the streptococcal cell (22). As expected for an essential activity, ifs has very little sequence 
divergence in these strains. However, NADase-inactive SPN haplotypes are associated with 
nonfunctional truncated alleles of ifs that are undergoing a pattern of random nucleotide change 
characteristic of a pseudogene. Thus, while ifs loses selective constraint and becomes non-
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functional, the same degradation does not occur for NADase-inactive spn, which remains under 
positive selection.   
During infection, SPN undergoes complicated interactions with host cells that provide 
some clues to its role. While S. pyogenes is an extracellular pathogen, SPN is delivered into the 
host cell cytoplasmic compartment by a process termed Cytolysin-Mediated Translocation 
(CMT). In this process, S. pyogenes first attaches to a host cell and exports SPN via the general 
secretory pathway. It is then translocated across the host cell membrane by an unknown 
mechanism that requires a second streptococcal protein, the cholesterol-dependent cytolysin 
streptolysin O (20). Analyses of CMT have revealed that SPN has multiple domains, including 
an N-terminal domain required for translocation and a C-terminal enzymatic domain (10). Both 
active and inactive SPN haplotypes undergo CMT and S. pyogenes mutants defective for 
expression of either SPN or SLO have a reduced cytotoxic effect for host epithelial cells. How 
these activities may contribute to niche specialization is not known. 
Multiple enzymatic activities have been attributed to NADase-active SPN that could 
contribute to cytotoxicity, including ADP-ribosyl transferase, ADP-ribosyl cyclase and NADase 
activities (15, 30). The structure of the enzymatic domain of SPN has recently been solved and 
shows that it is related to the ADP-ribosyl transferase family of bacterial toxins (29). However, a 
re-evaluation of SPN’s enzymatic activity using highly purified recombinant protein has shown 
that SPN functions strictly as a NADase (9). Interestingly, comparison of NADase-active and –
inactive subtypes reveals that the inactive haplotypes segregate into only 2 Bayesian clusters and 
these differ only minutely from the active haplotypes, varying at only 9-10 amino acid residues 
out of 454 total. Of these, only 5-6 polymorphic residues are located in the enzymatic domain, 
and all were identified as sites that are evolving under positive selection (26).  
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Although minor, these polymorphisms contribute to a significant difference in enzymatic 
activity and may affect pathogenesis and niche specialization. Thus, in order to gain greater 
insight into the function of SPN, its two phenotypic subtypes and the forces that are driving their 
evolution, we conducted a detailed analysis of the effect of polymorphism on enzymatic activity 
and the contribution of enzymatic activity to cytotoxicity. These studies revealed that differences 
in enzymatic activity were the result of polymorphism at not one, but rather multiple residues. 
Furthermore, this analysis revealed an unexpected NADase-independent cytotoxic activity that 
was retained by the enzymatically-inactive haplotypes. Together, these data reveal that SPN has 
multiple activities and provide insight into its molecular evolution.  
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RESULTS 	  
SPN Diversity. 
 As discussed above, all S. pyogenes genomes analyzed to date possess the gene encoding 
SPN. However, it has been recognized that this population has distinct functional heterogeneity, 
including haplotypes that lack SPN’s signature NADase activity. Our prior analysis of 113 
genomes from a strain collection assembled to reflect diversity indicated that these SPN 
haplotypes grouped into 4 Bayesian clusters 2 of which lacked detectable NADase activity (26).  
For the present study, we chose two strains (JRS4 and HSC5) whose SPN haplotypes were 
representative of the most common NADase active and inactive Bayesian Clusters (Clusters 2 
and 3, respectively). A direct comparison between NADase-active SPNJ4 (from strain JRS4), and 
NADase activity-deficient SPNH5, (from strain HSC5) revealed the presence of 9 polymorphic 
residues, each of which has previously been shown to be under positive selection in the activity-
deficient haplotypes (26). Of these, three were located in the translocation domain with the 
remaining residues distributed throughout the enzymatic domain (Fig. 1). As is typical, the gene 
encoding the NADase-active enzyme (SPNJ4) is associated with an intact gene for IFS, the 
endogenous inhibitor of SPN, while that of the activity-deficient protein (SPNH5) is associated 
with a truncated IFS gene (Figure 1) (26).   
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Figure 1. Distribution of polymorphic residues between two representative SPN alleles. The 
top of the Figure shows the domain structure of SPN from a strain (JRS4) with an active NAD+-
glycohydrolase (NADase) activity (SPNJ4). The signal sequence (SS) is not part of the mature 
protein. Indicated above the Figure are the locations of the various polymorphic residues when 
compared to SPN from a strain (HSC5) representative of the major class deficient for NAD+-
glycohydrolase activity (SPNH5). The asterisks below show the location of two glutamate 
residues implicated in catalysis. The bottom of the Figure lists the identities of the polymorphic 
resides at each position. Also indicated is whether the gene encoding the SPN allele is associated 
with an intact (full-length) or degraded (truncated) gene encoding IFS, the endogenous inhibitor 
of SPN. 
 
Multiple polymorphic residues at the C-terminal end of SPN contribute to enzymatic 
activity. To determine which polymorphic residues may affect NADase activity, mutations were 
made to switch residues in NADase-active SPNJ4 to their counterparts from activity-deficient 
SPNH5. To provide a uniform background for comparison, the mutant genes were expressed from 
a plasmid vector that was introduced into a derivative of strain JRS4 (SPN1) engineered to 
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contain an internal deletion of its native spn chromosomal locus (20). All proteins were found to 
be expressed at equivalent levels following analysis of cell-free culture supernatants by Western 
blotting (data not shown). These supernatants were then subjected to a standard end-point titer 
assay to determine the relative levels of NADase activity produced by each protein.  Individual 
swaps of the residues located in the translocation domain had no significant affect on the 
proteins’ ability to cleave a β-NAD+ substrate (R103H, G136R, M195I; Fig. 2) as compared to 
the native SPNJ4 (Unmod, Fig. 2). Similarly, swaps of the 3 N-terminal residues of the enzymatic 
domain (L199I, Q253H, L280V; Fig. 2) also did not affect activity.  In contrast, swaps of the 7th 
and 9th polymorphic residues (R289K, I374V) resulted in significant reductions in NADase 
activities (P > 0.05, Fig. 2). Consistent with prior reports (26, 32), a swap of the 8th polymorphic 
residue (G330D) resulted in an undetectable level of NADase activity in these supernatants (Fig. 
2). These data indicate that the activity of SPNJ4 is influenced to varying degrees by 3 different 
C-terminal polymorphic residues.  
 
 
 
 
 
 
 
 
Figure 2. Three residues are required to restore NADase activity to SPNH5. Polymorphic 
residues in SPNJ4 were changed to the corresponding residue in SPNH5, and those in SPNH5 
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changed to their counterparts in SPNJ4, as indicated by the grey and black bars, respectively for 
comparison to the unmodified proteins (Unmod). The genes encoding the mutations were 
expressed from a plasmid (Table S2) introduced into a derivative of JRS4 (SPN1) with a deletion 
of its resident gene. NADase activities were determined from cell-free culture supernatants as 
described in the Materials and Methods and are presented relative to SPNJ4. A “BL” indicates 
that activity was below the limit of detection (<0.5%).  A double asterisk indicates significantly 
less NADase activity when compared to unmodified SPNJ4 (P < 0.01). Data shown are the mean 
and standard error of the mean derived from at least three independent experiments. 
 
Conversion to a NADase-active enzyme requires three residues 
Reciprocal exchanges of the 3 C-terminal resides affecting activity of SPNJ4 were then 
made in NADase inactive SPNH5. Starting with the most N-terminal amino acids, a swap at 
residue 289 of SPNH5 (K289R) did not increase the NADase activity of the resulting protein 
above background levels (Fig. 2). Also, despite its dramatic effect on reduction of SPNJ4 activity, 
the reciprocal exchange at residue 330 of SPNH5 (D330G) resulted in only a very modest 
increase in NADase activity, to levels less than 3.0% of SPHJ4 (Fig. 2). An exchange of both of 
these C-terminal residues resulted in a protein with a significant increase in activity over the 
single-swap proteins (P < 0.01), however, the NADase activity of this protein was only at levels 
equivalent to approximately 30% of SPNJ4 (K289R + D330G, Fig. 2). Activity equivalent to that 
of SPNJ4 was obtained by the reciprocal swap of all 3 C-terminal residues (K289R + D330G + 
V374I, Fig. 2). Thus, all 3 of these residues make a critical contribution to the functional 
difference between these two naturally occurring variants of SPN.  
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SPNJ4 single and double residue swap proteins have detectable activity. 
In our prior analysis of 131 clinical isolates, all alleles from NADase-active Bayesian 
clusters 1 and 2 contained the identical C-terminal residues at the positions analyzed above for 
SPNJ4 (26). Similarly, all activity-deficient cluster 3 proteins had the identical polymorphisms at 
these positions found in SPNH5 (26). Thus, no naturally occurring intermediates containing just 
one or any combination of two of these polymorphisms were observed. To gain greater insight 
into this distribution, the properties of the engineered intermediate proteins were analyzed 
further. Recombinant versions of the intermediates were purified and their reaction products 
following incubation with β-NAD+ were analyzed by a more sensitive HPLC-based assay. After 
a one-hour reaction under these conditions, essentially all β-NAD+ was converted to 
nicotinamide and ADP-ribose by SPNJ4, while all β-NAD+ remained uncleaved following 
reaction with SPNH5 (Fig. 3A, 3B). In contrast to the assay described above, the R289K protein 
did not appear different from unmodified SPNJ4 and the G330D protein readily consumed 
substrate, although to a much lower extent than SPNJ4 (Fig. 3A, 3B). The ability of a double 
swap protein with these substitutions (R289K + G330D) to consume substrate was further 
reduced than by either single swap, although it was still more active than SPNH5 (Fig. 3A, 3B). 
Similarly, the introduction of the I374V along with G330D resulted in a more inactive enzyme 
than the G330D protein alone (Fig. 3A, 3B). Only when all 3 polymorphisms were combined in 
the same protein did activity become indistinguishable from SPNH5 (Fig. 3A, 3B). When 
combined with the results described above, these data suggest that the single and double swap 
proteins retain at least partial activity.   
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Figure 3. SPNJ4 single and double swap proteins have NADase activity. The various 
polymorphic residues from SPNH5 were introduced into SPNJ4 as indicated in the Figure. The 
NADase activity of purified proteins was then analyzed using an HPLC-based assay. A. 
Representative HPLC chromatograms showing the products of enzymatic cleavage of β-NAD+ 
following a one hour reaction at 37oC. Also evaluated was a reaction mixture lacking protein 
(NAD control). Identities of the various products, including β-NAD+ (NAD), Nicotinamide and 
ADPribose (ADPr) are indicated at the top of the Figure. B. Relative activity of each of the 
proteins shown in Panel A quantitated as the percentage of the β-NAD+ substrate remaining 
uncleaved following a one hour reaction. A “BL” indicates that values were below the limit of 
detection (<0.05%) and an asterisk indicates that significantly more substrate was consumed 
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when compared with SPNH5 (P < 0.05). Data presented are the mean and standard error of the 
mean derived from at least three independent experiments. 
 
The NADase-deficient Bayesian cluster 4 protein has partial activity. 
  As discussed above, Bayesian cluster 4 proteins represent a second distinct cluster of 
NADase-deficient SPN in clinical isolates with a truncated immunity factor. These cluster 4 
proteins differ from the activity proficient enzymes at 2 important residues.  Firstly, they share 
the G330D polymorphism with the cluster 3 SPNH5 (Fig. 4A). Secondly, instead of the lysine for 
arginine substitution found in SPNH5, the cluster 4 proteins substitute an asparagine (Fig. 4A). 
Finally, unlike the cluster 3 proteins, the cluster 4 proteins do not differ from the activity-
proficient (SPNJ4) proteins at residue 374 (Fig. 4A).  Single and double swaps of these 
polymorphic residues were introduced into SPNJ4, followed by purification and analysis utilizing 
HPLC-based assay as describe above. Similar to the cluster 3 R289K polymorphism, the cluster 
4 R289N single swap protein retained an appreciable ability to consume substrate (Fig. 4B). 
However, when combined with G330D, the resulting double swap protein failed to consume 
substrate and was indistinguishable from SPNH5 (Fig. 4B). Nevertheless, upon an extended 
period of incubation (up to 20 hrs), the cluster 4 double swap protein did demonstrate some 
activity, while both SPNH5 and its corresponding triple swap protein (R289K + G330D + I374V) 
failed to consume any β-NAD+ (Fig. 4C). Taken together, these data indicate that polymorphism 
at two positions contribute to the NADase-deficient property of the cluster 4 protein, although it 
is more active than the cluster 3 protein.   
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Figure 4. Cluster 4 swaps have low, but detectable NADase activity. A. Residues 
polymorphic between the Bayesian Cluster 2 (SPNJ4) and the Cluster 4 proteins are shown. An 
asterisk indicates that the Cluster 4 residue corresponds to the residue in the Cluster 3 NADase 
activity deficient (SPNH5) protein (compare to Fig. 1A). B. Polymorphic residues from NADase 
activity deficient Cluster 4 were introduced into SPNJ4 as indicated and analyzed as described in 
Fig. 3. Shown are representative HPLC chromatograms indicating the products of enzymatic 
cleavage of β-NAD+ following a one hour reaction. The NAD+ control is a reaction that does not 
include enzyme. C. Relative activity of selected proteins following the extended incubation 
periods shown in the Figure. Data presented are the mean and standard error of the mean derived 
from at least three independent experiments.  
 
Each C-terminal polymorphism reduces the rate of enzymatic activity. 
 In order to gain greater insight into the effect of each polymorphic residue on enzymatic 
activity, the kinetic properties of the various swap proteins were analyzed. Analysis of the SPNJ4 
derivative modified at residue 289 revealed a modest (< 2-fold) decrease in kcat (R289K, R289N; 
Table 1). However, despite being able to cleave substrate at a fast rate, alterations at this position 
did have a marked effect on catalytic efficiency for the R289K protein, resulting in over a 10-
fold increase in Km and an approximately 20-fold decrease in efficiency (kcat/Km, Table 2). The 
modification at residue 330 was more inhibitory, resulting in over a 5,000-fold decrease in kcat 
(G330D, Table 1) and in combination with other cluster 3 polymorphisms resulted in up to a 8-
fold further decrease in kcat (Table 1).  In the enzyme modified with both of the polymorphic 
residues of the cluster 4 protein, kcat was reduced nearly 60,000-fold, while for the enzyme with 
all 3 of the cluster 3 residues, kcat was below the limit of the assay (reduced over 2 x 108-fold vs 
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SPNJ4, Table 1).  For all proteins containing the G330D polymorphism, it was not possible to 
determine Km at the concentrations of β-NAD+ obtainable in the assay. Taken together, these data 
implicate a role for these 3 polymorphic residues in influencing substrate affinity.   
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IFS is not essential in strains encoding minimally active SPN.  
In order to protect its own pool of intracellular β-NAD+, S. pyogenes encodes IFS (Immunity 
Factor for SPN), an inhibitor of SPN’s NADase activity (22)However, in strains with a NADase-
negative allele, the gene encoding IFS has accumulated mutations and has become a pseudogene 
(22, 26).  Thus, to gain insight into the co-evolution of IFS and SPN, it was of interest to 
determine the requirement for IFS in strains of intermediate NADase activity. A test for 
essentiality was conducted using two different mutational strategies to determine if the IFS gene 
could be replaced or insertionally-inactivated in strains expressing various SPN alleles.  
Consistent with prior results (22), it was not possible to replace or inactivate ifs in a strain 
expressing SPNJ4 (JRS4, Table 3). However, when spn was deleted from this strain, mutations in 
ifs were readily obtained (SPN1, Table 3). Similarly, ifs was not essential for expression of the 
activity-deficient triple swap protein or any of the intermediate strains expressing a low activity 
SPN (Table 3). The exception was the intermediate strain of highest NADase activity (R289K) 
where no ifs insertion or replacement mutants could be recovered (Table 3).  These results show 
that IFS is not absolutely required for expression of NADase-active SPN, but is required when a 
certain threshold of activity is exceeded.  
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NADase-deficient SPN is cytotoxic to eukaryotic cells. 
 The observation that both clusters of NADase activity-deficient SPN are maintained 
under positive selection, while the gene encoding IFS degrades into a pseudogene (26), suggests 
that the cluster 3 and cluster 4 proteins make an important contribution to pathogenesis 
independent of NADase activity. One documented function for NADase-proficient SPN is that it 
is cytotoxic for mammalian cells when translocated into their cytosolic compartment via CMT 
(3, 23). To gain insight into the role of NADase activity in this context, the native spn allele of 
JRS4 (Fig. 5A) was modified so that various SPN proteins containing an influenza 
hemagglutinin (HA)-epitope tag (Fig. 5B) would be expressed from an identical host background 
for comparison to a derivative with an in-frame deletion (Fig. 5A, SPN1, (20)). These included a 
triple mutant of SPNJ4 (R289K + G330D + I374V) and SPNH5  (Fig. 5B), which were as 
efficiently translocated into A549 cell cytosols following infection as the SPNJ4 derivative (Fig. 
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5C, Inset). Surprisingly, while the deletion strain was minimally cytotoxic as expected (Fig. 5C, 
SPN1), the strains expressing both NADase activity-deficient proteins were as cytotoxic as the 
strain expressing the SPNJ4 protein, with nearly all A549 cells showing evidence of membrane 
compromise following 7 hours of infection (Fig. 5C). These data suggested that NADase activity 
could be uncoupled from cytotoxic activity revealing it is not the sole function of SPN that 
contributes to cytotoxicity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  5.  NADase-deficient SPN remains cytotoxic to A549 cells. A. The chromosomal spn 
loci of JRS4 and an in-frame deletion mutant of JRS4 (SPN1, (4)) are shown. Adjacent to the 
gene encoding SPNJ4 (spn), ifs encodes Immunity Factor for SPN and slo encodes Streptolysin 
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O. B. Strain Joy1 is a derivative of JRS4 expressing SPNJ4 with an HA epitope tag (black box) 
from the native spn locus. Derived from Joy1 are strains Suki2 and Joy110, which express the 
chimeric SPN proteins listed in parentheses at the right of the Figure. Regions and residues 
derived from SPNH5 are shown by shaded boxes and in italics, respectively. C. The strains 
expressing the proteins listed in parentheses were used to infect A549 cells and cytotoxicity 
evaluated at the indicated times by fluorescent microscopy following Live/DeadTM staining. 
SPN1 does not express SPN protein (ΔSPN). Refer to Table S3 for detailed construction of these 
strains.  Data presented represents the mean and SEM derived from at least 3 independent 
experiments. BL, below the limit of detection (< 0.3%).  The Inset shows a Western blot analysis 
of A549 cytosolic fractions prepared after 5 hrs of infection developed with an HA-epitope 
antiserum. Lanes:1, MW standards; 2, Uninfected; 3, Joy1(SPNJ4); 4, SPN1(ΔSPN); 5, Suki2 
(SPNTM); 6, Joy110 (SPNH5).  The molecular weight of selected standards are indicated at the left 
of the inset.  
 
 
To confirm this, the bi-glutamic acid motif previously shown to be essential for catalysis 
(9) was exchanged for glycines in all 3 of these proteins and cytotoxicity assessed. Again, all 
derivatives demonstrated an ability to damage A549 cells as compared to the deletion strain (Fig. 
6).  The strains expressing the proteins derived from either the triple mutant or SPNH5 were not 
as cytotoxic as the SPNJ4 derivate, but this likely reflects a lower level of translocation into the 
host cell cytosols (Fig. 6, Inset).   
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Figure 6. Catalytic bi-glutamic acid residues are not required for cytotoxicity. The bi-
glutamic acid residues involved in catalysis (see Fig. 1) were changed to glycines in SPN 
proteins SPNJ4, SPNTM (R289K + G330D +I374V) and SPNH5 at the chromosomal SPN locus in 
strain JRS4 to generate strains SPNJ4-GG, SPNTM-GG and SPNH5-GG, respectively. Refer to Table 
S3 for detailed construction of these strains. The strains expressing the  proteins listed in 
parentheses shown in the Figure were used to infected A549 cells and cytotoxicity monitored at 
the indicated times as described for Fig. 5. SPN1 does not express SPN protein (ΔSPN). The data 
presented shows the mean and SEM derived from at least 3 independent experiments.  The inset 
shows a Western blot analysis of the cytosolic fraction of A549 cells following a 5 hr infection 
using an HA epitope antiserum. Lanes: 1, MW standards; 2, Uninfected; 3, Joy1 (SPNJ4); 4, 
SPN1 (ΔSPN); 5, Suki6 (SPNJ4-GG); 6, Suki7 (SPNTM-GG); 7, Suki8 (SPNH5-GG). The molecular 
weight of selected standards are indicated at the left of the inset.    
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DISCUSSION 
 
Understanding the functional consequences of polymorphism can provide insight into 
how a specific virulence factor has been adapted in disparately evolving lineages, including those 
that are diverging with regards to niche selection.  The present analysis of SPN has revealed that 
differences in enzymatic activity between haplotypes cannot be attributed to a single 
polymorphic residue. Rather, the transition from an enzymatically active to an inactive protein 
required changes at multiple positions among polymorphic residues universally conserved in 
both activity-deficient haplotype clusters 3 and 4. Furthermore, despite a precipitous loss of 
NADase activity, these variants retained their cytotoxic activities for cultured epithelial cells. 
These data provide insight into the evolution of SPN by demonstrating that this toxin has at least 
two distinct activities, a NADase activity whose loss has been selected for in certain lineages, 
and a NADase-independent cytotoxic activity.  An important and conserved role for this latter 
activity may explain why SPN remains under positive selection even in those lineages that lack 
NADase activity. 
Most analyses of selection with regard to niche specialization in S. pyogenes have 
focused on events that have been facilitated by this organism’s high rate of recombination. 
Prominent among these are horizontal gene transfer events, including interspecies transfer of 
pathogenicity islands (34) and toxin alleles (14), recombination between orthologous regulatory 
genes (18), and the gain or loss of adhesins at defined loci (2, 16).  However, the fact that the 
SPN haplotypes lacking NADase activity are found only in S. pyogenes, that intermediate 
variants containing only a subset of the activity-associated polymorphic alleles have never been 
observed, and that these alleles are always associated with a degraded variant of IFS (26) suggest 
that recombination may not have played a major role in the evolution of these variants.  Thus, 
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how these variant haplotypes may have descended from the activity-proficient versions is not 
clear. It can be speculated that because multiple residues are involved and because the two 
haplotypes share features in common, adaptation may have followed a step-wise course. Both 
NADase-inactive haplotypes share the D330G polymorphism, suggesting that a change at this 
position may be the progenitor of both alleles. However, as shown in this study, intermediate 
combinations of these activity-associated residues, including the G330D change, retain partial 
activities.  Given the extremely high NADase activity of SPN, the partial activities observed in 
the engineered intermediate forms remain relatively high when compared to other classes of 
enzymes that share this activity, including NAD ribosyl transferases and NAD cyclases (9).  This 
suggests that additional alterations are required for complete loss of NADase activity. Since both 
variant haplotypes share polymorphism at residue 289, this may have been the next residue to 
come under selection. In the case of the Bayesian cluster 4 variant, the R289N variation further 
reduced NADase activity to levels that are not toxic for the streptococcal cell, since this 
haplotype no longer requires a functional immunity protein for its expression.  
The evolution of IFS is likely intimately linked with that of SPN. Consistent with the 
scheme described above, IFS is no longer essential when paired with a SPN that has the G330D 
polymorphism. The development of this variant would then release ifs from selective pressure to 
begin its transition to a pseudogene.  If correct, this model implies several things about SPN-IFS 
co-evolution. Firstly, the fact that ifs has become a pseudogene in the absence of robust NADase 
activity indicates that inhibition of this activity is its principal function, rather than having any 
additional contributions to virulence, including SPN secretion or the CMT injection process. 
Secondly, that the fact that S. pyogenes can tolerate a low level of NADase activity in the 
absence of IFS indicates that alterations to ifs itself was not a major driver of SPN’s continuing 
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evolution to an activity-deficient phenotype. Instead, the lack of intermediates for the SPN 
NADase-deficient haplotypes in the S. pyogenes population structure suggests that the near to 
complete loss of NADase activity in these lineages was driven exclusively by selective pressure 
imparted by some virulence-related function associated with how SPN interacts with host cells.   
While their origins may not be clear, insight into the mechanistic role of polymorphism on 
function can be gained from analysis of the structure of SPN. The three-dimensional structure of 
the enzymatic domain of SPN has recently been determined, revealing that it is structurally 
related to the broad family of NAD+ ribosyl transferases (29). These proteins share a conserved 
core structure consisting of seven β strands arranged in two perpendicular β sheets that bracket 
the β-NAD+ binding pocket.  In addition, SPN and the NAD+ ribosyl transferases share an active 
site ADP-ribosyl turn-turn (ARTT) motif that contains a catalytically essential glutamate residue 
(E391 for SPN), that lies at the base of a bowl-like substrate binding pocket (Fig. 7A). The three 
positions of interest are all situated in the wall of the substrate binding pocket, although two of 
these are distal to the active site and are located near the lip of the bowl.  One of these is G330, 
which hydrogen bonds with Q216 from the opposing surface to form one of the outside walls of 
the bowl (Fig. 7B). Molecular modeling of the glutamate polymorphism reveals significant steric 
clashes with Q216, which likely lead to a significant distortion of this wall, possibly leading to a 
reorientation of the two halves of the enzyme relative to each other.  Consistent with this, the 
G330D change had the highest impact on NADase activity as compared with changes at the 
other two sites, and likely radically altered substrate binding, as the Km was raised to a level that 
was difficult to determine with precision. On a different face of the wall, R289 interacts with 
D286 and K288 to form a surface that molecular modeling suggests may be involved in 
positioning the ribose moiety of the β-NAD+ substrate in the active site cleft (Fig. 7C). While the 
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lysine polymorphism in the cluster 3 variant SPN also represents a highly conserved substitution, 
the reduced ability of lysine to form hydrogen bonds likely results in some disruption of the 
extensive network of interactions contributed by arginine at this position. Consistent with this, 
the lysine substitution had the least effect on NADase activity, but was still substantial, resulting 
in a near 20-fold decrease in enzymatic efficiency. The much greater decrease in NADase 
activity found in the cluster 4 variants can be explained by the considerable loss of interactions 
that would result from the substitution of glutamine. The third position of interest, I374, is 
located at the bottom of the bowl near catalytic E391. However, while the latter’s side chain 
extends into the lumen of the bowl, the side chain of I374 is buried in the hydrophobic core (Fig. 
7D). Molecular modeling of the I374V substitution reveals extensive steric clashes with F199 
and Y243 from two adjacent helices, which likely would distort the position of the side chain of 
E391 to an orientation less favorable for interaction with the glycosidic bond of the β-NAD+ 
substrate.  
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Figure 7. Polymorphic residues that influence catalysis are located in the substrate binding 
pocket of SPN. A. Orthogonal view of the enzymatic domain of SPN (residues 191-451) 
modeled in complex with β -NAD+. The model was developed from a structural alignment with 
cholera toxin bound to β-NAD+ (PDI accession 2a5f) followed by superimposition of β-NAD+ 
into the binding pocket of SPN. Residues of the ARTT motif, catalytic residues and relevant 
polymorphic resides are labeled and are highlighted in red, β-NAD+ is shown in blue. B. G330 
forms a hydrogen bond with Q216 to form one wall of the binding pocket. C. Proximity of R289 
to adjacent residues D286 and K288, which form a surface that may position β-NAD+ in the 
binding pocket. D. I374 is in proximity to catalytic residue E391, but lies buried in an adjacent 
hydrophobic pocket that includes F200 and Y243. 	  
 
The fact that adaptation produced two distinct variant haplotypes suggests this event was 
subject to considerable selective pressure. Why this process involved selection at multiple 
residues is not clear, since a single mutation at residue E391 would lead to a drastic reduction in 
NADase activity. It is possible that significant structural constraint was imposed by a dual 
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requirement for loss of NADase activity and selection for the cytotoxic activity. However, this 
scenario would imply a larger conserved role for E391 beyond cytotoxicity because mutation at 
this position did not influence cytotoxicity for cultured epithelial cells.  A pathway of multiple 
changes may have been necessary because any single mutation resulted in a less stable protein. 
Some evidence for this comes from the observation that the enzymatic activity of some of the 
engineered intermediate forms was more erratic using low salt conditions that had no effect on 
activity of the SPNJ4 enzyme.  However, all engineered intermediate forms were readily 
expressed by either S. pyogenes or E. coli and none exhibited any obvious differences with 
solubility or degradation relative to the unmodified proteins. Thus, a more detailed understanding 
of adaptation will require uncovering the mechanism of the NADase-independent cytotoxic 
activity.  
Multifunctionality is not an uncommon property of many bacterial toxins that are 
recognized to be subject to ongoing adaptation (7). For example, the VacA vacuolating cytotoxin 
of Helicobacter pylori is an important determinant of colonization, persistence and pathogenesis 
of its human host and exhibits considerable diversity. Like SPN, VacA diversity is restricted to 
specific regions of the toxin and generates a wide range of toxin efficacy, from variants that 
produce extensive vacuolation, to those that only produce vacuolation in a limited range of 
cultured cells, to variants that fail to cause any detectable cytotoxicity in in vitro assays (7, 12) . 
Also like SPN, variation has a functional consequence, although for VacA this appears to 
correlate with the risk of developing certain complications of long-term colonization like peptic 
ulcer disease or gastric cancer (1, 33).  However, VacA is multifunctional and in addition to 
cytotoxicity has been reported to alter membrane permeability, to target and damage 
mitochondria, and to activate numerous host cell signaling pathways (7). Similar to SPN, it is 
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thought that this multifunctional nature likely explains why VacA is found in essentially all H. 
pylori strains that infect humans, despite extensive variation in vacuolating ability (1) . 
A common property of multifunctional toxins exhibited by VacA is the ability to cause 
distinct cellular effects by acting at different cellular locations (7). Whether SPN acts at different 
cellular locations is not clear. Translocated SPN is found exclusively in the cytoplasmic 
compartment (4, 20), although the presence or absence of SPN in defined mutants has been 
reported to affect the invasiveness of S. pyogenes during infection of cultured epithelial cells (3), 
a property that could contribute to niche selection.  SPN itself is a multi-domain protein and in 
addition to its NADase domain, has an N-terminal domain that is essential for its translocation 
(10). While the structure of this domain has not been solved, homology modeling indicates that it 
adopts a “jelly-roll” fold common to many carbohydrate-binding proteins that suggests it may 
promote interaction at the cell surface (10).  The role of this domain in cytotoxicity remains to be 
determined.  Prior reports suggested that SPN may have multiple enzymatic activities that could 
produce differential cellular effects, including ADP-ribosyl transferase and cyclase activities (15, 
30). However, more refined analyses of highly purified recombinantly-produced SPN have failed 
to confirm these additional activities (9). It is possible that there are two modes of SPN 
cytotoxicity, a NADase-dependent activity in the activity-proficient haplotypes and a gain-of-
function cytotoxic activity that results from the multiple polymorphisms in the NADase-deficient 
haplotypes. Support for a role for NADase activity in cytotoxicity comes from studies in E. coli 
and yeast that show that expression of SPN in the absence of IFS, the endogenous inhibitor of its 
NADase activity, is lethal (9, 23). In contrast, expression in yeast of an activity-deficient 
haplotype is not lethal (9).  Yeast may lack a target required for the NADase independent activity 
or this may be due to the observation that full penetrance of the cytotoxic effect on epithelial 
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cells requires a synergistic interaction with the pore-forming activity of the streptococcal SLO 
protein (21). 
 The studies described here have expanded our understanding of SPN structure and 
function and the molecular basis for its evolution. However, several important questions remain, 
including the structural and molecular basis of its NADase-independent cytotoxic activity and 
how its various activities contribute to tissue tropism. Several studies have suggested that the 
number of S. pyogenes isolates that demonstrate NADase activity has been increasing since the 
late 1980’s and that the activity-proficient SPN haplotypes have entered into some lineages that 
are now more frequently isolated from invasive disease (30-32).  Thus, a detailed understanding 
of SPN function and evolution will further our understanding of how S. pyogenes populations 
continue to evolve.   
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Supplemental Figure 1. Bayesian clusters and the corresponding polymorphic amino acids. 
Diagrams are based on (26). Data was determined by Bayesian analysis of 113 clinical isolates.  
The first 6 polymorphic residues vary between NADase types however the 3 C-terminal residues 
are conserved to each Bayesian cluster.  
 
Supplemental Figure 1 
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Supplemental Figure 2. Graph of slopes used to determine NAD+ cleavage rates of variants 
of SPNJ4. Various protein concentrations were used with 2.5 mM β-NAD+ incubated at 37°C. 
Rates were determined as Moles of NAD+/Minutes/Moles of SPN. See Methods for details.  
 
Supplemental Figure 2 
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MATERIALS AND METHODS 	  
Bacterial Strains and Media. The studies with S. pyogenes utilized the M serotype 6 strain 
JRS4 (28) and derivatives including SPN1 (Δspn, (20)) and JOY1, which expresses SPN with a 
carboxy-terminal HA epitope tag. Chromosomal DNA from strain HSC5 (11) was used a 
template in PCR reactions for molecular cloning of SPNH5.  Construction of all strains is 
described in Table S3. Other molecular cloning and protein expression studies utilized E. coli 
TOP10 (Invitrogen).  Routine culture of S. pyogenes and E. coli was conducted using Todd 
Hewitt Yeast Extract and Luria-Bertani media, respectively, as described (9). Where appropriate, 
antibiotics were used at the following concentrations: chloramphenicol, 7.5 µg/ml for E. coli and 
3 µg/ml for S. pyogenes; erythromycin, 500 µg/ml for E. coli and 1 µg/ml for S. pyogenes and 
carbenicillin, 50 µg/ml for E. coli.  
 
Manipulation of DNA- Transformation of E. coli used the method of Kushner (17) and S. 
pyogenes was transformed by electroporation (6). Plasmid DNA was isolated by standard 
techniques and all enzymes, including restriction endonucleases, ligases (New England Biolabs), 
and polymerases (Pfx, Invitrogen) were used according to the manufacturers’ recommendations. 
All site-specific mutations described in the text were generated by PCR with the mutagenic 
oligonucleotide primers listed in Tables S1 and S2 and the DpnI digestion method to degrade 
template DNA using a commercial kit (QuikChange XL kit, Stratagene).  Fidelity of all DNA 
sequences generated by PCR was verified by DNA sequence analyses performed by commercial 
vendors (SeqWright, Galveston, TX; GeneWiz, South Plainfield, NJ).   
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Expression of SPN derivatives in S. pyogenes. Plasmids for expression of SPN in S. pyogenes 
were based on pJOY3 (10) and include pJOY7, which expresses SPNJ4 with a carboxy-terminal 
Influenza Hemagglutinin epitope tag (HA epitope tag). A fragment containing SPNH5 was 
amplified from HSC5 chromosomal DNA using primers oJOY5 and oJOY6 (Table S1) and 
introduced between the EcoRI and BstEII sites of pJOY7. The resulting plasmid (pJOY39) 
expresses SPNH5 with a carboxy-terminal HA-tag (Table S1).  The various site-specific 
mutations were then introduced into pJOY7 and pJOY39 by PCR using the primers listed in 
Table S1. For expression and analysis, each plasmid was used to transform the SPN deletion 
strain SPN1 and the resulting strains were analyzed by the assays described below. Plasmid 
constructions are summarized in Table S1.  
 
Expression and purification of recombinant SPNs. PCR was used to introduce the various 
site-specific mutations of interest into a derivative of the E. coli expression plasmid pBAD 
(Invitrogen) that encodes a His6-tagged SPNJ4 (pMAM3.18, (22)). Mutagenic primers and the 
relevant features of this panel of expression plasmids are summarized in Table S2.  Expression 
and purification of the His6-tagged recombinant proteins was performed as previously described 
(9). As a final step, the purified proteins were dialyzed at 4°C against a buffer consisting of 50 
mM potassium phosphate and 100 mM sodium chloride.  Purity of the 48.6 kDa proteins was 
routinely assessed by SDS-PAGE and staining with Coomasie Brilliant Blue and protein 
concentrations determined using a BCA assay (Pierce) with a BSA standard.   
 
Single-copy S. pyogenes SPN expression strains-. SPNJ4 and SPNH5 were amplified by PCR 
from templates pJOY7 and pJOY39, respectively, using primers oJOY180 (5' CGGTGGTTTAC 
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TCGAGAAACAAAAAAGTAACATTAGC-3') and oJOY6 (Table S1). The resulting fragments 
were inserted between the XhoI and PstI sites of pJRS233 (25) to produce pJOY109 and 
pJOY110.  A mutant of SPNJ4 containing the cluster 3 polymorphisms (“triple mutant”) and a 
carboxy-terminal HA tag was produced by sequential site directed mutagenesis of pJOY7 using 
primer pairs oJOY85/oJOY86 (R289K), oJOY89/oJOY90 (G330D) and oJOY93/oJOY94 
(I374V) as detailed above (primers are described in Table S2).  The modified SPN gene of the 
resulting plasmid (pASuki2) was amplified using oJOY180 and oJOY6 and inserted between the 
XhoI and PstI  sites of pJRS233 to produce pJSuki2. Site directed mutagenesis of pJoy109 was 
performed to generate the single (R289K, G330D) and double polymorphic mutants 
(R289K+G330D) in SPNJ4 (primers and strains described in Table S3).  The five plasmids 
(pJOY109, pJOY110, pJSuki2, pJSuki3, pJSuki4, pJSuki5) were then used to replace the native 
SPN allele in JRS4 by a standard method (13) to generate strains designated SPN-J4, SPN-H5 
and SPN-TM, SPN-R289K, SPN-G330D, and SPN - R289K/G330D. Chromosomal sequences 
were verified by DNA sequence analysis of PCR products generated using appropriate primers. 
 
Tests for ifs essentiality.  The requirement for ifs to support viability of strains expressing SPN 
of differing NADase activities was assessed by two complementary mutational strategies.  In the 
first, an attempt was made to replace ifs with the aad9 spectinomyin-resistance gene. In the 
second, an attempt was made to insertionally-inactivate ifs using an integrational plasmid.  Both 
strategies were based on established methods using plasmids with conditional temperature-
sensitive replication (25) (19). The construction of the two mutagenic plasmids and steps 
involved in mutagenesis are described in detail in the Supplemental Experimental Procedures. It 
was concluded that ifs was essential in a given strain if both strategies failed to generate an ifs-
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deficient mutant. In successful ifs mutants, DNA sequence analyses of spn and its promoter each 
mutant retained the expected SPN allele.   
 
β-NAD+ Glycohydrolase Activity of SPN from S. pyogenes-. A fluorimetric assay was used to 
analyze the β-NAD+ glycohydrolase activity in culture supernatants from S. pyogenes strains 
expressing the various SPN constructs (9). Concentrations of SPN in culture supernatants were 
normalized by immunoblotting to detect an HA epitope tag as previously described (9). Specific 
activities of each SPN mutant is reported relative to wild type JRS4 as described (10).  Data 
presented are derived from three independent experiments, each performed in triplicate. 
 
β-NAD+ glycohydrolase activities of recombinant enzymes.  Rates of β-NAD+ cleavage were 
determined by analytical HPLC as described (Supplemental figure 1) (9).  In initial trials, it was 
found that inconsistencies in results obtained from several of the low activity enzymes could be 
eliminated by the inclusion of NaCl in the reaction mixture (100 mM). Since this had no effect 
on the Km of SPNJ4, all analyses were conducted using this modification.  Briefly, the molar 
concentrations of SPN indicated in the text were incubated with 2.5 mM β-NAD+ in 100 µl of 
reaction buffer (50 mM potassium phosphate, 100 mM sodium chloride, pH 7.4, 0.5 mg/ml 
BSA) at 37˚C. Reactions were quenched by the addition of 100 µl of 20% ice-cold perchloric 
acid and incubated on ice for 30 min to precipitate protein and BSA. Precipitates were removed 
by centrifugation, supernatants diluted into 980 µl of deionized water and the mixture subjected 
to reversed-phase HPLC (SunFire, C18 column, Waters, 5 µm, 4.6 x 250 mm) developed 
isocratically with 1% (v/v) acetonitrile in buffer A (10 mM diammonium phosphate buffer, pH 
6.4) with a flow rate of 1.5 ml/min over 22 min.  Quantitation of reaction products and 
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determination of initial reaction rates and other kinetic parameters were performed as described 
in detail elsewhere (9). Data presented are derived from three independent experiments, each 
performed in triplicate. 
 
End point β-NAD+ glycohydrolase activity assay. A single end point assay to determine the 
amount of uncleaved β-NAD+ remaining following reaction with various SPN derivatives was 
conducted a follows: Enzyme (20 picomoles) was incubated in reaction buffer (50 mM 
potassium phosphate, 100 mM sodium chloride, pH 7.4, 0.5 mg/ml BSA) with 1 mM β-NAD+ 
for 1, 5, 7 and 20 hrs at 37˚C.  Reactions were quenched by chromatography using a centrifugal 
column (Millipore, 3 kDa exclusion). The flow-through fraction was diluted into deionized water 
and analyzed by reverse-phase HPLC as described above.  Data presented are derived from three 
independent experiments, each performed in triplicate. 
 
Infection of epithelial cells.  Analysis of cytolysin-mediated translocation (CMT) and 
cytotoxicity were assessed following infection of A549 epithelial cells, conducted as described in 
detail elsewhere (20). Briefly, various S. pyogenes strains were cultured overnight, back diluted, 
and grown to mid-logarithmic phase and used to infect confluent monolayers of A549 cells.  
Following incubation for 285 min., cells were lysed by the addition of Saponin to a final 
concentration of 0.1%, the lysate fractionated by ultracentrifugation and the concentration of 
SPN in the cytosolic fraction determined by immunoblotting to detect the HA epitope tag.  
Efficiencies of CMT were quantitated relative to a strain expressing SPNJ4 as described (10). 
Cytotoxicity of various SPN-expressing S. pyogenes strains was assessed by the ability of 
infected cells to exclude the membrane-impermeable fluorescent probe ethidium homodimer-1 
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(Live/Dead®, cat. #L3224, Invitrogen) as described previously (20). Data presented represents 
the mean and standard error of the mean derived from at least 3 independent experiments.  
 
Computational methods and statistical analyses. Molecular modeling employed the 
PyMOL Molecular Graphics System (Version 1.5.0.1, Schrödinger, LLC) and the structure of 
the enzymatic domain of SPN (PDB accession 3PNT) determined by Smith et al. (29).  Where 
indicated, differences between observed experimental mean values were tested for significance 
using Tukey-Kramer Multiple Comparisons Test.  The null hypothesis was rejected for P < 0.05. 
 
 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Tests for ifs essentiality.  A plasmid was constructed for replacement of ifs (SPy_0166) with the 
gene encoding the aad9 spectinomycin-resistance determinant as follows:  A DNA fragment that 
included sequences extending 229bp upstream and 231bp downstream of the 486bp ifs ORF was 
amplified and inserted into the temperature-sensitive shuttle vector pJRS233 (25) by overlap 
extension PCR (5) using primer pair GP972/GP973 (Table S4). The resulting plasmid 
(pGCP858) has the ifs fragment located between the M13F and M13R primer binding sites of the 
pJRS233 vector. Next, aad9 lacking a promoter sequence was amplified from pSPC18 (19)  
using primer pair GP921/GP922 (Table S4) by PCR and then overlap extension PCR was used to 
flank promoterless aad9 with chromosomal sequences from upstream and downstream of ifs 
using primer pairs GP972/GP925 and GP926/GP973. The resulting fragment was used to replace 
the ifs open reading frame in pGCP858 by overlap extension PCR. The resulting plasmid 
(pGCP867, Fig. S3A) was then used to attempt to replace ifs in the chromosome of various 
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strains using a standard method (27) with selection for erythromycin-resistance (1 µg/ml) at the 
permissive temperature (30oC) followed by selection for resistance to both erythromycin and 
spectinomycin (100 µg/ml) at the non-permissive temperature (37oC). This latter culture was 
plated to obtain individual spectinomycin-resistant colonies and 3 independent colonies were 
picked and cultured at the permissive temperature in media containing spectinomycin, but 
lacking erythromycin. Every 24 hrs, each of these cultures was plated for single spectinomycin-
resistant colonies and also diluted 1:1000 in fresh medium with spectinomycin and the 
incubation continued. Since aad9 lacks its own promoter in pGCP863, recombination with the 
chromosomal copy of ifs will place aad9 under the control of the SPN-SLO operon promoter 
(Fig. S3A).  At least 150 colonies from each time point were replica plated to identify those 
resistant to spectinomycin, but sensitive to erythromycin, which were then screened for allelic 
replacement by PCR using primer pair GP956/GP957 and DNA sequence analysis with primers 
GP200 and GP250. Successful allelic replacement typically required 2-5 passages (Table S5). 
However, a conclusion that allelic replacement was not possible was only made following at 
least 16 passages with screening of a minimum of 900 individual colonies (Table S5).   
While sensitive, this method involves competition between the mutant, the intermediate 
merodiploid and wild type, and a significant difference in fitness can result in a failure to recover 
the mutant leading to a false assignment of essentiality. Therefore, these data were confirmed by 
a second strategy involving a single-step insertional inactivation of ifs, conducted as follows: a 
246 bp fragment of the ifs open reading frame (nucleotides 83-246) lacking its 5’ and 3’ ends 
was amplified from a JRS4 chromosomal DNA template and inserted into the temperature-
sensitive shuttle vector pGCP213 (24) by overlap extension PCR using the primer pair 
GP879/GP880 (Table S4).  In the resulting plasmid (pGCP773) the ifs fragment is located 
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between M13F and M13R primer binding sites (Fig. S3B).  To test for essentiality, pGCP773 
was used to transform the various S. pyogenes strains to resistance to erythromycin and plated for 
single colonies at the permissive temperature (30oC).  For each strain, 6 colonies were picked 
and cultured individually overnight at the non-permissive temperature (37oC) in the presence of 
erythromycin. Cultures were then diluted 1:1000 in fresh medium containing erythromycin and 
cultured overnight at the non-permissive temperature. Cultures that continued to grow at 37oC 
for a minimum of 3 successive passages were screened by PCR to confirm the loss of a full 
length ifs open reading frame, for disruption of ifs and for integration of the plasmid into the ifs 
locus (Table S5).  DNA sequence analyses of spn and its promoter confirmed that each ifs 
mutant retained the expected SPN activity phenotype.   
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Supplemental Figure 3. ifs mutagenesis plasmids.  Two plasmids were generated to test for 
essentiality of IFS in strains of intermediate NADase activity. (A) The plasmid pGCP867 
containing a promoterless aad9 spectinomycin-resistance gene flanked by 229bp and 231bp 
DNA regions homologous to those immediately upstream and downstream of ifs, respectively, 
was constructed for a two-step replacement of ifs (SPy_0166).  A promoterless copy of aad9 was 
utilized to enrich for spectinomycin resistant transformants in which the first crossover event 
occurs upstream of ifs (labeled 1) placing aad9 under the transcriptional control of the SPN-SLO 
operon promoter. Upon plasmid excision but maintained spectinomycin resistance selection, a 
second crossover event occurs downstream of ifs (labeled 2) resulting in replacement of ifs for 
aad9. (B) The plasmid pGCP773 containing a 246bp internal fragment of the ifs open reading 
frame was constructed for a single-step insertional inactivation of ifs.   
pGCP867orits
ermC
oripSC101
spn ifs slo
7,058 bp
aad9
(SpcR)1 2
pGCP773
spn ifs slo
orits
ermC
ori pUC
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A
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Table S1. Construction of plasmids for protein expression in S. pyogenes 
Primer Sequencea Template Plasmidb
SPN   
mutantc
A. Derivatives of SPNJ4
oJOY53 CCTACAAGTTTGCGTCCCCGATGCATATTGGGAGAATTTTAATTG
oJOY54 CAATTAAAATTCTCCCAATATGCATCGGGGACGCAAACTTGTAGG
oJOY55 GCTGATGTTAAATACTATAACCGGAATAAATTGGTCCTCTTTC
oJOY56 GAAAGAGGACCAATTTATTCCGGTTATAGTATTTAACATCAGC
oJOY57 GGTCACTTTTGGCAATATTGAACGCGATCTTTTTG
oJOY58 CAAAAAGATCGCGTTCAATATTGCCAAAAGTGACC
oJOY59 GGCAATATGGAACGCGATATTTTTGAAAAAAAGTTTAAAG
oJOY60 CTTTAAACTTTTTTTCAAAAATATCGCGTTCCATATTGCC
oJOY83 GTATGTTAGCCGCAAATACCACTACAAAAAAGAGTTTGTTGAAAAAC
oJOY84 GTTTTTCAACAAACTCTTTTTTGTAGTGGTATTTGCGGCTAACATAC
oJOY61 CGTTACAAGTAAAAAAGATGTGATGTTAGCTTTTGATGATGC
oJOY62 GCATCATCAAAAGCTAACATCACATCTTTTTTACTTGTAACG
oJOY85 GTTAGCTTTTGATGATGCTAAAAAAAAGTCAACGATTGGTCGACAAG
oJOY86 CTTGTCGACCAATCGTTGACTTTTTTTTAGCATCATCAAAAGCTAAC
oJOY89 CAGCTGACCAAATTGAAAATATAAAAGATGTCGATAGCGGAAAATATAGTG
oJOY90 CACTATATTTTCCGCTATCGACATCTTTTATATTTTCAATTTGGTCAGCTG
oJOY93 CTGGAGCAAATTCGCTCAACGTTCCTGGTTGCCAAACGTGGTCAGG
oJOY94 CCTGACCACGTTTGGCAACCAGGAACGTTGAGCGAATTTGCTCCAG
B. Derivatives of SPNH5
oJOY5 CCGGAATTCGGTGGTTTACATGAGAAACAAAAAAGTAACATTAGC
oJOY6 GTTCTGCAGTTCTAAAATGTTTCTATTGTTCTTTCGACC
oJOY174 GATGTGATGTTAGCTTTTGACGATGCTAAAAGAAAGTCAACGATTG                                                     GTCGACAAGAAAACG
oJOY175 CGTTTTCTTGTCGACCAATCGTTGACTTTCTTTTAGCATCGTCAAA                                                                AGCTAACATCACATC
oJOY147 GCTGACCAAATTGAAAATATAAAAGGTGTCGATAGCGGAAAATATAGCGATGG
oJOY148 CCATCGCTATATTTTCCGCTATCGACACCTTTTATATTTTCAATTTGGTCAGC
oJOY174 See Above
oJOY175
oJOY250 GGAGATACTCCTGGAGCAAATTCGCTCAACATTCCTGGTTGCCAAACGTGGTCAGG
oJOY251 CCTGACCACGTTTGGCAACCAGGAATGTTGAGCGAATTTGCTCCAGGAGTATCTCC
a Nucleotides sequences are 5' to 3'.
b All plasmids express full length IFS and SPN with indicated mutation.
c All secreted proteins have a C-terminal HA tag.
D330G
pJoy84 pJoy101 K289R           D330G         
K289R           
D330G          
V374I
pJoy101 pJoy127
pJoy7 pJoy44 G330D
pJoy7 pJoy46 I374V
pJoy39 pJoy81 K289R
 HSC5 pJoy39 SPN H5
pJoy39 pJoy84
Q253H
pJoy7 pJoy38 L280V
pJoy7 pJoy42 R289K
pJoy7 pJoy41
pJoy7 pJoy34 R103H
pJoy7 pJoy35 G137R
pJoy7 pJoy36 M195I
pJoy7 pJoy37 L199I
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Table S2. Construction of  plasmids for expression of protein in E. coli for purification
Primer Sequencea Template Plasmidb Proteinc
oJOY89 CAGCTGACCAAATTGAAAATATAAAAGATGTCGATAGCGGAAAATATAGTG
oJOY90 CACTATATTTTCCGCTATCGACATCTTTTATATTTTCAATTTGGTCAGCTG
oJOY93 CTGGAGCAAATTCGCTCAACGTTCCTGGTTGCCAAACGTGGTCAGG
oJOY94 CCTGACCACGTTTGGCAACCAGGAACGTTGAGCGAATTTGCTCCAG
oJOY85   GTTAGCTTTTGATGATGCTAAAAAAAAGTCAACGATTGGTCGACAAG  
oJOY86 CTTGTCGACCAATCGTTGACTTTTTTTTAGCATCATCAAAAGCTAAC
oEK1 AGATTTGATGTTAGCTTTTGATGATGCTAAAAACAAGTCAACGATTGGTCG     
oEK2 CGACCAATCGTTGACTTGTTTTTAGCATCATCAAAAGCTAACATCAAATCT
oJOY89 CAGCTGACCAAATTGAAAATATAAAAGATGTCGATAGCGGAAAATATAGTG
oJOY90 CACTATATTTTCCGCTATCGACATCTTTTATATTTTCAATTTGGTCAGCTG
a Nucleotide sequences are 5' to 3'
b All plasmids express full length IFS without a signal sequence
c All proteins have a N-terminal 6xHis tag
G330D        
I374V
R289N
pJoy79 pSuki 5
pEK1
pJoy79 pSuki1
R289N       
G330D
pSuki1 pSuki2
R289K        
G330D        
I374V
pMAM 3.18
R289K        
G330D
pMAM 3.18
pMAM 3.18 pJoy79 G330D
pEK1 pEK2
pSuki4 R289K
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Table S3. Mutagenesis of the spn chromosomal locus
Straina Primerb Template Plasmidc SPN Alleled
oJOY85
oJOY86
oJOY85
oJOY86
oJOY85
oJOY86
oJOY89
oJOY90
oJOY85
oJOY86
oJOY93
oJOY94
oJOY156
oJOY157
oJOY160
oJOY161
oJOY156
oJOY157
oJOY160
oJOY161
oJOY156
oJOY157
oJOY160
oJOY161
a All strains are derivatives of JRS4.  
b Sequence listed in Table S2; oJOY156, oJOY157, oJOY160, oJOY161 are from Reference (9).
c All plasmids are derivatives of pJRS233 (14) using indicated primers to generate
     specified SPN mutations.
d All SPN alleles contain a C-terminal HA tag.   Suki2, Suki3, Suki4, and Suki5 contain 
     mutations to swap residues in SPNJ4 to  SPNH5.  SPNTM is SPNJ4 with the 
     following point mutations: R289K, G330D, I374V. SPNJ4-GG, SPNTM-GG, SPNH5-GG 
     indicates the addition of E389G and E391G mutations to the designated SPN allele
pJSuki3
Suki5 
pJoy109
pJSuki4Suki4
Suki6 pJoy109 pJoy109GG      SPNJ4-GG
pJSuki5 pJSuki2      SPNTM
pJRS233 pJoy110 SPNH5
Suki2
Joy110
Joy1
     SPNR289K
     SPNG330D
     SPNR289K/G330DpJSuki4 pJSuki5
pJoy109
pJRS233 pJoy109 SPNJ4
Suki3
Suki7 pJSuki2 pJSuki2GG      SPNTM-GG
     SPNH5-GGpJoy110GGpJoy110Suki8
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Table S4.  Mutagenesis of the ifs chromosomal locus
Plasmid/Usea Primer Sequenceb
pGCP867 GP972 TGTAAAACGACGGCCAGTCAAACGTGGTCAGGAAAAC
GP973 CACACAGGAAACAGCTATGACGCATATCATCCATTTTCTGACC
GP921 GAATGCAAGATAGGAAGTAACAATGTGAGGAGGATATATTTGAATACATACG
GP922 TGTCCTTCATACCTTTTTATCATTTTATAATTTTTTTAATCTGTTATTTAAATAGTTT
GP925 CGTATGTATTCAAATATATCCTCCTCACATTGTTACTTCCTATCTTGCATTC
GP926 AAACTATTTAAATAACAGATTAAAAAAATTATAAAATGATAAAAAGGTATGAAGGACA
pGCP773 GP879 TGTAAAACGACGGCCAGTTGATAGGTAGTGACAAAGAGTATCG
GP880 CACACAGGAAACAGCTATGACGCAAGCTTTCGTAATAATTTAATAAC
Analysis GP956 AGATCTATTACTGATAACGGTGCTAC
GP957 ATTCTAGTGGCATTTCTTTGG
GP200 CATCTGCAGTTACTTCCTATCTTGCATTCTATC
GP250 GAGTTGGTTTCATCATCCTG
a Primers were used as described in "Supplemental Experimental Procedures" for construction of ifs mutagenesis 
     plasmids pGCP867 and pGCP773 or for DNA sequence analysis of the SPN-SLO operon.  
a Nucleotide sequences are 5' to 3'
Table S5.  IFS mutations generated in S. pyogenes
Mutation (Plasmid)a SPN allele (activity)b Host (Parent)c Strain
ΔIFS:aad9 (pGCP867) SPNG330D (+) Suki4 (JRS4) GCP897
SPNR289K/G330D (+) Suki5 (JRS4) GCP898
SPNTM (-) Suki2 (JRS4) GCP896
SPNH5 (-) Joy110 (JRS4) GCP895
ΔSPN (-) SPN1 (JRS4) GCP894
SPNH5 (-) HSC5 GCP899
ΩIFS::ermC (pGCP773) SPNG330D (+) Suki4 (JRS4) GCP970
SPNR289K/G330D (+) Suki5 (JRS4) GCP971
SPNTM (-) Suki2 (JRS4) GCP968
SPNH5 (-) Joy110 (JRS4) GCP967
ΔSPN (-) SPN1 (JRS4) GCP966
SPNH5 (-) HSC5 GCP973
a ΔIFS::aad9 and ΩIFS::ermC are deletion and insertion mutations, respectively, 
     generated using pGCP867 (for ΔIFS::aad9) and pGCP773 (for ΩIFS::ermC).  
b NADase activity defined as described in Table 3 as fold change in kcat relative to SPNJ4. 
c Host strain is the recipient of the mutagenic plasmid and is derived from the parent 
     indicated in parentheses where appropriate.  The construction of all Host strains is 
     described in "Experimental Procedures" and listed in Table S3 except SPN1 and 
     HSC5 which have been described previously (11, 20).  
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CHAPTER III 
SPN activity modulates PARylation in epithelial cells influencing the release 
of the pro-inflammatory molecule HMGB-1 
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SUMMARY 
 
The interaction between virulence factors produced by a pathogen and the affected host 
cell can determine the success of the pathogen. S. pyogenes employs several virulence factors 
during an infection making it one of the most versatile bacterial pathogens. One strategy involves 
modulating host response through cytolysin-mediated translocation (CMT). CMT involves two 
toxins, Streptolysin O and the NADase SPN, that contribute to pathogenesis in multiple ways.   
  Recent data showed that both the NADase active and inactive SPN are cytotoxic to 
epithelial cells.  In this study, we find the NAD+ glycohydrolase SPN has a multifunctional role 
in terms of both the active version capable of cleaving NAD+ and the inactive version capable of 
eliciting a different cellular response.  We found S. pyogenes to be capable of activating the 
eukaryotic enzyme Poly-ADP-ribose Polymerase-1 in an SLO dependent manner however the 
activity of this regulatory enzyme was influenced by the NADase activity of SPN. Remarkably, 
the NADase active SPN was not only capable of cleaving NAD+ in the cells but also has the 
potential to cleave PAR polymers, the product of PARP-1 activation. This may contribute to the 
release of the pro-inflammatory protein HMGB-1 from the nucleus, which does not occur in the 
NADase inactive SPN. In contrast, the SPN deletion and the NADase inactive SPN allows for 
the accumulation of PAR through the sustained activation of PARP-1. Normally PARP activity 
is transient and fleeting, however in these infections PAR accumulation was cyclical and 
sustained. Massive accumulation of PAR is often associated with cellular signaling and AIF 
translocation leading to cell death. In these infections, we found that AIF is not translocated and 
another mode of cell death is likely occurring in these infections.  
Together, this data indicates one virulence factor, SPN, in conjunction with SLO can 
influence the cellular response to an infection through its enzymatic activity.  
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INTRODUCTION 
 
For an organism to become a successful pathogen it must overcome host barriers, which 
often is achieved through the production of virulence factors. For bacteria, these factors are often 
secreted proteins that affect various processes in the host creating a battlefield between host and 
pathogen. Evolution and divergence of these proteins also play an important role in the ability of 
the microorganism to continue causing disease. For example, Legionella pneumophila encodes 
over 200 effectors many of which are redundant but are thought to allow the bacteria to thrive in 
various hosts like amoebas and alveolar macrophages (20). This redundancy also allows for L. 
pneumophila to evade the host in multiple ways.  Understanding the diversity and the cellular 
consequences of these proteins can provide insight into how microbes can subvert the host and 
cause destruction.  
 S. pyogenes is a versatile and successful pathogen on many levels which can largely be 
attributed to the wide variety of virulence factors the bacterium can produce during the course of 
an infection. This Gram-positive organism can cause a range of diseases including superficial 
infections such as pharyngitis and cellulitis as well as more invasive infections like necrotizing 
fasciitis. These initial infections can also lead to post-infection sequelae such as rheumatic fever 
and acute glomerulonephritis.  This disease range also includes both inflammatory and non-
inflammatory responses making this bacterium especially unique. S. pyogenes is known to 
secrete dozens of proteins affecting multiple processes within the host cell, modulating them to 
allow for further pathogenesis. One such protein is the S. pyogenes NAD+ glycohydrolase 
(NADase) known as SPN (or NGA). During an infection, S. pyogenes can adhere to the host cell 
through adhesive protein-protein interactions such as M protein to the eukaryotic receptor CD46. 
Through a general secretory pathway, SPN and a cholesterol dependent cytolysin termed 
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Streptolysin O (SLO) are secreted into the extracellular milieu and the interaction between these 
two proteins on the host cell membrane allow for the translocation of SPN into the host cell 
cytosol (16). This mechanism has not been completely elucidated however we know that it is not 
dependent on the pore formation of SLO as non-pore forming mutants of SLO still allow for the 
translocation of SPN (17).  
Originally, this enzyme was identified for its ability to cleave NAD+ into nicotinamide 
and adenosine diphosphoribose (ADPr). Since then, multiple subtypes of SPN have been 
discovered including those that lack the characteristic NADase activity and have been shown to 
be evolving under positive selection. Analysis of a collection of diverse isolates revealed that all 
strains examined encoded the full-length gene for SPN and that both active and inactive 
haplotypes were equally prevalent (23).  Variations in the enzymatic domain of SPN are also 
associated with tissue tropism indicating a functional role for these variants. Those strains with a 
NADase inactive allele were strongly associated with the ability to cause strictly pharyngeal or 
skin infections termed specialists while those strains with the NADase active allele were 
associated with the ability to cause disease in both sites termed generalists. Also of note is the 
presence of the endogenous inhibitor of SPN (IFS) necessary for S. pyogenes to maintain the 
NADase active allele. This gene is located within the same operon along with SLO, the 
necessary component for translocation of SPN into the host. It is thought that IFS resides within 
the bacterial cytosol where it can bind to SPN in a one to one ratio preventing NAD+ from 
interacting with the enzymatic pocket of SPN. IFS is truncated in those strains with NADase 
inactive SPN however SLO and SPN despite loss of NADase activity remain completely intact 
further indicating there is a role for NADase inactive SPN (23). 
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  The differences between these two haplotypes of SPN can be categorized into four 
Bayesian clusters and further dissection shows the differences between the NADase active and 
inactive forms are simply 10 polymorphic amino acid residues. Upon close examination, the 
polymorphic residues responsible for the enzymatic activity were found to be three specific 
residues in the C-terminal end of the protein.  Previously, we found NADase active SPN 
contributed to cytotoxicity when compared to both the SPN deletion and SLO deletion in HaCat 
keratinocytes (16). We examined the NADase inactive SPN’s contribution to cytotoxicity in 
epithelial cells and found this version to be equally cytotoxic as the NADase active form thus 
uncoupling the NADase activity from cell death. Little is understood about the function of this 
inactive version though we believe there is role in virulence since S. pyogenes has maintained 
both variants in its full length despite the active loss of IFS. It is thought the active form could 
kill cells by cleaving NAD+ stores within the cell yet the presence of the inactive form indicates 
another function for SPN. The role of SPN in cell death is dependent on SLO as knockouts of 
SLO are less cytotoxic than the single deletion of SPN alone. Studies examining SLO pore 
formation and the translocation of SPN has shown that translocation is not dependent on pore 
formation as both prepore and monomer locked SLO mutants can perform CMT (17). In the case 
of prepore locked SLO, SPN is translocated to wild type levels in the cytosol while monomer 
locked translocates about half that amount. In both cases, cytotoxicity assays showed that cells 
are still viable and membranes were intact suggesting that pore formation in conjunction with 
SPN is necessary for cell death. 
 We know that SLO and SPN are both necessary for toxicity to cells but we do not fully 
understand how each of these factors contribute to cell signaling and subsequently cell death. It 
is thought the NADase active SPN cleaves β-NAD+ stores in the cell creating both metabolic 
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dysfunction and signaling molecules from the cleavage reaction. However this does not explain 
how the NADase inactive version may be contributing to toxicity. The road to cell death is 
complicated and is the result of several different reactions the cell undergoes that eventually lead 
to its demise.  Often these are stress responses made by the cell necessary to rapidly adapt to 
environmental cues.  
 One such reaction is the activation of the nuclear protein Poly-ADP-ribose polymerase 
(PARP).  This protein resides in the nucleus where it performs a broad spectrum of functions 
including DNA damage control, transcriptional activation, chromatin modulation, cell division, 
stress response and inflammation (8). PARP-1 is an enzyme that cleaves NAD+ to create ADP-
ribose chains on target proteins in a process called poly ADP-ribosylation or PARylation. These 
poly-ADP-ribose (PAR) polymers are produced and removed rapidly in response to various 
stimuli. A counteracting enzyme called Poly-ADP-ribose glycohydrolase or PARG works to 
removed these scaffolds. The over-activation of PARP has multiple consequences that can each 
lead to cell death through different mechanisms. One pathway includes the depletion of NAD+ 
and ATP which leads to cell death (1). A second mechanism involves an overabundance of PAR 
polymers created by PARP and released by PARG that become signaling molecules contributing 
to a different form of cell death called parthanatos. This mechanism involves the release of PAR 
from the nucleus into the cytosol where it can interact with the mitochondria leading to the 
release of the protein Apoptosis Inducing Factor (AIF) from the membrane and can then travel to 
the nucleus to cause DNA damage and eventually cell death (28, 29). A third pathway PARP 
contributes to involves programmed necrosis through cell signaling and the production of ROS 
(3, 26).  
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Aside from the negative effects of over-activation of PARP, it also plays role in the 
inflammatory response.  It is also involved in the transcriptional regulation if iNOS and NF-κB 
(11, 30). One inflammatory protein that is directly modulated by PARP is the High Mobility 
Group Box-1 protein (HMGB-1). Normally, this protein resides in the nucleus where it helps to 
maintain chromatin stability however this protein can be released during necrosis and contribute 
to inflammation through its interaction with TLR 2, TLR 4 and the RAGE receptor (21, 25). 
However, for HMGB-1 to be released from the chromatin it depends on PARP-1 for both 
chromatin modification and PARylation (6).    
Little is known about the stress response to S. pyogenes in the context of both NADase 
variants of SPN and SLO. Though both versions of SPN are equally cytotoxic, their enzymatic 
differences likely contribute to pathogenesis through different pathways. Virtually nothing is 
known about how the NADase inactive version of SPN contributes to pathogenesis as it was 
always thought to be inert. Here, we report that PARP is activated in an SLO dependent manner 
and PARylation is modulated the NADase activity of SPN. The presence of the NADase active 
SPN likely has a dual role in the lack of PARylation seen in these infections: one is cleavage of 
NAD+ and second is the cleavage of PAR. This modulation by the NADase of SPN produces a 
different inflammatory response as the NADase active version of SPN also induces the release of 
HMGB-1 while SPN deletion and inactive SPN variant do not.  These results are the first to 
elucidate differences between the NADase active and inactive SPN and may have implications in 
the unidentified role of NADase inactive SPN.  
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RESULTS 
 
PARP is induced during an infection in an SLO dependent manner 
 To try and determine how the cells response to SPN variants and SLO we looked at the 
activation of PARP after an infection with strains of S. pyogenes with NADase active SPN (SPN-
J4), SPN deletion (SPNΔ), NADase inactive SPN (SPN-H5) and SLO deletion (SLOΔ). PARP 
responds to many different stimuli leading to its activation, which involves the addition of poly-
ADP-ribose polymers to itself and other proteins.  A Western blot analysis of HeLa lysates 
showed that the 116 KDa enzyme PARP is activated during an infection with S. pyogenes in an 
SLO dependent manner (Figure 1). SPN-J4, ΔSPN, SPN-H5 all express SLO.  While a band for 
PARP is present in the SPN-J4 infection, it seems to be masked by auto-ribosylation in the SPN 
deletion and SPN-H5 infection as indicated by the PAR polymers (Figure 1B).  During 
apoptosis, cleavage of PARP by caspase 3 can occur as control mechanism to prevent the 
overactivation of PARP. This process cleaves the 116 kDa protein into an 89 kDa and 27 kDa 
protein rendering it inactive. Cleavage of PARP can be seen in staurosporine treated cells, a 
known inducer of PARP and caspase 3, however this cleavage is not seen in any of the infections 
(Figure 1A) (2).  However, despite the activation of PARP in the NADase active infection, the 
presence of poly ADP ribose (PAR or PARylation) is only present in the SPN knockout infection 
and the NADase inactive SPN infection (Figure 1B).  PARylation appears as high molecular 
weights between 116 kDa and 200 kDa. Neither a band for PARP nor a band for PARylation 
could be seen in the SLO deletion infection indicating that SLO is necessary for PARP activation 
and PARylation. 
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       B. 
       
 
 
Figure 1. PARP is activated in an SLO dependent manner. A. HeLa cells were infected for 5 
hours with the indicated strains. Lysates were assessed by Western blots for PARP and actin for 
a loading control. Control indicates uninfected control cells. St represents cells treated with 1 uM 
staurosporine. B. The activity of PARP was assessed in the same HeLa lysates by Western blot 
analysis for poly-ADP-ribose polymers (PAR). Blots are representative of at least 3 independent 
experiments.  
 
To understand the importance of SLO and the activation of PARP, purified SLO was 
used to determine if SLO alone is enough to induce PARylation. Purified SLO was obtained 
from an E. coli expression system and hemolytic activity was verified. Various concentrations of 
purified SLO were used to treat HeLa cells. This included low amounts from one nanogram to 
100 nanograms (ng) (Figure 2A) for 5 hours. High concentrations of SLO from 100 ng to 2000 
ng were also used to treat HeLa cells (Figure 2B). Concentrations higher than these cause 
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immediate sloughing of cells. None of these concentrations were capable of activating PARP 
thus indicating SLO is necessary but not sufficient for PARylation.  
 
 
 
A. 
 
 
 
            B.   
 
 
 
 
Figure 2. Purified SLO is not sufficient to induce PARylation. A. Westerns blot of HeLa 
lysates after treatment with different concentrations of purified SLO at low concentrations.  PAR 
was absent at the indicated molecular weights. A non-specific band at 70 kDa appears in lysates 
and is used to verify equal loading. B. Western blot analysis of HeLa cells treated with buffer, or 
100ng to 2000 ng of SLO. C indicates untreated control cells and B indicates cells treated with 
buffer alone. Amounts of SLO are designated above the blot in nanograms.  Blots are 
representative of at least 3 independent experiments.  
 
 
116 - 200 kDa 
116 - 200 kDa 
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To address whether pore formation specifically is necessary for PARylation, non-pore 
forming SLO locked mutants were used to infect HeLa cells and PARylation was assessed by 
Western blots. Neither the monomer locked nor the prepore locked SLO were able to PARylate 
indicating that SLO pore formation in the context of an infection is necessary for PARylation 
(Figure 4A). Furthermore, these strains maintained a NADase active SPN, which could be 
depleting NAD+. These locked SLO mutants are still capable of translocating SPN into the host 
cell cytosol. The prepore locked SLO, which can still form oligomers, can translocate SPN at 
wild-type levels while the monomer locked can translocate to 50% of wild-type levels (17). To 
address whether the lack of PARylation in the cells is due to NADase active SPN, an NADase 
inactive form of SPN was also derived by mutating the three amino acid residues responsible for 
the NADase activity as previously discovered (Chapter 2).  These mutations include R289K, 
G330D and I374V at the C-terminus of SPN. This set of mutations is referred to as the triple 
mutant or TM. The monomer locked (Mono-TM) and prepore locked (Prepore-TM) strains 
lacking NADase activity were then used to infect HeLa cells for 5 hours and lysates were 
subjected to Western blots analysis (Figure 3B). Again, PARylation was absent in these 
infections confirming that pore formation is necessary for PARylation to occur during an 
infection.  
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            A. 
 
 
 
 
Figure 3. Monomer and Prepore locked SLO cannot induce PARylation. A. A PAR Western 
blot analysis after a 5 hour infection using monomer and prepore locked SLO strains with 
NADase active SPN. Non-specific band at 70 kDa appears to verify presence of lysate. B. PAR 
western blot with control untreated cells (C), SPN deletion (ΔSPN), SPN-H5, Monomer locked 
SLO with NADase inactive SPN (Mono-TM) and Prepore locked SLO with NADase inactive 
SPN (Prepore-TM). Images are representative of at least 3 independent experiments.  
 
 One common mode of PARP-1 activation is DNA damage. To address whether or not 
extensive DNA damage is present in these infection we isolated DNA from HeLa cells after a 5 
infection. At this time point, high levels of PAR is present and the majority of cells are dying. 
Agarose gel analysis indicated that neither apoptotic nor extensive necrotic DNA was present at 
this time point(Figure 4A). To verify this we also analyzed HeLa lysates for phosphorylated 
H2AX (gamma H2AX). This histone is a checkpoint marker which is phosphorylated when 
double stranded DNA breaks occur (31).  The phosphorylated from of H2AX could be detected 
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in an SLO dependent manner however it was hard to detect in most replicate experiments. It is 
also possible this phosphorylation is occurring because cells are dying and are not necessarily the 
cause of PARP-1 activation or cell death. 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Extensive DNA damage is not present during an infection. A. A 2% agarose gel 
with 1 ug of DNA from HeLa cell after a 5 hour infection with the indicated strains. B. Western 
blot analysis of HeLa lysates after a 5 hour infection with the indicated strains for 
phosphorylated H2AX. Representative images are from at least 3 independent experiments.   
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PARP activation is cyclical and sustained 
The normal cycle of PAR formation and degradation is quick often within minutes of 
each other (26, 33).  The primary PAR glycohydrolase, PARG, quickly cleaves PAR with its 
endoglycohydrolysis and exoglycohydrolysis activity (8). This activity can be seen almost as 
quickly as synthesis of PAR.  Since PARP-1 has so many roles in cell regulation PAR 
production is thought to be tightly controlled and transient. To determine when PAR formation 
appeared we used western blot analysis after an infection with varying O.D.s of SPN-J4, ∆SPN, 
and SPN-H5 to determine if a minimum amount of bacteria is necessary to induce this response. 
(Figure 5A). The standard assays utilizes an O.D. of 0.5 and causes massive cell death by 5 hours 
however PARylation can be seen with an O.D. as little as 0.1 which is not sufficient to cause cell 
death at this time point. At 5hrs, all concentrations of the SPN-J4 strain lacked PARylation. 
However, infections with the SPN deletion and the NADase inactive SPN-H5, PAR levels varied 
with O.D. Part of this variation could be due PARylation occurring in a cyclical manner as seen 
in the time course. A time course at an O.D. of 0.5 was also utilized to determine if PAR 
formation is transient or sustained (Figure 5B). During these infections we can see PARylation 
as early as 30 minutes. It also appears that PARylation is cyclical since levels appear to decrease 
and increase again over time. This process is also sustained in the SPN deletion and the NADase 
inactive SPN-H5 strains. Remarkably, in the NADase active infection PARylation does occur 
early but eventually disappears. This is likely due to the NADase activity of SPN and is 
addressed later in this chapter.  
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Figure 5. PARylation is cyclical and is sustained for hours.  A. Western blot analysis of PAR 
after an infection with different O.D.s of indicated strains. The bracket denotes PAR on the blot. 
Actin Western blots are shown below each PAR Western blot. The O.D.s are indicated at the 
bottom of the panel B.  A Western blot analysis of PAR during a time course infecting HeLa 
cells with the same strains. Actin Western blots were used as a loading control. Representative 
blots of 2 independent experiments.  
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SPN modulates PARylation through its NADase activity 
 As seen in the PAR western blot in Figure 1B, the NADase active SPN lacks PARylation 
despite activating PARP. There were two hypotheses we tried to address. One of which includes 
the possibility that all available NAD+ has been depleted thus prohibiting PARP from using 
NAD+ to form PAR. This study is detailed later in the chapter. The second possibility is that SPN 
is actively cleaving these polymers. Studies involving a detailed analysis of SPN's enzymatic 
activity showed that SPN has an affinity to ADP ribose and does not have product inhibition with 
nicotinamide (13). To determine if the NADase activity directly affects PAR levels, SPN 
mutants with varying levels of NADase activity were used to infect HeLa cells.  Single and 
double polymorphic mutations that reduce the NADase activity were introduced into SPN 
through allelic replacement (Figure 6A). These mutants included single mutations R289K (SPN-
R289K) and G330D (SPN-G330D) as well as the combination of the two (SPN-RK/GD). The 
reduction in the ability to cleave NAD+ molecules per minute ranged from 1.58 fold lower up to 
30,000 fold lower (Figure 4A). In addition to these 3, the triple mutant lacking any NADase 
activity, SPN-TM, was also utilized.  Cytolysin-mediated translocation was verified after an 
infection with all variant SPN strains (Figure 6B).  We then tested whether the levels of PAR 
correlated with SPN's ability to cleave NAD+ (Figure 6C). As seen in the Western, the amount of 
PAR present in the lysates was dependent on the activity of SPN. The highest amounts of PAR 
were present in infections with the least active SPN variants. This indicates that SPN can 
modulate PAR levels through its NADase activity. 
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Figure 6. The NADase active SPN reduces PAR levels through its enzymatic activity.  
A. Single and double mutations were made in the S. pyogenes SPN-J4 chromosome to create 
mutants with reduced NADase activity. Fold differences in the rate of catalytic activity are 
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shown in reference to wild-type NADase active SPN. These values were determined in chapter 2 
All strains are HA at the C- terminus. B. Cytolysin-mediated translocation of SPN was assessed 
by HA antibody after an infection with strains indicated above the blot. C.  PAR levels were 
assessed after infecting HeLa cells with the indicated strains. The mean intensities of 3 
experiments are shown below with standard deviation.  
 
 
The reduced levels of PAR could also be due to the ability of SPN to cleave PAR 
polymers.  To test this hypothesis, we performed an assay by infecting HeLa cells with the two 
strains that induced high levels of PARylation: the SPN deletion and the NADase inactive SPN-
H5. Cells were then lysed and purified SPN was then added to these lysates and incubated at 
room temperature for 90 minutes. Western blots indicated only the NADase active form of SPN 
was able to reduce the amount of PAR in lysates post infection as compared to the NADase 
inactive SPN, buffer alone and those lysates saved without incubation (Figure 7).  Treatment of 
lysates with NADase active SPN reduced PAR up to 50% in both lysates compared to starting 
PAR levels indicating that SPN has a PARG-like activity. PAR levels with the cell play an 
important role in cell signaling and metabolic homeostasis. Within the cells, PAR levels are 
regulated by Poly-ADP-ribose glycohydrolase (PARG), which breaks down PAR using both an 
endoglycosidase and exoglycosidase mechanism. It is possible SPN is also acting as PARG-like 
enzyme thus reducing the PAR levels. This has implications in terms of both cell signaling and 
cell survival since PAR is a charged and bulky molecule.  The lack of PARylation in the 
NADase active SPN infection could also be due to the depletion of NAD+ by SPN.  
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Figure 7.  Purified NADase active SPN can reduce PAR in lysates post-infection. Lysates 
from SPN deletion and SPN-H5 infections were treated with buffer alone, 5 ug of purified SPNJ4 
or SPNH5 for 90 minutes at room temperature. The treatment of both types of lysates are 
indicated in the box below the column. Time 0 indicates an equivalent portion of lysate saved 
immediately following infection. Black columns represent SPN deletion lysates and gray 
columns represent NADase inactive SPN-H5 lysates. Actin was used as a loading control. 
Western blot is a representative of at least 3 independent experiments. Below the Western is the 
blot intensity and S.D. from those experiments.  
 
NAD+ and ATP levels are affected by S. pyogenes and SPN 
 Since active SPN and PARP can cleave NAD+, intracellular NAD+ levels were assessed 
in HeLa cells at three, five, and seven hours post infection. Infections with S. pyogenes showed 
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that NAD+ levels increase nearly two-fold at the five hour time point unless the NADase active 
SPN is present with the SPN-J4 infection. These levels remained at or near control uninfected 
levels at all time points (Figure 8A). A treatment with staurosporine, which activates PARP-1 
showed a gradual decrease in NAD+ levels over time.  Monomer and Prepore locked SLO with 
NADase active SPN (SPNJ4) also had a decrease in NAD+ levels while the NADase inactive SPN 
(SPNTM) with the SLO mutants showed an increase in NAD+ levels (Figure 8B). This spike in 
NAD+ levels is likely due to a stress response as this increase is not dependent on SLO or SPN. 
To verify this, RT-PCR was performed to verify if the transcription of any NAD+ biosynthesis 
genes were upregulated during an infection. These included 3 isoforms of NMNAT. NMNAT-1 
is present in the nucleus, NMNAT-2 in the mitochondria and NMNAT-3 in cytosol as well as 
NAMPT another prominent cytosolic enzyme (12). Analysis of these mRNAs indicated that 
NAMPT transcription is up regulated two-fold in all infections including the NADase active 
strain while NMNAT isoforms were all at control uninfected levels (Figure 8C). This was in 
contrast to treatment with staurosporine which had a dramatic increase in NMNAT-1, a nuclear 
enzyme, which has been shown previously to respond to an over activation of PARP-1.  
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Figure 8. NAD+ levels increase during an infection with S. pyogenes in an SLO independent 
manner. A.  Intracellular NAD+ levels were assessed at 3, 5, and 7 hours in HeLa cells after an 
infection with various strains or treatment with 1 uM of Staurosporine, a PARP-1 activator. B. 
NAD+ levels in monomer locked and prepore locked SLO mutants with either NADase active 
SPN (SPNJ4) or NADase inactive SPN (SPNTM) were assessed at 5 hours. C. Total RNA was 
isolated from HeLa cells after an infection and used for real time RT-PCR. Transcript levels for 
the NAD+ biosynthesis genes NMNAT-1, NMNAT-2. NMNAT-3, and NAMPt were assessed 
and compared to uninfected control. The dotted line represents no fold change from the control 
uninfected cells. Data shown is the mean and standard deviation of at least 3 independent 
experiments performed in triplicate.  
 
 
Since these cells were up-regulating NAD+ and ATP is necessary for the generation of 
NAD+, ATP levels were evaluated after a 5 hour infection where the greatest amounts of NAD+ 
were observed. ATP levels were reduced in all infections but were significantly reduced in the 
NADase active SPN infection (Figure 9). This suggests the cells are attempting to increase 
NAD+ levels and are failing due to the presence of the enzymatically active SPN. In this attempt, 
these cells are also depleting ATP making the active SPN much like an over-activated PARP 
where NAD+ and ATP are depleted causing metabolic cell death.  
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Figure 9. ATP levels are decreased in a NADase active infection.  HeLa cells were lysed and 
ATP levels were assessed after a 5 hour infection with indicated S. pyogenes strains. Asterisk 
indicates the ATP level is significantly lower than control levels. Student T-test (P <0.05). At 
least 3 independent experiments were performed and normalized to control.  
 
 
Not only can the over-activation of PARP deplete NAD+ stores and ATP but it also create 
an abundance of PAR which can interact with the mitochondria, release AIF from the 
mitochondrial membrane that can translocate to the nucleus, cause DNA damage and ultimately 
lead to cell death known as parthanatos (28). This type of cell death was assessed since SPN-J4 
and SPN-H5 infection leads to cytotoxicity. In the case of SPN-H5 there is an accumulation of 
PAR, which could lead to AIF translocation from the mitochondria to the nucleus. To evaluate 
whether parthanatos cell death was occurring, immune-fluorescence of AIF was carried out to 
visualize the localization of AIF. AIF appeared to localize with mitochondria and did not localize 
to the nucleus in any S. pyogenes infections indicating that AIF does not contribute to cell death 
in any of these infections (Figure 10).  
*	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Figure 10.  AIF is not translocated into the nucleus during an infection with S. pyogenes. 
Immunofluorescence of AIF was performed after a 5 hour infection with indicated strains. 
Nucleus is stained with DAPI (blue) and AIF in green.  Images are representative of at least 3 
experiments.  
 
 
HMGB-1 is released from the nucleus in NADase active infections. 
To try and assess what other effects PARylation has on the cell we evaluated cells for the 
release of High Mobility Group Box-1 (HMGB-1) after an infection. HMGB-1 is both a marker 
for necrosis and an inflammatory molecule. In healthy cells and during apoptosis, this protein 
resides in the nucleus tightly bound to chromatin. During necrosis, this protein can translocate 
out of the nucleus into the cytosol and ultimately be released into the extracellular milieu to 
interact with TLR2, 4, and RAGE receptors further contributing to inflammation through NF-kB 
activation (25). This molecule is also one of the few endogenous signals marking self-injury.   
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For HMGB-1 to be released from the chromatin, it first must be PARylated (6). PARylation 
occurs early on in all SLO infections but is sustained in the SPN deletion and the SPN-H5.  Since 
PARylation is modulated in our infections with the SPN variants we looked for the release of 
HMGB-1 from the nucleus into the cytosol. Infections with NADase active SPN had elevated 
levels of HMGB-1 in the cytosol as detected by immunofluorescence (Figure 11). In contrast this 
re-localization was not seen to the same levels in the SPN knockout, the NADase inactive SPN, 
nor the SLO knockout. The eventual release of this protein into the extracellular media was 
detectable by western blot in the NADase active infection (Data not shown) though not 
consistently. This was surprising as there is less PARylation in the NADase active infections 
however there is a cycle of PAR accumulation that occurs early infection  (Figure 5) and could 
be involved in this release of HMGB-1. Taken together, this data implicates the NADase activity 
of SPN modulates the inflammatory response through its effects on PARylation.    
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Figure 11. HMGB-1 is released from the nucleus during NADase inactive infections. A. 
Immunofluorescence of HMGB-1 in HeLa cells after a 4 hour infection. Nucleus in blue is 
stained with DAPI. HMGB-1 is in red.  The nucleus of cells that have a loss of HMGB-1 appears 
blue while co-localization appears magenta. B. Quantification of cells with HMGB-1 localized to 
cytosol. Cytoplasmic HMGB-1 is represented with the dark gray bar. Nuclear HMGB-1 is 
represented with the white bars. Student t-test indicates difference is extremely significant (P= 
0.0002). Three independent experiments were performed.  
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DISCUSSION 	  
The studies undertaken in this chapter give us insight into the impact of the SPN activity 
and SLO on the cell during an infection. The function of NADase active SPN in infection had 
always thought to be simply the depletion of NAD+ and ATP leading to cell death. However this 
enzymatic activity has a greater impact on the cell than previously thought.  PARP-1 is an 
important regulator in stress, transcriptional regulation and inflammation and SPN’s ability to 
influence PARP’s activity has several implications. The findings in this study not only show that 
NADase active SPN can cleave cellular stores of NAD+ but it also has the potential to cleave the 
product of PARP-1, PAR polymers. How SPN is capable of cleaving PAR is unclear but this is a 
novel finding for a NAD+-glycohydrolase. An in depth study of the NADase activity of SPN 
showed that it has little to no product inhibition. However, at high concentrations ADP ribose is 
capable of having en effect on SPN’s ability to cleave NAD+ (7). Perhaps this is an indication 
that SPN can interact with ADP ribose and is capable of cleaving polymers of ADP-ribose. 
Assays done prior to this study showed that SPN localizes to the cytosol (Supplemental Figure 1) 
therefore if SPN is cleaving PAR it is doing so in the cytosol. This may be another clue that PAR 
exits the nucleus to enter the cytosol during these infections. This has implications on cell 
signaling as well since PAR acting as a signaling molecule (27). In this case it seems to lead to a 
difference in downstream effects between these two infections like the release of HMGB-1.  
In the NADase active infection, the release of HMGB-1 from these cells indicates that 
enough PARylation has occurred to have some effect on the outcome of the cell and the 
inflammatory response. These cells are likely signaling to the neighboring cells to respond to this 
danger signal. The consequence of the differential PAR levels is likely greater than what we have 
explored in this chapter. PARylated HMGB-1has implications in the context of different cell 
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types since it has been found that the release of PARylated HMGB-1 inhibits efferocytosis, the 
process in which macrophages phagocytose apoptotic cells (5).  Perhaps, in vivo the release of 
HMGB-1 affects the recruitment and function of immune-modulating cells. It has been shown to 
aid in the recruitment and maturation of immune cells (4) (18). 
 In contrast to the NADase active SPN, the inactive SPN-H5 accumulates PAR readily as 
does the SPN deletion. PARP-1 responds to many types of stress including genotoxic, oxidative, 
thermal, metabolic and microbial (15). This response is SLO dependent and could be activated 
by the damage this cytolysin can cause to the membrane. Some evidence of this can be seen in 
the lack of PARylation seen with prepore and monomer locked SLO, which cannot induce 
PARylation but can interact with the host membrane. Though SLO is necessary to induce PARP 
activation it is not sufficient implying that more than factor is needed for this activation. Perhaps 
the pore cannot be healed as easily during an infection or the localization of the pore also plays a 
factor in this response.  It is also possible, the pores are allowing for passive diffusion of other 
bacterial products or simply allowing for an influx of ions like calcium, which may also 
contribute to a stress response.  Previously, we found that SLO pore formation in conjunction 
with SPN is necessary for cell death. The monomer locked and prepore locked SLO can 
translocate SPN however there is virtually no cell death in these infections (17). Pore formation 
could lead to an assortment of responses that are needed in conjunction with SPN’s activity to 
kill cells.  
Another interesting finding is that these cells have a considerable spike in intracellular 
NAD+ levels that can be attributed to NAMPt, a cytosolic enzyme. Though NAD+ increase was 
not SLO dependent it does seem to signify a stress response made by the cells to S. pyogenes. 
NAMPt was the only NAD+ biosynthesis gene up-regulated in response to S. pyogenes despite 
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PARP-1 activation in some infections. NAMPt is a cytosolic enzyme and responds to the levels 
of NAD+ in the cytosol, which could also indicate that SPN is acting in the cytosol. Previously it 
was found that NAMPt is more than just a biosynthetic enzyme. It was originally identified as a 
cytokine and has pro-inflammatory properties when released from the cell including the 
recruitment of neutrophils (24). Though this was not examined in these studies it would be 
interesting to know if the release of this enzyme from dying cells has any implications on the 
inflammatory response of the surrounding population of cells. In retrospect, the increase in 
NAD+ biosynthesis is not extraordinary, as these cells need this co-factor for many processes 
involved in metabolism and stress response.  One reason some NAD+ remains in the NADase 
active infection could be due to the compartmentalization of NAD+ within the cell. The pools of 
NAD+ within the cell reside in the mitochondria, cytosol and nucleus.  The highest concentration 
is in the mitochondria with no exchange between this pool and the cytosolic pool (14). However, 
there is crosstalk between the cytosolic and nuclear NAD+ that affect each other during NAD+ 
depletion.  PARP-1 and NADase active SPN can affect both of these pools but it is unlikely the 
mitochondrial pool is available to either of these enzymes.  
These studies indicate SLO is necessary to activate PARP-1 however we have not 
uncovered the exact mechanism for activation. Many studies involving PARP-1 activation utilize 
DNA damaging agents, however major DNA damage does not seem to be occurring in these 
infections. Aside from DNA damage, multiple factors have been uncovered which can activate 
PARP-1 including histone association, mono-ribosylation by other enzymes, acetylation and 
phosphorylation by Mitogen Activated Protein Kinases (MAPK) (8). The role of MAPK 
activation will be addressed in the next chapter. The fact that PARP-1 can be stimulated by many 
different factors which can lead to several different outcome highlights the importance of PARP-
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1 to cell integrity and stability. Though PARP-1 is not essential for life of the cell it still 
contributes to great number of processes within the cell with not only stress but also general 
transcriptional activation programs.  The roles for PARP-1 in the cell continue to be revealed 
with more extensive studies.  
 Other bacteria have been shown to activate PARP-1 however this list has only recently 
started to grow. One bacteria known to cause activation is Helicobacter pylori with the 
multifaceted VacA toxin (22) and a heat and protease sensitive factor found in the H. pylori 
culture filtrate (HPCF) (19). H. pylori was the first bacteria discovered to activate PARP-1 
directly and is a newly discovered strategy for host pathogen interactions. Although this is a new 
pathway to be discovered in terms of host pathogen interactions it is not new that PARP-1 is 
important in inflammatory responses as it is also involved in the activation of inflammatory 
responses including iNOS production, NF-κB activation and cytokine production (9-11, 30, 32).  
 The differential release of HMGB-1 from NADase active SPN infection gives us two 
clues to the differences between the variants of SPN. One is the indication necrosis is occurring 
in the NADase active infection but also that NADase activity of SPN may be dictating the 
inflammatory outcome of an infection.  The next chapter will address these possibilities 
including the role of the MAPK JNK, its role in cell signaling and the inflammatory response.  
The discoveries in this chapter are the first elucidating the differences between the NADase 
activities of SPN and how they might contribute to pathogenesis. Further studies are necessary to 
determine how each contributes to cell signaling and cell death. 
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Supplemental Figure 1.  A549 cells were infected with either SPN-J4 or ΔSPN. The T indicates 
total cell lysates after an infection with SPN-J4. Cytosol and nuclear fractions are indicated. 
Anti-GAPDH was used to verify purity of cytosolic fractions and anti-HDAC for nuclear 
fractions. Control indicates uninfected cells. Anti-HA was used to detect SPN. 
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MATERIALS AND METHODS 	  
Bacterial Strains and Media.  S. pyogenes utilized were of the M serotype 6 strain JRS4. This 
includes all derivatives utilized in this work. SPN-J4, SPN-H5, SPN-R289K, SPN-G330D,  
SPN-R289K/G330D and SPN-TM express SPN with a carboxy-terminal HA epitope tag. The 
construction of these strains are described in Chapter 2. Routine culture of S. pyogenes was 
conducted using Todd Hewitt Yeast Extract supplemented with 0.2% yeast extract.  
 
Infection of HeLa cells.  S. pyogenes strains were inoculated in ThyB and grown overnight at 
37˚C. The following day, strains were sub-cultured 1:10 and allowed to double twice. Cultures 
were then subjected to centrifugation, washed with phosphate saline buffer (PBS), and re-
suspended in tissue culture media. HeLa cells were then infected with an OD600 of 0.5 for 5 
hours unless otherwise specified.  
 
Isolation of DNA from HeLa cells. DNA was isolated from HeLa cells after an infection using 
Qiagen’s DNeasy Blood and Tissue kit. Briefly, cells were washed twice with D-PBS, scraped 
and centrifuged at 500 x g to collect cells. Cells were then treated per manufacturer’s protocol. 
One ug of DNA was dry-loaded into a 2% agarose gel for electrophoresis.  
 
Treatment of cells for Western Blot analysis. After infection, cells were scraped and 
centrifuged at 700xG for 10 min. Supernatants were discarded and cells were lysed with M-PER 
(Thermo scientific) by incubating in appropriate volumes based on number of cells at room 
temperature for ten minutes and then centrifuged for 10 min at max speed typically 20K x G.  
SDS-loading buffer (4x) was added, samples boiled and saved at 20°C until further analysis.  
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Antibodies.  Antibodies for PARP, H2AX-p, AIF and HMGB-1 were purchased from Cell 
Signaling Technologies. PAR antibody was purchased from BD biosciences and Actin mouse 
monoclonal and anti-HA was purchased from Sigma.  
 
Purification of SLO: WT SLO was expressed in E. coli by using the pTrc vector. The bacteria 
were grown in Luria Bertani medium containing 50 ug/ml Kanamycin and induced with 1mM 
IPTG. The cells were pelleted, resuspended in buffer (50 mM sodium phosphate buffer) 
incubated on ice with lysozyme (10 mg/mL) in the presence a protease inhibitor, sonicated and 
centrifuged for supernatants. Supernatants were used in purification by metal ion affinity 
chromatography using commercial matrix (Cat. No. 635503, Clontech). Protein concentrations 
were determined using a BCA assay (Pierce). Hemolytic activity was verified through a red 
blood cell lysis assay as described before (17).  
Purifcation of SPN. Expression and purification of the His6-tagged recombinant proteins was 
performed using a periplasm preparation as previously described (13). As a final step, the 
purified proteins were dialyzed at 4°C against a buffer consisting of 50 mM potassium phosphate 
and 100 mM sodium chloride. Purity of the 50 kDa proteins was routinely assessed by SDS-
PAGE and staining with Coomassie Brilliant Blue and protein concentrations determined using a 
BCA assay (Pierce) with a BSA standard. 
Intracellular NAD+ Quantification.  After the infection, HeLa cells were washed twice with D-
PBS and harvested according to manufacturer’s instructions (Biovision, NAD+/NADH 
Quantification kit). Briefly, cells were resuspended in NADH/NAD buffer and extracted by 
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freezing on dry ice and thawing at 37°C twice. Cells were then vortexed and centrifuged at 
maximum speed for 5 minutes. To remove any NAD+ consuming enzymes, samples were filtered 
through a 3 kd molecular weight cut off column. For total NAD+ detection, 50 microliters of the 
samples were placed into the 96 well in duplicates. To detect NADH, 200 microliters were 
aliquoted to tubes and heated at 60°C for 30 minutes to decompose NAD+. Samples were cooled 
and 50 microliters were aliquoted into the 96 well in duplicates. The NAD cycling enzyme mix 
(100 microliters) was added to each sample and NADH standards. Plates were incubated at room 
temperature for 5 minutes and 10 microliters of NADH developed was added. The cycling 
reaction proceeded for one hour at room temperature and plates were read 450nm on a Tecan 
M200 Pro Infinite plate reader. Calculations were based on the standard curve and normalized to 
control uninfected cells.  
 
ATP analysis. To determine ATP levels in HeLa cells, cells were seeded in a 96 well black clear 
flat bottom plate prior to the infection. Post infection cells were lysed by the addition of 50 
microliters of the mammalian cell lysis solution provided by the manufacturer (Perkin Elmer, 
ATPlite) directly to 100 microliters of media. The plate was placed on an orbital shaker at 700 
rpm for 5 minutes. Then 50 microliters of substrate solution containing luciferase and luciferin 
was added and plate was placed on an orbital shaker for 5 minutes. Plate was then dark adapted 
for ten minutes and luminescence was measured on the Tecan M200 Pro Infinite plate reader. 
ATP levels were calculated using a standard curve and then normalized to control uninfected 
levels.  
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Immunofluorescence. Two days prior to infection cells were seeded into 8 well chamber slides. 
Confluent cells were then infected for specified times and subsequently washed with PBS before 
fixing with 4% paraformaldehyde for 15 minutes at room temperature. Cells were washed with 
PBS twice and permeabilized with 0.5% saponin/PBS. After three PBS washes, cells were 
blocked with 1% BSA diluted into PBS-Tween 0.1% (PBS-T/BSA).  Primary antibodies were 
diluted into PBS-T/BSA 1:100 and incubated overnight at 4°C. Fluorescent secondary anti-rabbit 
antibodies, Alexa-fluor 594 or 488 (Invitrogen) 1:300, were incubated for two hours at room 
temperature in the dark. Following this incubation, cells were washed in PBS and the chamber 
removed. Ten microliters of Prolong Gold with DAPI was placed on each chamber square and a 
glass slide overlayed and set overnight. Cells were imaged using a Leica DMRE2 fluorescent 
microscope and images were obtained using Openlab software (Provision). 
 
RNA isolation and Real-Time PCR. Total cellular RNA was isolated from HeLa cells after the 
indicated infection or treatment using Qiagen RNeasy. cDNA was created by subjecting RNA to 
reverse transcription using iScript (BioRad) as per manufacturer’s instructions. Real-time PCR 
analysis of cDNA samples was carried out using iTaq SYBR green supermix (Bio-Rad) using 
primers listed in Table S1. Relative transcript levels were analyzed using the ∆∆Ct method with 
β-actin as a control standard. Data presented are the mean and standard error of the mean 
resulting from triplicate analysis of samples prepared from at least three independent 
experiments.  
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Table S1. RT- PCR primers used in this study. 
Gene Sequence 5' to 3' 
β-Actin Forward ACCTTCTACAATGAGCTGCG 
β-Actin Reverse CCTGGATAGCAACGTACATGG 
NAMPT Forward AAGCCGAGTTCAACATCCTC 
NAMPT Reverse GCTTGTGTTGGGTGGATATTG 
NMNAT-1 Forward TCACCAACATGCACCTCAG 
NMNAT-1 Reverse GGTGATAGGCAGGAATGAGTC 
NMNAT-2 Forward GTGATGCGGTATGAAGAGATTG 
NMNAT-2 Reverse CACAATCCCAAAGTCACCAAC 
NMNAT-3 Forward CTTGGGAGAGTGAGCAGG 
NMNAT-3 Reverse GGTGGAGATCTGAGCAGTTTG 
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CHAPTER IV 
 
SPN influences cellular signaling and death in epithelial cells 
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SUMMARY 	  
Virulence factors are often multifunctional and contribute to pathogenesis through 
different mechanisms. SPN and SLO are two factors that each has more than one role in the 
pathogenesis of S. pyogenes. SLO not only forms pores but also allows for the translocation of 
the NAD+- glycohydrolase SPN. This pore contributes to cell death along with SPN but is not 
necessary for the translocation of SPN.  SPN exists as two subtypes, one that exhibits this 
NADase activity and one that lacks this function. Despite this loss of enzymatic activity, S. 
pyogenes has continued to maintain SPN in its entirety and is associated with tissue tropism. 
Recent data indicates that each SPN can modulate different pathways with in epithelial cells after 
an infection. Both versions of SPN can cause cell death to equal degrees however little is known 
about the NADase inactive SPN or the mechanism of cell death. The active SPN can cleave 
NAD+, eventually causing the depletion of both NAD+ and ATP, likely creating a metabolic cell 
death. This does not explain how the NADase inactive SPN can contribute to cell death.  The 
studies described in this chapter suggest that SPN is capable of eliciting necrosis through two 
distinct mechanisms: metabolic and programmed.  S. pyogenes activates the MAPK JNK in an 
SLO dependent manner. This activation is sustained in all infections with pore forming SLO. 
Silencing JNK increased cell survival only in the NADase inactive SPN.  Silencing JNK also 
increased mitochondrial membrane potential in the infections involving SPN. Silencing PARP 
did not increase cell survival in any infection however it did increase mitochondrial potential. 
These differences also led to distinct inflammatory profiles for the NADase active and inactive 
SPN. The inactive SPN created more Il-8 and TNF alpha while the NADase active had little to 
no cytokine production. Taken together, this data indicates a role for each SPN during an 
infection and likely contributes to how the bacteria interact with the host cell.  
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INTRODUCTION 	  
Pathogenic bacteria must evolve to adapt to the host they live in often developing 
sophisticated means to create an advantage against the host. Multi-functional toxins allow 
bacteria to maximize these tools needed to colonize and infect their host.  S. pyogenes is a strict 
human pathogen thus making their pathogenic mechanisms specific to human cell biology.  
S. pyogenes produces two toxins, SPN and SLO that not only work together in causing 
cytotoxicity to human cells but also maintain multifunctional roles in their interactions with the 
host.  
The relationship between SPN and SLO continues to be unraveled.  Recent studies have 
revealed that pore formation is not necessary for the translocation of SPN however is it necessary 
for cell death. SPN is also multifunctional as 2 subtypes of this enzyme exist however little is 
known about how these variants interact with the host cell. The previous chapter highlighted the 
differences in the cascade following PARP activation after an infection with either the NADase 
active SPN or the NADase inactive SPN. An important partner in these findings is SLO.  We 
know that both are necessary to cause cell death as deletions of either reduce cytotoxicity and we 
now know that SLO pore formation is also necessary to induce responses that are subsequently 
modulated by SPN.  
 Questions remains regarding how the NADase inactive SPN contributes to cell death. 
Several studies have been done focused on SLO and various cell types.  One study showed that 
SLO plays an integral role in causing apoptosis in macrophages however these studies were done 
in the absence of either versions of SPN (33). Another study in macrophages showed S. pyogenes 
can induce pyroptosis in an SLO dependent manner (16). A study in keratinocytes reported 
apoptosis occurred in an SLO dependent manner however this study also ignored the role of SPN 
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completely (8). Macrophages and epithelial cells are programmed to deal with pathogens in 
distinct manners making the comparison between these two types of cells difficult. In light of 
this evidence in conjunction with recent data indicating the NADase inactive SPN is equally 
toxin, it has become important to study the role of both variants of SPN and SLO in epithelial 
cell death. In the context of an infection, these cells are often the first barrier the bacteria need to 
overcome, colonize and disseminate.  To date, there have been no studies on the possible role of 
NADase inactive variant and how either SPN in conjunction with SLO contributes to cell 
signaling and ultimately cell death.  
NADase active SPN has a high catalytic rate and is capable of cleaving NAD+ at fast 
rates. Studies done by others and work described in the prior chapter showed that NADase active 
SPN reduces NAD+ levels in the cell as well as ATP levels (23). It is likely these cells are 
undergoing metabolic catastrophe. However this does not provide an explanation for the possible 
mechanism of cell death in the NADase inactive infection. This SPN has no detectable NADase 
activity yet it is capable of killing cells to the same capacity as the NADase active SPN. Much 
remains to be understood about the function of the NADase inactive form of SPN, why it is 
maintained in clinical isolates and why it is associated with tissue tropism. We now know that 
these cells also have sustained PARP activation and high levels of PAR however we don’t know 
how this SPN contributes to cell signaling and eventually cell death. 
 Although cell death can be broadly categorized into a few groups recent in depth studies 
have shown these processes to be complicated within these classes. It was once thought that cells 
either die by apoptosis or necrosis but now we have a greater understanding and have since 
discovered other pathways including pyroptosis, programmed necrosis and even the combination 
of the two – pyronecrosis (40). Each pathway has a defining set of characteristics (11). For 
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example, apoptosis is a programmed non-inflammatory mode of death owing to the activation of 
various caspases depending on the stimulus. This cascade leads to quiet break down of cells into 
smaller apoptotic bodies that are eventually taken up by resident macrophages.  The release of 
caspase-1 is a defining characteristic of pyroptosis that leads to an inflammatory outcome 
involving the production of Il-1β and Il-8 and is largely found to be a mechanism of cell death in 
immune competent cells such as macrophages (12).  Finally, necrosis, an inflammatory outcome, 
and can be further characterized into two distinctive groups, programmed and un-programmed. 
Several different stimuli and signaling cascades can lead to this outcome. Recently, the term 
programmed cell death or necroptosis has been recently been elucidated since a specific set of 
proteins has been found to be involved in necrotic cell death via receptor signaling including 
RIP1 and TRAF (9).  These two proteins are involved in several different pathways involving 
several different partners and events that ultimately lead to necrosis.  
Dysfunction within the cell can lead to cell death however the path can involve several 
different factors. One of these includes the regulatory eukaryotic protein PARP-1, which can 
cleave NAD+ and form poly ADP ribose polymers (PAR) on itself and substrates. Normally, this 
protein oversees and recruits DNA repair proteins to sites of DNA damage (22). It also plays a 
role in transcriptional regulation, chromatin reorganization and DNA replication thus making the 
protein multifunctional. Over-activation of this protein can lead to death through the depletion of 
NAD+ and subsequently ATP in effort to restore NAD+ levels. The antagonizing enzyme Poly 
ADP-ribose glycohydrolase (PARG) degrades and releases these PAR polymers to bring the 
state back to normal. When abundant, these PAR polymers can be released from the nucleus and 
subsequently lead to several transduction pathway including inflammation and cell death.  
Previously, we found that this protein is activated in an SLO dependent manner and the 
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formation of PAR polymers is modulated by SPN’s NADase activity. Though we found that 
PARylation does not cause parthonatos, a form of cell death involving PAR induced AIF 
translocation, it does not rule out a role for PARP in cell signaling that can add to cell death. In 
fact, PARP-1 has been shown to be involved in RIP1 mediated necroptosis often involving the 
activation of the MAPK JNK (10, 41).  
  There are several activators of PARP, one of which includes the multifunctional MAPK 
JNK (15, 45). JNK has previously been shown to play a decisive role in cell fate. Depending on 
the presence of other signaling cascades as well as the stimulation of the TNF receptor, JNK 
activation can have multiple outcomes including cell survival, apoptosis or necrosis (24). This 
cascade also involves cross talk with the transcriptional activator NF-κB that can prevent JNK 
mediated cell death by conducting a different transcriptional activation program that leads to cell 
survival.  Several of these gene products involve inhibiting the production of reactive oxygen 
species (43) that can cause necrosis. Though JNK can activate PARP-1, PARP-1 activation can 
also precede of JNK activation (41).  The factors that decide the timing of these activation events 
are unclear.  
So far we have found PARP-1 activation is SLO dependent but have not determined the 
exact mechanism for this activation. Cytolysin dependent cytolysins (CDCs) including SLO have 
been shown to activate MAPKs, specifically p38. As mentioned above, MAPKs are involved in 
several signaling pathways including PARP-1 activation and cell death. Little is known about 
how the interplay of these pathways during an infection with S. pyogenes. Though SLO can 
activate MAPKs, nothing is known about the role of both SPN and SLO in regard to MAPK 
activation during an infection (18, 20, 27). With this information, we decided to study what roles 
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MAPKs and PARP-1 had with each other and if these two proteins participate in cell signaling 
and cell death during an infection with SLO and the NADase SPN variants.  
Our study shows that in epithelial cells SLO was necessary to activate JNK. Unlike other 
studies, the activation of p38 or ERK was not dependent on SLO but rather a general response to 
infection. The synergistic relationship between SPN and SLO leads to necrosis but the NADase 
activity of SPN dictates the inflammatory profile of these dying epithelial cells. NADase inactive 
SPN undergoes a JNK mediated cell death as silencing JNK leads to increased cell survival. 
Though silencing PARP did not increase cell survival, it did increase mitochondrial potential in 
the NADase inactive infection indicating PARP has a factor in the demise of these cells. These 
findings ultimately tell us that although both types of SPN cause necrosis, they each create 
divergent pathways that lead to two different types of necrosis: metabolic and programmed. This 
data has given us clues to why NADase inactive SPN is still under positive selection.  
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RESULTS 	  
SPN and SLO act synergistically to cause necrosis in epithelial cells 
  Previously, we showed SLO and SPN are both necessary to cause accelerated cell death 
as knocking out either protein reduced cytotoxicity in epithelial cells. Strains with wild-type SLO   
but lacking SPN are more cytotoxic than a SLO knockout strain however the kinetics of this are 
slower than then infecting with strains including both SLO and SPN.  This outcome is not 
dependent on the NADase activity of SPN since removing this function of SPN does not inhibit 
cell death indicating that SPN has a dual role in the pathogenesis of S. pyogenes.  To determine 
how epithelial cells are affected by SLO and its relationship with variants of SPN we performed 
several assays to determine what pathway of cell death these cells undergo. The enzymatic 
activity of SPN is likely influencing how these cells die, however the robust NADase activity 
cannot be the only contributing factor of SPN.   Assays were done to establish what mode of cell 
death is occurring during these infections including apoptosis, pyroptosis, and necrosis and to 
differentiate between these two naturally occurring variants of SPN. Prior to our study, pore 
formation in macrophages during an S. pyogenes infection was found to be an inducer of 
pyroptosis, a caspase-1 dependent process of cell death (12). Studies to determine whether 
pyroptosis occurred during an infection were concluded as negative since this mechanism could 
not be induced in HeLa cells suggesting this is not a characteristic mode of cell death in 
epithelial cells.  Other studies have suggested that SLO alone is necessary to cause apoptosis in 
keratinocytes (8). Though we know that SLO is vital to cell death, our assays indicate that 
apoptosis is not occurring in our infections. Hallmarks of apoptosis such as nuclear 
fragmentation, impermeable membranes and caspase activation were assessed after a 5 hour 
infection with the NADase active SPN-J4, the NADase inactive SPN-H5, SPN deletion (ΔSPN) 
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and SLO deletion (ΔSLO).  The presence of SPN increased cell permeability greatly compared to 
the SPN knockout infection (Figure 1A). Over 90% of cells are compromised in comparison to 
either the SPN deletion with about 10% permeability and SLO deletion that is almost completely 
impermeable. This was also compared to staurosporine treated cells, a known inducer of 
apoptosis. The membranes of these cells remained intact however their morphology showed a 
significant change. To get a more detailed look at the cells during an infection, we assessed the 
status of both the mitochondria and the nucleus after a 5 hour infection.  Both SPN variants also 
affected mitochondrial potential (Figure 1B). Using TMRE as an indicator for membrane 
potential, the presence of either SPN variant abolished the mitochondrial potential equally while 
the SPN deletion and the SLO deletion affected the mitochondria. DAPI staining of the nucleus 
showed that nuclear fragmentation does not occur during these infections in contrast to 
staurosporine treated cells, which undergo apoptosis causing DNA condensation (Figure 1C). 
Both variants of SPN had a greater effect on cells than with the SPN knockout that has SLO 
alone.  In order to verify apoptosis did not occur in these infections, the presence of activated 
caspase in HeLa lysates was assessed. Using a synthetic substrate of caspase 3, a converging 
player in both the intrinsic and extrinsic apoptotic pathway, we found none of the strains could 
stimulate activation of these caspases (Figure 1D).  To verify this, caspase 8 activation was 
examined as it can be activated by TNF alpha-receptor stimulation. Again, this was compared to 
staurosporine treatment of cells, which can activate caspase 3 and 8.  Taken all together, we can 
conclude that these cells are undergoing a mode of necrosis dependent on both SLO and SPN, 
eventually leading to compromised cell membranes and loss of mitochondrial potential. As 
recent literature indicates, this is not a simple pathway to death nor is it confined to one 
modality.  
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Figure 1. SPN induces necrosis A. HeLa cells were stained the membrane permeable dye 
Calcien AM (green) and the impermeable dye ethidium homodimer-2 (red) after a 5 hour 
infection with the indicated strains. Live cells are stained green and dead cells red. B. The 
mitochondrial dye TMRE (red) was used to assess mitochondrial membrane polarization. Images 
are overlaid with brightfield images of cells. Mitochondria with membrane potential retain this 
dye and appear red.  C. The nuclei of cells were stained with DAPI and images were taken at 
63x. Strains used are indicated above the image D.  Caspase 3 and Caspase 8 activation was 
assessed by the addition of caspase 3 and 8 synthetic substrates to lysates of infected HeLa cells 
and read at 405nm. Data presented is the mean and S.D. of 3 independent experiments.  
A.	  
B.	  
C..	  
D..	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S. pyogenes induces JNK activation in an SLO dependent manner 
 Previously, we found that PARP is activated in an SLO dependent manner. The most well 
studied activator of PARP is DNA damage however we found that was likely not the case.  
MAPK activation is also known to activate PARP and MAPK activation has been shown to 
occur in a CDC dependent manner.  Previously, pore forming toxins from a variety of gram-
positive bacteria including SLO were shown to activate p38 (18, 20, 27, 31).  To examine what 
role SPN and SLO may play with MAPK activation during in an infection we examined HeLa 
cells for the phosphorylated forms of p38, ERK and JNK after infection.  All three pathways 
were activated during an infection however only JNK was activated in a strictly SLO dependent 
manner (Figure 2). This was similar to our findings with PARP. Pore formation was necessary 
for this activation, as the prepore locked SLO could not activate JNK to the same levels as wild-
type SLO. The prepore locked SLO induced some JNK activation but at low levels and is likely 
due to membrane perturbation. Monomer locked SLO had near background levels of activated 
JNK compared to those infections with wild type SLO (Figure 2B) 
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Figure 2.  S. pyogenes activates several MAPKs however JNK activation is SLO pore 
dependent. A. Western blot analysis of HeLa lysates after a 5 hour infection with the indicated 
strains. Antibodies for the activated MAPKs were used as probes. Actin was used as a loading 
control. The C indicates uninfected control. St indicates treatment with 1 uM of staurosporine. B.  
Strains expressing monomer locked and prepore locked SLO in the JRS4 background were also 
assessed and compared to both the NADase active (SPN-J4) and inactive (SPN-H5) variant. Both 
express SLO capable of forming pores. Actin was used as loading control. Blots are 
representative of at least 3 independent experiments.  
 
 
The activation of JNK in healthy cells is often transient and it is thought the sustained 
activation of JNK leads to deadly cellular outcomes (34, 45). This activation has an important 
function in cell differentiation and stress response. The duration of activation of these kinases 
help determine the cell fate.  Differentiation tends to have transient JNK activation while 
sustained JNK activation can lead to cell death (19). To assess the time course of JNK activation 
in HeLa cells after an infection, we used Western blot analysis after several time points as well 
B. A. 
C      SPN   ΔSPN  SPN   ΔSLO  St 
          J4               H5 
 SPN    SPN   Mono  Prepore 
  J4        H5     SLO     SLO 
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as several optical densities of bacteria (OD600) to determine if there is a minimum amount of 
bacteria needed to activate this pathway.  Lower amounts of bacteria could stimulate JNK 
activation (Figure 3A). We also found that it took 3 hours to activate JNK at an OD of 0.5 
(Figure 3B). During these infections, activation of JNK was not transient and was sustained for 
long periods of time, a known marker for cell death. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  JNK activation is O.D. and time dependent. A. Western blot analysis of HeLa cells 
for phosphorylated JNK after a 5 hour infection using several indicated ODs. Strains used are 
indicated to the left of the blot. B. Phosphorylated JNK was also assessed after each indicated 
time point for SPN-J4 and SPN-H5. Actin was used as a loading control and blots are presented 
below each pJNK Western.  Westerns are representative of at least 2 independent experiments.  
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JNK and PARP contribute to mitochondrial depolarization  
As mentioned before the activation of JNK has multiple outcomes, which include NF-κB 
activation, apoptosis and necrosis. Interestingly, PARP can also contribute to these same 
outcomes through different pathways (3, 17, 39, 41).  In an effort to reveal the role of JNK in 
SPN mediated cell death, we utilized a siRNA targeted to JNK1 and PARP-1.  We also used a 
combination of a non-targeted siControl and siGLO, a fluorescent transfection efficiency 
indicator.  These controls were used at the same concentration as targeted siRNAs (100nM). 
siGLO indicated that almost 100% of cells were transfected (Data not shown).   As indicated in 
Figure 3, efficient knockdown was achieved in both JNK silenced cells (98% knockdown) and 
PARP-1 (undetectable PARylation activity) (Figure 4A).  Control, uninfected cells were 
compared to cells infected with the SPN-H5 strain to verify both PAR and JNK1 was not present 
as a SPN-J4 infection does not accumulate PAR. Cytolysin-mediated translocation of SPN was 
unaffected by these siRNAs (Figure 4B). The silencing of JNK1 also provided evidence that 
JNK1 does not activate PARP since this blot also indicates knockdown of JNK1 does not prevent 
PARylation. We could not assess through Western blot analysis whether the silencing of PARP 
affected JNK1 activation since all isoforms of JNK (1, 2, and 3) are phosphorylated at the same 
residues making it impossible to create specific antibodies for pJNK1.  
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Figure 4. Silencing PARP and JNK is efficient and does not inhibit CMT. A. Western blot 
analysis of total JNK1 and PAR in PARP silenced and JNK1 silenced cells. Control indicates 
uninfected cells. siControl are cells treated with a non-targeted siRNA and siGLO a transfection 
indicator to measure efficiency. Efficiency of knockdown was measured using Actin band 
intensities. B.  Western blot analysis of HeLa lysates using anti-HA to verify SPN is translocated 
into the host cell cytosol. Blots are representative of 2 independent experiments.  
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Both activated JNK and PAR polymers can be released from the nucleus, interact with 
the mitochondrial membrane and cause membrane depolarization (5, 37).  To evaluate the 
possibility that these molecules contribute to depolarization we stained the mitochondria to 
assess membrane potential after a 5 hour infection in JNK and PARP silenced cells. As with an 
infection with strains expressing either SPN, the siControl and GLO treated cells lost 
mitochondrial potential with both the NADase active and inactive SPN strains.  In contrast, 
mitochondrial membrane potential was protected in JNK silenced in the NADase inactive SPN-
H5 infection and to a lesser degree in the NADase active SPN-J4 infection (Figure 5). 
Interestingly, silencing PARP also increased mitochondrial polarization in the NADase inactive 
infection where PAR levels can be high however it had no effect in the NADase active infection. 
This is not surprising, as there is virtually no PAR in these infections at this time point and these 
cells are undergoing metabolic dysfunction through the loss of NAD+ and ATP. This data 
indicates both PAR polymers and activated JNK have an effect on the mitochondria during an 
infection with either SPN variants.  
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Figure 5. Mitochondrial polarization increases with JNK and PARP silencing. A.TMRE was 
used to stain mitochondria (red). Healthy, polarized mitochondria are able to retain this 
fluorescent dye. First panel are cells treated with siControl and siGlo, second panel are cells 
treated with siPARP and third panel is treated with siJNK 72 hours prior to infection to ensure 
efficient silencing as seen in Figure 3.  Indicated within the image is the strain used to infect 
HeLa cells. Control indicates uninfected cells. B. Quantification of healthy mitochondria capable 
of retaining TMRE. White bars represent siControl treated cells, gray bars represent siPARP 
treated cells, and black bars represent siJNK treated cells. Data represents 2 independent 
experiments.  
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JNK contributes to cytotoxicity in NADase inactive infections 
Since these molecules have an effect on the mitochondrial membrane and are known 
contributors to cell death we examined cytotoxicity in the PARP and JNK silenced cells after an 
infection.  The reduction of PARP did not increase cell survival in the SPN infections that 
typically cause massive cell death (Figure 6). Remarkably, silencing JNK did increase cell 
survival drastically in NADase inactive SPN infections with approximately 60% cell survival. 
Survival was increased to a smaller degree in the NADase active infection with about 25% cell 
survival. This data further solidifies that the NADase active SPN infection is undergoing 
metabolic catastrophe despite active JNK signaling and that silencing JNK can save some 
population of the cells. With the NADase inactive SPN infection, this data indicates that these 
cells are experiencing signaling mediated cell death with JNK1 as a major contributor to this 
outcome. Cells in the SPN deletion were unaffected by either PARP or JNK silencing (Data not 
shown).  
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Figure 6. Silencing JNK, but not PARP, increases cell survival. Cytotoxicity was assessed 
after a 5 hour infection using calcein-AM which stains live cells and ethidium homodimer-2 
which stains dead cells. Cells were treated with siRNA 72 hours prior to infection.   The ** 
indicates P < 0.01 and *** indicates P < 0.001 using a Student t-test. Data represents at least 3 
independent experiments.  
 
The NADase activity of SPN affects the downstream events of JNK and PAR 
JNK and PARP activation occurs when SLO is present and both of these proteins are well 
knock players in various signaling cascades. Based on our earlier studies, we could conclude that 
apoptosis is likely not occurring leaving NF-κB activation and programmed necrosis as possible 
outcomes of this activation. Prior reports showed SLO alone can activate the transcription of 
inflammatory cytokines however studies involving SPN have not been done (28). We then asked 
the question how does the NADase activity of SPN effect cell signaling. NADase active SPN 
depletes the cell of NAD+, ATP, and lacks PAR which can lead to different outcome from those 
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infections that have either a SPN knockout or NADase inactive SPN that have an abundance of 
these three metabolites. We examined the presence of inflammatory markers to determine what 
cytokine profile each of these infections present.  Previously, we found that High Mobility Group 
Box-1 (HMGB-1), a marker for necrosis and an inflammatory molecule, was released into the 
cytosol in NADase active SPN infections. In contrast this re-localization was not seen to the 
same levels in the SPN knockout, the NADase inactive SPN, nor the SLO knockout. During 
necrosis, this protein can be released into the extracellular milieu to interact with TLR2, 4, and 
RAGE receptors further contributing to inflammation through NF-κB activation (21, 25). This 
data implicates not only is necrosis occurring but also a different signaling cascade is likely 
occurring.  Since HMGB-1 can interact with several receptors that eventually lead to the 
activation of NF-κB.  Aside from HMGB-1, PARP1 also activates NF-κB adding to the list of 
proteins that could contribute to inflammation (44). In unstimulated cells, this subunit is found in 
the cytosol however once this pathway is activated, the NF-κB inhibitor degrades releasing the 
p65 subunit to allow for its translocation to the nucleus where it acts a transcriptional activator 
for several genes involved in immune response. We used immunofluorescence to detect the 
translocation of the NF-κB p65 subunit into the nucleus after an infection with each SPN variant, 
the SPN deletion and the SLO deletion.  Activated NF-κB could be visualized in the majority of 
cells infected with either the SPN knockout or the NADase inactive SPN and about half the cells 
in a NADase active infection (Figure 7). Though there was a reduction in the number of cells 
with translocated p65 subunit in the NADase active infection, it was not statistically significant.  
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Figure 7. NF-κB is activated in an SLO dependent manner. A.  Immunofluorescence for the 
translocation of the NF-κB p65 subunit in HeLa cells after a 5 hour infection. Nuclei are stained 
with DAPI (blue) and NF-κB p65 (red). B.  Quantification of 3 independent experiments. 
Nuclear translocation of the p65 subunit is represented by dark gray and cytosolic NF-κB p65 is 
represented by light gray.  
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To verify the significance of this translocation, RT-PCR was performed to detect the up-
regulation of cytokines that are regulated by NF-κB such as Il-6, IL-8 and TNF alpha. In 
correlation with activated NF-κB, transcripts of cytokines were also augmented in the SPN 
knockout infection and NADase inactive SPN. Compared to the uninfected control these 
transcripts were also elevated in the NADase active SPN infection however not to the same 
levels as the SPN knockout or NADase inactive SPN (Figure 8A). Specifically, Il-8 and TNF 
alpha were highly up regulated in those two infections compared to the NADase active SPN. To 
verify transcript levels correlated to levels of protein produced, ELISAs of supernatants after an 
infection were performed to detect the presence of cytokines (Figure 8B). In correlation with 
transcript data, IL-8 and TNF alpha cytokines were present in the supernatants of NADase 
inactive and SPN deletion infections at significantly higher levels than the uninfected control and 
NADase active infection. However, Il-6 protein levels did not differ between any of the infected 
or uninfected condition.  SPN deletion and NADase inactive SPN-H5 create more cytokines than 
the NADase active SPN-J4 implying these cells have a greater capacity to signal neighboring 
cells. Taken together, this cytokine profile indicates the enzymatic activity of SPN can modulate 
the downstream signaling events that lead to different inflammatory cascade. SLO plays an 
important role in this stimulation as the SLO knockout had reduced amounts of NF-κB 
translocation and thus cytokines compared to the other infections.  
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Figure 8. Differential cytokine production in NADase active and inactive SPN infections.  
A.  Cells were infected with indicated strains. Total RNA was isolated and used for quantitative 
RT-PCR for the indicated genes. Transcript levels were normalized to B-actin compared to 
control uninfected cells. Data indicates fold change B. Cytokine levels were assessed in culture 
supernatants after a 5 hour infection with indicated strains. Concentrations are in pictograms per 
milliliter. All experiments are the S.D. of 5 independent experiments.  
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DISCUSSION 
 
Ultimately, our findings suggest that SPN is necessary to modulate cell signaling that is 
initiated by SLO leading to necrosis. Though both variants of SPN lead to necrosis we found 
major differences between these two infections that affect the steps leading to cell death (Figure 
9). This is also the first report that SPN can cause necrosis via 2 mechanisms. This data gives 
insight into why a NADase inactive version of SPN is maintained and perhaps why every strain 
maintains SPN and SLO.  One virulence factor, SPN, dictates the inflammatory profile through 
the presence or absence of NADase activity thus signifying a role in the pathogenesis of S. 
pyogenes.   
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Figure 9. A Model of Necrosis Mediated by SPN and SLO. In an SLO dependent manner, 
PARP and JNK are activated leading to NF-κB activation. However, with the translocation of 
NADase active SPN, NAD+ and ATP are depleted leading to metabolic necrosis. The lack of 
PAR accumulation could be due to both the activity of SPN as well as lack of NAD+ substrate. 
These processes lead to HMGB-1 release. With the translocation of NADase inactive, PAR is 
allowed to accumulate and in conjunction with activated JNK lead to mitochondrial 
depolarization, cytokine release and eventually JNK signaling mediated cell death.  
 
The NADase active SPN has an obvious function – to cleave available NAD+ leading to 
several downstream effects. The first and foremost is the effect of depleting a co-factor that is 
important in several metabolic processes necessary. The cell then attempts to replenish NAD+ 
stores however this attempt is futile eventually depleting the cell of both NAD+ and ATP.  
Another downstream effect is that the cleavage of NAD+ creates two small molecule products 
could be involved in involved in intracellular signaling: ADP ribose and nicotinamide. 
Nicotinamide is an inhibitor of ADP-ribosylating proteins but is also the starting molecule 
needed to make NAD by NAMPt (2). Free ADP ribose can activate the TRPM2 channel 
allowing an influx of calcium that amplifies several signaling pathways including ERK and cell 
death (32, 42). The ADP-ribose formed from PARP-1 activity has been associated with TRPM2 
activation thus this could also be occurring during our infections (13). The implication that SPN 
could also be cleaving PAR polymers also adds to the list of differences between signaling 
molecules present in NADase active infections versus the inactive infection.  An in depth study 
involving any of these pathways would give us more insight into how the molecules modulated 
by SPN contribute to inflammation and death.  
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 The function of the NADase inactive SPN remained a complete mystery until these 
studies were undertaken. Prior to this study, we found the NADase inactive SPN was not toxic to 
yeast as it was readily expressed by S. cerevisiae (Figure S1). In contrast, plasmid with NADase 
active SPN could not be transformed to create viable yeast.  Although we have yet to determine 
the secondary target of SPN, we now know the inactive SPN contributes to cell death through 
JNK signaling and subsequently leads to greater cytokine production. SPN modulation of PARP 
induction is also of consequence.  A study by the Dawson group showed that the introduction of 
PAR polymers is toxic to cells at certain concentrations (1).  PAR polymers may also be 
associated with mitochondrial depolarization since silencing PARP increasing the mitochondrial 
potential during a NADase inactive infection. The interaction between these molecules and the 
mitochondria is not uncommon. Silencing PARP does not increase cell survival and it may even 
have the opposite effect than initially expected. As discussed in the previous chapter, PARP is a 
multifaceted enzyme and is involved in numerous processes including transcriptional control and 
genome integrity. Removing this protein from the cell’s arsenal has many effects aside from 
simply a loss of PAR polymers.  PARP-1 is also involved in cell division and spindle segregation 
(30) (7). Immunofluorescent staining of these cells indicate that both cell shape and nucleus are 
dysmorphic suggesting that loss of PARP has many different effects on the cell (Data not 
shown).  
   Initially, the activation of MAPKs was pursued to identify if these proteins were 
activating PARP-1.  We found that JNK1 was activated in an SLO dependent manner as was 
PARP-1 activation however Figure 3 shows us that silencing JNK1 has no effect on the 
activation of PARP-1 as PAR formation was abundant. PAR formation also occurs early and 
before JNK activation. In this case, it is possible PARP-1 and JNK1 are stimulated by two 
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independent pathways, eventually converging to contribute to cell death potentially through 
mitochondrial depolarization. One possible convergence point is the production of reactive 
oxygen species (43). Both the abundance of PAR and activated JNK1 has been shown in 
stimulate the mitochondria and produce ROS to the point of cell death (41, 45). The order of 
these events can dictate whether apoptosis or necrosis occurs (24, 26, 36).  JNK activation can 
stimulate ROS production and has been associated with TNF alpha induced necrosis (36) while 
JNK activation due to ROS production has been linked to apoptosis (26, 29).  While we know 
that JNK activation and necrosis occur in our infections, we have yet to elucidate the 
intermediates steps between these two factors. Programmed necrosis, termed necroptosis is a 
well-orchestrated form of necrosis and involves the serine/threonine kinase RIP1. This kinase is 
downstream of TNF receptor, TLRs, and PARP activation and is at the crossroads of several 
different signaling cascades that all have the potential to lead to necrosis (10). Necroptosis and 
necrosis share many morphological and biochemical features however the inhibition of RIP1 
cannot prevent un-programmed necrosis like necrosis founded on metabolic dysfunction (35).  It 
is striking that one virulence factor, SPN, has the ability to provoke both types of necrosis 
depending it on its NADase activity. How the NADase inactive SPN is capable of stimulating 
necrosis remains unknown but it is clear JNK plays a major role. A closer look at the role of 
RIP1 is needed to further validate the NADase inactive SPN promotes necroptosis.  
Phosphorylated JNK has been shown to directly interact with the mitochondria. Results 
from a study using anisomycin stressed HeLa cells suggested that cellular stress altered 
mitochondria, which caused JNK to translocate to the mitochondria creating a large 
amplification of ROS (4).  The mitochondrial binding partner for JNK is Sab and its been shown 
that interfering with this interaction can reduce ROS production (6).  In our studies we found that 
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silencing JNK increases mitochondrial potential in both the NADase inactive and to a lesse 
degree in the active infections despite the lack of cell survival in the NAD active infection. This 
data suggests that activated JNK interacts with the mitochondria and this interaction plays a 
larger role in cell death in the NADase inactive infections.  The production of ROS during these 
infections is the next step to understand cell signaling in these cells. S. pyogenes also produces an 
enzyme called lactate oxidase (lctO), which generates large amounts of hydrogen peroxide. It 
would be interesting to determine what role LctO plays in cell signaling and if this directly 
induces PARP-1, JNK1 and necrosis.  
 The outcome of JNK activation is dictated by the activation of NF-κB. JNK is capable of 
causing either apoptosis or necrosis however the transcriptional activator NF-κB can suppress 
these outcomes through the activation of several genes that work to counteract different aspects 
of TNF receptor activation including ROS production.  In our infections, we see that SPN 
deletion and the NADase inactive SPN-H5 have similar effects on the cell: PAR formation, NF-
κB activation and cytokine production. However the SPN deletion infections are not as cytotoxic 
to these cells in this time frame. Perhaps the differences between these infection at these early 
times points can be attributed to the pro-survival genes up-regulated by NF-κB. NF-κB 
activation can lead to cell survival through the production of several genes that combat JNK 
activation as well as the production pro-inflammatory cytokines to recruit immune to cells to 
control infection.  It is possible during the SPN deletion infection some SLO pores are healed 
allowing for prolonged cell survival.  In fact the resealing of SLO pores has been accompanied 
by NF-κB activation (38). The differences contributing to cell death in the NADase inactive SPN 
infection versus the SPN deletion is subject to further study.  
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 These studies have given us further understanding into how these SPN variants affect the 
cell during an infection and why they are both maintained in clinical isolates. The differences in 
inflammatory profiles may indicate why two variants of this NADase activity exist. The NADase 
active SPN is associated with generalist strains while the NADase inactive SPN is associated 
with specialists and perhaps this inflammatory response influences the strains ability to cause 
infections at different sites.  Conceivably, dissemination and versatility of the bacteria would be 
altered if a greater inflammatory response occurs bringing in immune cells to police the 
infection. While we have discovered differences in cellular response between these two types of 
SPN the list of experiments to fully elucidate the mechanism of cell death continues to grow. 
There is much to be discovered in to terms of how these two function in the cell, how it 
contributes to the pathogenesis of S. pyogenes and how SPN factors into tissue tropism. 	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Figure S1. NADase inactive SPN is not toxic to S. cerevisiae. A.Western blot analysis of 
whole cell extracts prepared from S. cerevisiae yeast expressing SPN that lacks NAD+-
glycohydrolase activity or the plasmid vector alone (vector). SPN is expressed from the pYES2 
vector under a galactose-inducible promoter. Expression was assessed at the times indicated (in 
hours) following growth in the presence of 2% glucose (Glc) or 2% galactose (Gal). B. Growth 
of the indicated strains in the presence of 2% galactose. Viable yeast transformants with 
plasmids expressing NADase active SPN were unobtainable.  Adapted from (14). 
A. 
B.  
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MATERIALS AND METHODS 	  
Bacterial Strains and Media.  S. pyogenes utilized were of the M serotype 6 strain JRS4 and 
derivatives including SPN1 (spnΔ), SLO1 (sloΔ) SPN-J4, and SPN-H5 which expresses SPN 
with a carboxy-terminal HA epitope tag. The construction of these strains are detailed in chapter 
2. Routine culture of S. pyogenes was conducted using Todd Hewitt Yeast Extract supplemented 
with 0.2% yeast extract.  
 
Infection of HeLa cells.  S. pyogenes strains were inoculated in ThyB and grown overnight at 
37˚C. The following day, strains were sub-cultured 1:10 and allowed to double twice. Cultures 
were then subjected to centrifugation, washed with phosphate saline buffer (PBS), and 
resuspended in tissue culture media. HeLa cells were then infected with an OD600 of 0.5 for 5 
hours unless otherwise specified.  
 
Cell lysis for Western Blot analysis. After infection, cells were scraped and centrifuged at 700 
x g for 10 minutes to pellet intact cells. Supernatants were discarded and cells were lysed with 
M-PER (Thermo scientific) by incubating in appropriate volumes at room temperature for ten 
minutes and then centrifuged for 10 minutes at max speed typically 20K x g.  SDS-loading 
buffer (4x) was added, samples boiled and saved at 20°C until further analysis.  
 
Antibodies. Antibodies for P-JNK, P-ERK,P- p38, JNK1, NF-κB p65 were purchased from Cell 
Signaling Technologies. PAR antibody was purchased from BD biosciences. Actin AC-40 was 
used as a loading control. Anti-hemagglutinin antibody was purchased from Sigma.  
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Caspase Activation Assay. Caspase activation was assessed using a colorimetric substrate assay 
(Alexis ALX-850-228).  HeLa cells were infected for 5 hours and lysed according to 
manufacturer's instructions. Briefly, 2x reaction buffer with DTT was then added to lysed cells. 
Five microliters of the 4 mM pNA conjugated substrates (200 uM final) for Caspase 3 and 8 
were added and incubated for 1 hour at 37˚C. Samples were read in a 96 well plate read (Tecan 
M200 Infinite Pro) at 405 nm. 
 
Cell Permeability and cytotoxicity Assay. After an infection, HeLa cell membrane integrity 
was assessed by the cell’s ability to exclude the membrane impermeable fluorescent dye 
ethidium homodimer-1 by using a commercial probe (Live/Dead, Invitrogen) as described 
previously.  Live cells were stained with the green fluorescent calcein-AM probe. 
 
Fluorescent staining. For nuclear staining, Prolong Gold with DAPI was used from Invitrogen. 
For mitochondrial membrane potential detection,	  tetramethylrhodamine ethyl ester (TMRE) was 
diluted into D-PBS for a final concentration of 150 nM. For a positive mitochondrial membrane 
potential, carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was used at 50 uM for 1 hour 
prior to staining. After an infection, cells were washed with D-PBS once and TMRE was 
incubated with the cells for 20 minutes at 37C.  After this time, the stain was removed and 
replaced with D-PBS. Cells were imaged using a Leica DMRE2 fluorescent microscope and 
images were obtained using Openlab software (Provision). 
 
Immunofluorescence. Two days prior to infection cells were seeded into 8 well chamber slides. 
Confluent cells were then infected for specified times and subsequently washed with PBS before 
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fixing with 4% paraformaldehyde for 15 minutes at room temperature. Cells were washed with 
PBS twice and permeabilized with 0.5% saponin/PBS. After three PBS washes, cells were 
blocked with 1% BSA diluted into PBS-Tween 0.1% (PBS-T/BSA).  Primary antibodies were 
diluted into 0.1% PBS-T/1%BSA 1:100 and incubated overnight at 4°C. Fluorescent secondary 
anti-rabbit antibodies, Alexa-fluor 594 or 488 (Invitrogen) 1:300, were incubated for two hours 
at room temperature in the dark. Following this incubation, cells were washed in PBS and the 
chamber removed. Ten microliters of Prolong Gold with DAPI was placed on each chamber 
square and a glass slide overlayed and set overnight. Cells were imaged using a Leica DMRE2 
fluorescent microscope and images were obtained using Openlab software (Provision). 
 
siRNA silencing of JNK and PARP. siRNAs knockdown was performed with 100 nM of  
siRNA duplexes targeting JNK1 and PARP-1 purchased from Cell Signaling. siControl and 
siGlo were purchased from Dharmacon and used at a total concentration of 100nm. Lipid and 
siRNA complexes were made per manufacturer’s instructions using Lipofectamine 2000 and 
OPTI-MEM I from Invitrogen. Using a reverse transfection method, these complexes were added 
to trypsinized cells in each well in complete media.  Cells and complexes were incubated for at 
least 24 hours up to 48 hours before media was removed and fresh complete media added. Cells 
were infected 72 hours after treatment with siRNAs.  
 
RNA isolation and Real-Time PCR. Total cellular RNA was isolated from HeLa cells after the 
indicated infection or treatment using Qiagen RNeasy. cDNA was created by subjecting RNA to 
reverse transcription using iScript (BioRad) as per manufacturer’s instructions. Real-time PCR 
analysis of cDNA samples was carried out using iTaq SYBR green supermix (Bio-Rad) using 
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primers listed in Table S1.  C1000 Thermal cycler with CFX96 Real Time System was used for 
analysis. Relative transcript levels were analyzed using the ∆∆Ct method with β-actin as a 
control standard.  Data presented are the mean and standard error of the mean resulting from 
triplicate analysis of samples prepared from at least three independent experiments 
 
ELISA. For Il-6 (44 HS600B) and Il-8 (44D8000C) Quantikine ELISA kits were purchased 
from R and D Systems. TNF alpha Ready-Set-Go ELISA (Cat. No. 88-7346-22) was purchased 
from eBiosciences. The manufacturer’s protocol was followed. After a 5 hour infection, cell 
supernatants were collected, subjected to centrifugation at 6000 x g rpm for 10 minutes, and 
stored at -80°C for analysis. The data presented represent the mean and the standard deviation of 
5 experiments.  
     
Table S1. RT-PCR Primer Table 
    
 
 
 	  	  
 
 
 
 
 
 
 
 
 
Gene Sequence(5'(to(3'
β/Actin(Forward ACCTTCTACAATGAGCTGCG
β/Actin(Reverse CCTGGATAGCAACGTACATGG
NAMPT(Forward AAGCCGAGTTCAACATCCTC
NAMPT(Reverse GCTTGTGTTGGGTGGATATTG
NMNAT/1(Forward TCACCAACATGCACCTCAG
NMNAT/1(Reverse GGTGATAGGCAGGAATGAGTC
NMNAT/2(Forward GTGATGCGGTATGAAGAGATTG
NMNAT/2(Reverse CACAATCCCAAAGTCACCAAC
NMNAT/3(Forward CTTGGGAGAGTGAGCAGG
NMNAT/3(Reverse GGTGGAGATCTGAGCAGTTTG
Gene Sequence 5' to 3'
β-Actin Forward ACCTTCTACAATGAGCTGCG
β-Actin Reverse CCTGGATAGCAACGTACATGG
Il-6 Forward CCACTCACCTCTTCAGAACG
Il-6 Reverse CATCTTTGGAAGGTTCAGGTTG
Il-8 Forward ATACTCTCAAACCTTTCCACCCC
Il-8 Reverse TCTGCACCCAGTTTTCCTTG
TNFalpha Forward ACTTTGGAGTGATCGGCC
TNFalpha Reverse GCTTGAGGGTTTGCTACAAC
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CONCLUSIONS 
 
  Pathogens maintain tools to either subvert the host or establish a commensal-like 
relationship.  In the case of S. pyogenes, the secretion of several virulence factors throughout the 
infection allows the bacteria to be versatile. The ability to infect or colonize several sites within 
the host as well as cause both inflammatory and non-inflammatory infections make this bacteria 
especially unique. One process S. pyogenes utilizes against the host is cytolysin-mediated 
translocation (CMT). Studies within the Caparon lab continue to unravel how the process occurs 
and reveal more functions for the proteins involved.  We know the process involves an intimate 
interaction between SLO and SPN at the host membrane allowing for the translocation of SPN 
into the host cell cytosol. Previously, we found the process of CMT is not pore dependent 
indicating that SLO has two distinct roles: to form pores and to translocate SPN (4). This finding 
also revealed that pore formation in conjunction with SPN is necessary for cell death since SPN 
in the cell alone did not kill cells.  
 In addition to SLO’s multiple functions, SPN also appears to have dual roles. Analysis of 
over a hundred strains indicated a NADase negative version of SPN that was equally prevalent 
associated with tissue tropism (7). In these strains, IFS was truncated while SPN was preserved 
despite the loss of this enzymatic activity suggesting that SPN was under positive selection. Prior 
to these studies, the NADase inactive SPN was thought to be inert and unable to contribute to 
pathogenesis. Analysis of the polymorphic residues between these two alleles of SPN showed 
that only 9 amino acids differ between these subtypes and was under positive selection. This 
work determined the three polymorphic residues at the C-terminus contributed to the NADase 
activity. Each change in the amino acid residue contributed to enzymatic activity to varying 
degree. One polymorphic residue that drastically reduces enzymatic activity, G330D, was once 
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used as a marker for NADase inactive SPN.  Interestingly, two alleles of the NADase inactive 
SPN was found one of which only had two polymorphic residues from the active SPN-J4 
including G330D residue. Closer examination of the NADase activity of this SPN showed that it 
actually had minimal activity, over 60,000 fold slower than the active SPN. This allele was the 
only intermediate version of SPN found suggesting that near complete loss of NADase activity 
has selective advantage that eventually leads to the loss of IFS. The loss of IFS is likely to be 
secondary to the loss of NADase activity. IFS was found to be essential to maintain only the 
fully active SPN-J4 and SPN-R289K, the next most active version of SPN. This indicates that 
less activity than SPN-R289K is tolerable.  However, these combinations of SPN and loss of IFS 
are not seen in clinical isolates suggesting there is no advantage to maintaining these 
intermediate types of SPN for S. pyogenes.  
 Most remarkable was that both the NADase active and inactive SPN expressed from the 
same strain were capable of killing epithelial cells to the same degree. This gave us a definitive 
clue that there is another function to SPN aside from the NADase activity. This led to more in 
depth studies regarding cellular responses and cell death. A closer look at how SPN’s activity 
affects the cell showed the NADase activity modulates several processes creating divergent cell 
signaling pathways ultimately leading to necrosis. Even more interesting is the method by which 
SPN causes necrosis, as there seems to be two distinct mechanisms depending on the NADase 
activity of SPN. While the NADase activity of SPN can cleave NAD+ eventually causing the 
depletion of ATP killing the cell metabolically, the NADase inactive SPN undergoes a JNK 
mediated cell death. Even aside from cell death, these two versions of SPN create different stress 
responses including the modulation PARP activation product PAR that may eventually 
contribute to cell death. The active SPN depletes NAD+ but also seems to cleave PAR polymers 
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a known signaling molecule (3) while these two molecules are abundant in the inactive SPN 
infection. PARylation seems to have some part in decreasing mitochondrial function since the 
silencing of PAR increases mitochondrial potential in the NADase inactive infection.   
The results of these differences led to distinct inflammatory responses with these two 
SPN variants. While all infections with wild-type SLO led to the activation of JNK1 and PARP-
1, SPN was capable of modulating these events causing the release of different pro-inflammatory 
molecules. The SPN deletion infection and the NADase inactive SPN had many of the same 
characteristics during an infection: PARylation, JNK activation, lack of HMGB-1 release, 
increase in NAD+ levels and cytokine release. However, the SPN deletion infection does not kill 
cells within the same time frame. The exact mechanism of how NADase inactive SPN is capable 
of causing JNK mediated cell death is unknown. Determining this may give us insight into how 
cells infected with the SPN deletion strain survive for a longer period of time. 
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FUTURE DIRECTIONS 	  
Several questions remain concerning how SPN causes toxicity on both the host side as 
well as the non-NADase function of SPN. While we know of some key components to cell death 
many experiments remain to determine what other factors play a role in this outcome. As 
mentioned before RIP1 is a key mediator of several pathways that involve MAPKs, NF-κB 
activation, apoptosis, and necrosis. These signaling cascades involve many different aspects of 
cellular biology including the production of acid sphingomyelinase, phospholipases, ROS 
generation, proteases, and mitochondrial dysfunction that can all contribute to programmed 
necrosis.  There is not just one described pathway and it is likely more than one of these 
mechanisms is occurring during necroptosis. Data thus far points to necroptosis as the 
mechanism of cell death for the NADase inactive SPN but more experiments are needed to 
confirm this hypothesis. 
 
 
 
 
 
 
 
 
 
Figure 1. A diagram depicting RIP1 as the central player of several pathways that lead to 
necrotic cell death.  The stimulation of multiple receptors converges on RIP1, which is central 
[196,203–205]. mRNA released from necrotic cells is a potent
host-derived activator of TLR3, inducing the activation of NF-
κB and the expression of TNFα, IRF-1 and IL-1 receptor
associated kinase-M (IRAK-M) in DCs [206]. This results in
DC activation with concomitant secretion of IFNα.
However, the activation of macrophages by “danger signals”
present in the extracellular environment due to spillage of
necrotic debris remains controversial. We and others showed
that exposure of macrophages to necrotic cells is not sufficient
to trigger macrophage activation and the concomitant induction
of proinflammatory cytokines [19,20]. Rather, necrotic cells
trigger the enhanced secretion of proinflammatory cytokines
from independently activated macrophages [20].
It is also conceivable that the active release of proin-
flammatory cytokines from necrotic cells due to the
activation of NF-κB and MAPKs [21] (see below) may be
crucial for an inflammatory response. In contrast, binding of
apoptotic cells to macrophages immediately leads to inhibi-
tion of proinflammatory cytokine gene transcription [188],
underscoring the innate immune discrimination of apoptotic
cells. These observations are in agreement with the inhibition
of translation during apoptosis, but not during necrosis
[123,207,208]. Apoptotic signalling thus negatively regulates
the release of inflammatory cytokines by down-regulating the
transcription and translation machineries.
5.2. Activation of proinflammatory pathways can be uncoupled
from the activation of necrotic cell death
The role of MAPKs in cell death signalling pathways is not
yet clear [209]. It was suggested that transient activation of
p38 MAPK or JNK can protect from cytotoxicity [210],
whereas their prolonged activation may induce apoptotic death
[211]. Sustained activation of both p38 MAPK and JNK is
observed following treatment of MEF cells with the DNA-
alkylating agent N-methyl-N′-nitro-N-nitrosoguanidine
(MNNG). However, only JNK contributes to the MNNG-
induced necrosis, as demonstrated by the survival of JNK1−/−
and JNK2−/− MEFs, but not p38−/− MEFs, following MNNG
treatment [61]. During TNFα-, TNFα/zVAD-fmk and IFNβ/
dsRNA-induced necrosis, early and transient activation of p38
MAPK and JNK could be seen. However, this was not the case
for FasL/zVAD-fmk-induced necrosis [21], indicating that
these pathways are not absolutely required. TNFα also induced
a secondary prolonged activation of p38 MAPK, which was
absent for JNK. Prolonged activation of JNK has been
attributed to accumulation of ROS. The ROS hamper the
function of phosphatases that are important for inactivating
MKK, which is involved in the phosphorylation of JNK
[212,213]. NF-κB counteracts this process [212,213]. This
may explain why a secondary peak of JNK activation does not
occur during necrotic death of L929 cells, which is associated
with high levels of NF-κB [21]. Inhibition of NF-κB activation
blocked IL-6 production but did not block TNFα-induced
necrosis, instead it sensitized for it. This observation supports
the finding that NF-κB may act to inhibit ROS accumulation
[212,213] and thus may have anti-necrotic properties [31].
Necrotic cell death was not affected by inhibition of p38
MAPK [21]. These data clearly show that activation of
proinflammatory pathways could be uncoupled from activation
of necrotic cell death following certain stimuli.
6. Occurrence of necrosis in physiological and
pathophysiological conditions
Necrotic cell death has long been described as a consequence
of physico-chemical stress, such as freeze–thawing or severe
hyperthermia [14], and thus as accidental and uncontrolled
[214]. However, necrotic cell death has emerged as an important
and physiologically relevant signalling process that seems to
contribute to ovulation [215], immune defence [216,217], death
of chondrocytes controlling the longitudinal growth of bones
[218], and cellular turnover in the intestine [219]. In addition,
removal of interdigital cells in the paws of Apaf 1−/− mice
during embryogenesis occurs by a caspase-independent necro-
tic-like process [220]. Noteworthy, the occurrence of necrosis in
these in vivo models was mostly defined morphologically.
Several reports also illustrate the occurrence of necrotic cell
death during viral and bacterial infections. HIV-1 was shown to
kill CD4+ T lymphocytes by necrosis [221–223] and Shigella
and Salmonella can induce necrotic cell death of infected
neutrophils and macrophages, respectively [224,225]. Caspase-
independent death is also strongly induced in ischemia–
reperfusion injury after cerebral ischemia and myocardial
infarction, ROS-induced injury, and glutamate excitotoxicity
Fig. 6. Necrotic cell death is the result of interplay between several signalling
cascades. RIP1 appears to be a central initiator of necrosis. RIP1 has been
implicated in the generation of ceramide upon TNFα-induced necrosis, and its
kinase activity was shown to be crucial for Fas-, TNF-R1- and TRAIL-R-
induced necrosis. Necrotically dying cells can actively release inflammatory
cytokines due to the activation of NF-κB and MAPKs, a process in which RIP1
is also implicated. ROS and Ca2+ are main players during the propagation and
execution phases of necrotic cell death. ROS can be produced in the cytosol
when the glycolytic rate is high, but mitochondria are the main producers of
ROS. An increase in cytosolic Ca2+ concentrations can increase oxidative stress
by activating NOS, or by affecting mitochondrial respiration. On the other hand,
Ca2+ contributes to the activation of proteases, cPLA2 or lipoxygenases, which
in turn disrupt organelle and cell integrity by damaging protein structures or lipid
bilayers. (See text for details).
1380 N. Festjens et al. / Biochimica et Biophysica Acta 1757 (2006) 1371–1387
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to numerous aspects of cellular function that contribute to death.  Dying cells can release 
cytokines due to the activation of NF-κB and MAPKS that can occur downstream of RIP1. The 
mitochondria, ROS generation and Ca2+ influx can also take part in multiple pathways.  Figure is 
adapted from (1). 
 
Finding another component of the cell death signaling pathway would validate our 
current results. Preliminary validation of JNK silencing yielded varying results with Chapter 4. A 
pool of siRNAs targeted to JNK1 from another company (Dharmacon) silenced JNK1 efficiently 
however it did not result in a survival phenotype. To try and determine if the single siRNAs were 
as efficient as the pool, we also tested each one individually and pooled. Using the single 
siRNAs from this pool alone at the same concentration (100 nM) did not give an efficient 
knockdown of JNK1 and gave variable results with cytotoxicity. It is important to note this pool 
is based on an algorithm and not validated by Dharmacon. The siRNA used in Chapter 4 is a 
single sequence from a different company and was efficient at 100 nM. One follow up method 
would be to utilize another siRNA to validate the findings in Chapter 4.  The most direct method 
would involve infection of JNK1-/- cells and verify the death phenotype through the re-
introduction of JNK expression on a plasmid. In any case, determining what other factors aside 
from JNK1 contribute to death would give us more insight into the role NADase inactive SPN 
has during an infection and help determine if programmed necrosis is occurring. 
Experiments to determine if ROS generation contributes to cell death is the next logical 
step since this process involves both JNK activation and the mitochondria (6, 11).  Determining 
the sequence of events between which occurs first would also be helpful to understand cellular 
signaling. ROS can activate JNK but the activation of JNK can stimulate the mitochondria to 
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generate ROS. Both events can be inhibited by NF-κB activation (5, 9).  Oxidative stress could 
be fueling the sustained JNK activation in these infections that ultimately contributes to 
programmed necrosis. Along the same lines, understanding the role of calcium would also be 
informative since it is likely SLO pore formation allows for an influx of this ion into the host cell 
and likely contributes to cell signaling. In addition to SLO pore formation, the cleavage of PAR 
and NAD+ leads to increase in ADP ribose, which can also cause an influx of calcium the TRPM 
channel (2).  Prior attempts to study calcium have proven difficult as removing calcium from the 
media during an infection causes S. pyogenes to halt growth. Perhaps understanding the role of 
Ca+2 by studying the influx through the SLO pores and the TRPM channel would give us more 
insight. 
The most central factor in programmed necrosis is the kinase RIP1. The silencing of 
RIP1 could provide some clues however there is a risk that NF-κB activation would also be 
affected, removing the cells chance at survival. One method to try and determine what genes are 
important in necrosis mediated by either types of SPN would be to perform a siRNA screen 
using a cytotoxicity assay as a read out.  This would be comprehensive and yield many more 
targets than simply silencing one predicted partner at a time.  Another benefit of the screen will 
be the potential identification of targets that are important for cytolysin-mediated translocation of 
SPN.  
Another remaining question from these studies involves identifying the factor that 
activates PARP-1. We originally pursued MAPKs and focused on JNK since both the activation 
of PARP and JNK were SLO dependent. However, we saw that the silencing of JNK1 did not 
prevent PARylation from occurring. ERK1/2 can also activate PARP and though it is not 
activated in an SLO dependent manner it cannot be ruled out since we do see activation with an 
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infection with S. pyogenes. Another possibility for the activation of PARP is the entry of 
bacterial products through the SLO pore. This pore is large and can easily allow for the entry of 
proteins and ions (10). As mentioned in Chapter 2, S. pyogenes makes large amounts of 
hydrogen peroxide, a known stimulator of PARP and cell death. Though the cause of PARP-1 
activation remains elusive, much remains to be understood with signaling pathways in the cell. 
 Yet another comprehensive approach would be to analyze the phospho-proteome of the 
cell during infections with SPN and SLO variants. This would contribute to understanding the 
role of these toxins in cell signaling during an infection. This technique would be more 
informative than a microarray since many proteins are post-translationally modified and their 
involvement would not be identified in a microarray.  For example, PARP-1 can be modified in 
several different ways and its activity is not transcriptionally regulated. This is also true of the 
MAPKs. Using the stable-isotope labeling by amino acids in cell culture or SILAC method 
would give an overview of how an infection with different SPN modulates the cell. This method 
was employed in the analysis with Salmonella and the SopB effector deletion (8). This method 
allowed the authors to measure 9500 phosphorylation events and they discovered that over half 
of the Salmonella induced events were due to the T3SS effector SopB. In our system, SILAC 
could be employed with various conditions including infections with SPN deletion (which still 
forms SLO pores), locked SLO and the two NADase variants.  This would give us an overview 
of many processes that occur in the cell in response to S. pyogenes and specifically to CMT.  
 One of the most obvious unanswered questions from this thesis is in regard to the second 
function of SPN. It is surprising that both SPN are equally cytotoxic when it would seem like the 
NADase active SPN would have two functions. Between these alleles, there are only typically 9-
10 residues that are polymorphic. While we know that 3 of these at the C-terminal are 
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responsible for the NADase activity and are generally conserved to either the NADase active or 
inactive, the other six residues are found in both subtypes making these residues unlikely 
contributors to the second function. However, this same study found a total of 23 residues under 
positive selection (7) and perhaps these 13 polymorphic resides that do not segregate to either 
NADase clusters are involved in the second function. Unfortunately for the current system we 
use, a high throughput screen for SPN mutagenesis is not feasible. SPN and SLO must be 
expressed from the chromosome of S. pyogenes to get secreted into the host cytosol. After 
creating each mutant plasmid, the native allele would have to be replaced to create mutant 
strains, then screened, and used to infect cells for a cytotoxicity screen. One method could 
involve targeting portions of SPN for mutagenesis aside from the terminus involved in NADase 
activity and verifying these mutants in a cytotoxicity screen.  Perhaps one starting point would be 
to mutate these 13 residues.  Though this is not a quick method it would be a start to determine 
what portion of SPN is responsible for cytotoxicity. The other side of this question is 
understanding what SPN targeting in the host cell. This also remains an unanswered question 
since thus far pull-down assays with eukaryotic lysates have given negative results.  Perhaps this 
interaction is transient and cross-linking would be necessary. The previous assays were 
performed with HeLa lysates and purified protein and perhaps this should be done after an 
infection where all the necessary components for the interaction would be present.  
Finally, determining a role for the NADase inactive SPN in vivo would complement these 
studies. The strain utilized, JRS4, is not virulent in mice however studies involving 
asymptomatic carriage does not require virulence. SPN and SLO are produced during the 
exponential phase of bacterial growth and shuts during the stationary phase. During stationary 
phase, another virulence factor SpeB is made abundantly. This factor can cleave both bacterial 
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factors like SLO as well as host proteins. Perhaps SPN and SLO contribute to the initial 
colonization of S. pyogenes that is later regulated by SpeB production.  Not all strains make 
SpeB however and perhaps these strains utilize different sets of tools to subvert the host. In 
either case, it would be interesting to determine exactly how SPN and SLO contribute to an 
infection in a host. These studies revealed that the inflammatory profiles of the NADase variants 
differ and this must play a more significant role in the context of other cells especially immune 
cells.  
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